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Abstract 
 
Linear cationic antimicrobial peptides are a diverse family of membrane-active peptides, linked by 
physiochemical characteristics that induce membrane disruptive effects, including the formation of 
membrane spanning pores. They offer potential development as novel antimicrobial therapeutics, due to 
their high potency and evidenced resistance to bacterial drug resistance mechanisms. Complex lipid-
peptide interactions are believed to govern their pore formation activity, and their mechanism of 
selectivity between prokaryotic and eukaryotic cells. Some peptides (e.g. magainin) show a high degree 
of selectivity for bacterial cells, while some (e.g. melittin) target bacterial and mammalian cells 
indiscriminately. Within this report, high-throughput microfluidics is used to investigate the pore 
formation capabilities, of selective and non-selective antimicrobial peptides, within biomimetic vesicles 
representing both bacterial and mammalian cells. Microfluidics offers precise control over the exposure 
of lipid membranes to antimicrobial peptides, allowing the pore-formation process to be elucidated in 
greater detail than conventional techniques. A new model for their mechanism of action is proposed, 
where lipid topography and lipid-peptide steric interactions exert influence over both pore formation and 
the selectivity mechanism. The model has potential to inform the rational drug design of future 
antimicrobial agents, using linear cationic antimicrobial peptides as a template. 
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1. Introduction 
1.1 Bacterial drug-resistance 
Drug-resistant bacterial strains are one of the emerging challenges to developed world medicine in 
the 21st century[1]; in many countries, drug-resistant bacterial infections are the leading cause of death 
from infectious agents. The CDC statistics for 2013 show that there were over 2 million new cases of 
bacterial infections that failed to respond to conventional treatments, with over 23,000 deaths.[2] The 
CDC figures for the same year for HIV infection show less than 50,000 new incidences of the disease, 
with over 15,000 deaths attributed to AIDS. Coming less than 50 years after the famous quote often 
attributed to the United States Surgeon General (1965 – 1969) Dr. William H. Stewart – “It is time to 
close the book on infectious diseases, and declare the war against pestilence won.”, these statistics are 
an alarming indication that progress made in treating infectious pathogens in the preceding decades 
may be becoming undone.  
Driven by societal and technological progress, deaths from infectious agents have been greatly 
reduced in the last few centuries. Better nutrition and housing lead to decreased host susceptibility, 
while curtailing disease transmission though improved housing and safer food and water, led to huge 
reductions in the prevalence of death due to infectious agents.[1] From the discovery of bacteria as 
infectious agents in the late 19th century, it was almost fifty years before the production of the first 
effective treatment for a bacterial infection; the sulphonamides introduced in 1937.[3] Bacterial acquired 
drug-resistance operates via a quick timeline, with the average time for appearance of drug resistant 
strains being less than two years.[4][5] For example, the first sulphonamide-resistant strain was reported 
in the late 1930’s.[3]  
Widespread introduction of antimicrobial agents in the mid-twentieth century was a major factor in 
the decline of deaths from infectious diseases,[1] and is rightly credited as one of the greatest advances 
of modern medicine. Thanks to the upsurge in drug-resistance within bacterial populations, this trend 
looks to be reversing, as the prevalence of drug-resistant strains increases world-wide.[1][2] Infection with 
a drug-resistant bacterial strain greatly reduces treatment efficacy, and increases the risk of 
complications and mortality rates,[6] and the ongoing pandemic of drug-resistant bacteria in first-world 
hospitals threatens a return to the preantibiotic era. 
 
1.1.1 Antibiotics 
Antibiotics are chemotherapeutic agents that are selectively toxic for bacterial cells over host cells, 
and can be classed as either bactericidal, where the action of the antibiotic kills the target bacteria, or 
bacteriostatic, where the antibiotic inhibits the growth of the pathogen. 
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1.1.2. Causes of bacterial drug-resistance 
There are three major factors underpinning the development drug-resistant bacterial strains, 
namely the increased selective pressure from over prescription of antimicrobials;[1][7][8] the decreased 
production of novel antibiotic agents[1] and the huge population and high mutation rate of bacteria.[5] 
The rampant prescription of antibiotics is perhaps the leading cause of drug-resistance, in the sixty years 
since their introduction, many millions of tons of antibiotics have entered circulation.[3][6] and worldwide 
between 100 – 200 thousand tons of antibiotic materials are produced annually.[9] A large proportion of 
antibiotics are consumed by the meat and dairy industries, up to 70% of total production in the US.[10] 
Agricultural animals are therefore an important reservoir for the emergence of drug-resistant 
pathogens. The current paradigm of producing new or modified antibiotics to combat the emergence of 
bacterial strains resistant to older antibiotics is failing, due to the low drug-pipeline delivery of novel 
antimicrobial agents.[1][11][12] Medical history demonstrates the adaptive nature of bacterial populations, 
with perhaps the most pertinent the story of methicillin, the first designer “anti-resistance” antibiotic. 
From the introduction of methicillin, it was less than three years before widespread emergence of 
resistant bacteria emerged.[3] The huge populations and high mutation rates of bacteria mean that it is a 
question of when, not if, the necessary mutations will occur that confer drug-resistance. 
 
1.2. Drug targets for conventional antibiotics 
There are three proven targets for the main antimicrobial therapeutics; bacterial cell wall synthesis, 
bacterial protein synthesis and bacterial DNA replication and repair. The following sections provide a 
brief outline of these drug targets, giving specific examples in each case for antimicrobial agents 
affecting these targets. 
 
1.2.1. Bacterial cell-wall synthesis 
The bacterial cell is a sophisticated and complex multi-layered structure, contributing significant 
mechanical strength and resistance to osmotic shock.[5][13] Bacteria can be divided into classes, gram-
positive, gram-negative and gram-variable, based on their retention of the gram stain.[13][14] Common 
within all classes is the presence of peptidoglycan, a highly covalently interlinked mesh of peptides and 
glycans.[5][13][15] Peptidoglycan forms a rigid exoskeleton, providing much of the mechanical strength and 
resistance to osmolysis present in bacteria, with the degree of cross-linking within the network directly 
correlated to the structural integrity of the bacteria.[5][15] Cross-linking in the peptidoglycan layer is 
modulated by two enzyme families; transpeptidases, linking adjacent peptide strands with amide 
bridges and transglycosylases, lengthening the peptideoglycan strands.[5][15] Disruption of bacterial cell-
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wall synthesis is an established antibiotic target,[11] and several classes of antibiotics exploit the 
biochemistry of peptidoglycan synthesis to exert their bactericidal or bacteriostatic effects.  
The ß-lactam antibiotic family, which includes penicillins and cephalosporins, contain a four carbon 
lactam ring. The sterically strained ring is the antibiotic warhead, targeting both transpeptidase and 
transglycosylase enzymes, acting as a psuedosubstrate peptidoglycan biosynthesis intermediate.[5] The 
antibiotic attacks the enzyme, opening the lactam ring to covalently bind to the enzymes active site. The 
enzyme is unable to hydrolyse this bond, and the active site is blocked, removing the enzyme from 
participation in peptidoglycan biosynthesis reactions.[15] The antibiotic vancomycin also targets 
peptidoglycan synthesis, but unlike the ß-lactam family of antibiotics, it sequesters the peptide 
substrate rather than a direct attack on the enzyme.[16] Both penicillins and vancomycin prevent the 
crosslinking of peptidoglycan chains, reducing its mechanical strength, and leaving the bacteria 
vulnerable to osmotically-induced lysis.[5][15] 
 
1.2.2. Bacterial protein synthesis 
Bacterial protein synthesis is an attractive drug target, as prokaryotic RNA and ribosomal machinery 
are distinct enough from the host cells protein synthesis machinery, that bacterial protein synthesis can 
be targeted without interrupting eukaryotic cellular protein synthesis.[5] The complex biosynthesis 
pathways offer many interdiction points for antibiotic chemotherapy, during the initiation, elongation 
and termination phases of protein synthesis, creating a multifaceted target for new antibiotics.[15] 
Tetracyclines were the first antibiotics to be described as broad-spectrum antimicrobial agents, i.e. 
possessing activity against a wide range of gram-positive and gram-negative bacteria. They exert their 
antimicrobial activity through blocking access of aminoacyl-tRNAs to the 30S bacterial ribosomal 
subunit, preventing the synthesis of new proteins.[15][17] Aminoglycosides also bind to prokaryotic 
ribosomal subunit 30S, but are unique amongst antibiotics targeted at protein synthesis pathways, in 
that they are bactericidal rather than bacteriostatic. 
 
1.2.3. Bacterial DNA replication and repair 
The fluoroquinolones are a synthetic class of antimicrobial agents, specifically designed to target 
members of the DNA gyrase enzymes (specifically topoisomerases II and IV), which are responsible for 
uncoiling double-stranded bacterial DNA after replication.[15] Drug-bound topoisomerases and cleaved 
DNA form a stable complex, arresting the DNA replication process at the cleavage stage, leading to 
immediate bacteriostasis and eventual cell death. 
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1.3. Mechanisms of acquired bacterial drug-resistance 
The mechanism of action of antimicrobial agents, and the development of acquired resistance are 
intimately linked,[18] for a complete discussion of the emergence of drug-resistance in bacterial 
populations, it is necessary to explore the molecular mechanisms underpinning the acquisition of 
resistance.  Bacterial populations utilise a number of mechanisms to achieve resistance to antibiotics. To 
illustrate this point different mechanisms of resistance will be provided, for each of the drug targets 
mentioned in the previous section. Note however, that process of acquiring drug-resistance is extremely 
adaptable, and multiple mechanisms of resistance for each antibiotic are typically reported,[5][12][17] with 
>20,000 potential resistance genes reported in bacteria.[3] 
 
1.3.1. Destruction of antibiotic warhead 
The classic example of bacterial resistance is the acquisition of penicillin-resistance, via a single 
nucleotide polymorphism that creates ß-lactamase enzymes, which target the ß-lactam ring of 
penicillin.[19][20] Over 1,000 resistance related lactamase enzymes have been identified,[3] acting via 
hydrolysis of the sterically strained lactam ring that characterises penicillin-derived antibiotics.[19][20] 
Bacterial strains have been isolated that are resistant to the latest generation of penicillin derived 
antibiotics, through the expression of the New Delhi metallo-ß-lactamase enzyme.[21] 
 
1.3.2. Drug efflux pumps 
Effective treatment requires administered antibiotics to reach their target site, and accumulate to 
therapeutic levels. For example, tetracycline antibiotics which impair bacterial protein synthesis must 
first penetrate the outer membrane (in gram-negative bacteria), cross the periplasmic space and 
permeate the inner cytoplasmic membrane before reaching their target – the bacterial ribosome. Both 
gram-negative and gram-positive bacteria have been observed to overproduce membrane proteins that 
act as drug efflux pumps, transporting antibiotics back against the desirable concentration 
gradient.[5][22][23] The acquisition of drug-resistance via the production of drug efflux pumps is simplified, 
due to strains of bacteria producing natural antibiotic compounds, in order to supress neighbouring 
bacterial populations. To render those compounds ineffective in themselves, many of these antibiotic 
producing species utilise drug efflux pumps to remove the compound from within their membrane 
compartments, and rendering it therapeutically ineffective.[22] As many antibiotics are derived from 
bacterial compounds, it requires relatively little changes in the bacterial genome to acquire a plasmid 
containing a drug efflux pump, and overexpress the protein. Drug efflux pumps typically display low 
substrate selectivity, meaning that whole classes of antimicrobial agents can be rendered ineffective by 
the overexpression of one drug efflux pump.[22][23] 
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1.3.3. Modification of drug target 
Another path to bacterial drug-resistance is through modification of the drug target structure, 
typically a protein within a biosynthesis pathway, rendering the antibiotic vulnerable to bacterial 
genome mutations which change the target proteins sequence. There are many examples of extremely 
rapid resistance development, when antimicrobials are targeted at a specific protein, which can be 
easily mutated. To illustrate this point, consider the emergence of M. tuberculosis strains which are 
resistant to the first-line indicated treatment with fluoroquinone antibiotics. Fluoroquinones act by 
forming a stable complex with DNA gyrase enzymes, interrupting bacterial cell replication, leading to cell 
death. Piton and co-workers (2010) report a clear relationship between amino acid mutation and the M. 
tuberculosis resistance phenotype. Fluoroquinolones bind to the gyrase-DNA complex at the quinolone 
binding pocket, which is comprised of both amino acid and DNA residues.[24][25] Mutations to amino acids 
within this pocket confer varying levels of fluoroquinolone resistance, with three residues demonstrated 
to play particularly key roles.[24] 
 
1.4. Horizontal gene transfer (HGT) 
HGT is a form of genetic exchange between bacteria, that can occur via uptake of extracellular DNA 
released by other bacteria (transformation), or by phage-mediated transfer from phage-infected donor 
cells (transduction) or via plasmid exchange during bacterial conjugation.[26] These processes have 
played a considerable role in the emergence of resistance to the ß-lactam antibiotics.[3] Numerous 
resistance genes can be gathering in single plasmids,[4][27] enabling efficient transfer of multidrug 
resistance between bacterial populations. 
 
1.5. Multidrug resistant strains 
Commonly described by the term “superbugs”, these pathogens demonstrate increased morbidity 
and mortality, due to the acquisition of multiple mutations bestowing enhanced resistance to the 
antimicrobials commonly prescribed for their treatment. Commonly known as multidrug-resistant 
bacteria, the most notorious strain is multidrug-resistant Staphylococcus aureus (MRSA), which attained 
its infamy mainly through intensive press coverage in the mid to late 1990’s. For example MDR Vibrio 
cholera is a far more virulent pathogen, far exceeding MRSA in infection, both in numbers and 
deleterious consequences.[3] A frightening new phenomenon is the emergence of totally drug-resistant 
strains of M. tuberculosis,[28] which are highly resistant to all the first- and second-line therapeutics 
indicated for tuberculosis treatment. Although the resistant strains of Vibrio cholera and M. tuberculosis 
are (so far) restricted to Asia and South America leading to low press coverage, and hence given low 
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priority by the medical research complex, these pathogens mark a return to preantibiotic era levels of 
treatment. 
 
1.6. Combating drug-resistance 
Several strategies have been proposed to overcome bacteria drug-resistance, including 
coadministration of antibiotics with agents that block common resistance mechanisms;[3] dual antibiotic 
therapy;[3][28] and the chemical evolution of the therapeutic warhead. Certain antimicrobial agents are 
withheld from general prescription, to reserve for the treatment of problematic drug-resistant bacterial 
infections. Vancomycin is one of these, but even these “last resort therapeutics” are becoming 
ineffective,[8] with vancomycin-resistant enterococcus now at pandemic levels in US hospitals.[29] It is 
never-the-less clear from the statistics that the war against infectious disease is far from won, and new 
strategies are desperately required, in the battle to stay ahead of the ever changing front lines of the 
single-celled enemy. 
 
1.7. Future of antimicrobial chemotherapy 
The cycle of rapid bacterial acquisition of drug-resistance to novel antibiotics must be broken, with 
the optimal strategy being the development of new antibiotics immune to the mechanisms of drug 
resistance. The three main drug targets for conventional antimicrobials, i.e. bacterial cell-wall and 
protein synthesis together with DNA replication and repair, are all vulnerable to the acquisition of 
resistance through small changes in the genome of the target organism. New antibiotics with low 
specificity targets would involve a much more complicated, and thus less commonly occurring, 
resistance mechanism; one such possible target is the bacterial cell membrane. 
 
1.8. Lipid membranes 
In-vivo lipid membranes are complex, heterogeneous mixtures of a large variety of constituent 
lipids.[30][31] The complexity of membranes suggests their function is not to merely separate cellular 
compartments and delineate the boundaries of the cell, and indeed many roles in biological processes 
have been attributed to lipids.[30][32] Cellular functions fulfilled by membrane lipids included serving as 
membrane protein anchoring sites;[32] cell-to-cell signalling[33][34] and vesicle trafficking.[35] Synthesised in 
the endoplasmic reticulum,[30] lipids are then redistributed to the desired membrane via a complex 
vesicle trafficking network.[33] Cells carefully modulate their membrane lipid composition as part of 
cellular homeostasis, and typical membrane composition is characterised by the presence of a large 
variety of lipids. The total eukaryotic lipidome possesses over 1000 members,[30] and human 
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erythrocytes alone are estimated to have over 200 different lipid species.[31] The large variety of lipid 
species is reflected in the genome, with around 5% of genes dedicated to the production and 
maintenance of a diverse portfolio of cellular lipids.[30] These factors suggest it is advantageous to 
maintain large and varied lipid stocks within the membrane. 
 
1.8.1. Physiochemical structure and properties of lipids 
The properties of phospholipids, the most numerous class of eukaryotic membrane lipids,[30] are 
primarily a result of their physiochemical characteristics. Their strong amphipathic character, results in a 
“love-hate” relationship with water and defines their behaviour, including their self-assembly into 
supramolecular structures and their lipid-lipid and lipid-peptide interactions. The chemical components 
of a phospholipid can be split into three parts, the polar headgroup moiety; the polar glycerol backbone 
and two non-polar hydrophobic fatty acid tailgroups, depicted in figure 1.1.  
 
Figure 1.1: Space-filling diagram of DPPC, a phospholipid with two palmitoyl (16:0) fatty acid tailgroups, with carbon atoms are 
shown as green spheres; hydrogen as white spheres; oxygen as red spheres; phosphor as purple spheres and nitrogen as blue 
spheres. The red overlay depicts the polar headgroup region of the amphipathic lipid structure, containing the oxygen, nitrogen 
and phosphor atoms of the glycerol backbone and Phosphatidylcholine headgroup. The yellow overlay covers the non-polar 
tailgroup region, containing the hydrophobic acyl chains. 
Lipid shape and lytic peptides Page 24 
 
 
Aggregation is a characteristic phenomenon of amphipathic materials in polar solvents;[36] the high 
energy cost of exposing the hydrophobic fatty acid chains to the surrounding aqueous solution, is the 
primary force driving the formation of supramolecular structures.[31] 
 
1.8.2. Lipid topology and the geometrical membrane model 
The role of lipid topography in the organisation of biological membranes has been the subject of 
recent research activity, as with many biological process, lipid structure and lipid function are 
interdependent. Lipids possess varying topographies, dependent on their headgroup and tailgroup 
components, that can be described as conical, inverse-conical and cylindrical (figure 1.2). 
 
Figure 1.2: Space-filling models of the phospholipids DOPE (left), DPPC (middle) and DOPC (right), with the blue overlay depicting 
their topographic character. Carbon atoms are shown in green; hydrogen in white; oxygen in red; phosphor in purple and 
nitrogen in blue. DOPE possesses two oleic fatty acid chains, with a 9z unsaturated bond adding a kink to the 18C chain, 
increasing the hydrophobic volume. Together with its small PE headgroup, this lends the lipid a conical geometry, and a packing 
parameter > 1. DPPC has a larger PC headgroup coupled with lower volume palmitoyl fatty acid chains, which are 16C long and 
saturated, giving the lipid inverted cone geometry and a packing parameter < 1. DOPC possesses cylindrical geometry, due to its 
large headgroup, and high volume fatty acid chains (18:1, 9z), and a packing parameter ~ 1. 
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The form of the supramolecular structure adopted by lipids in aqueous solution is controlled by 
their topography. A useful metric for assessing the shape of a lipid molecule within a membrane is the 
packing parameter (S), introduced by Israelachvili and colleagues,[37] which is defined as the ratio 
between the  lipid headgroup area to the lipid tailgroup volume (equation 1). 
 
𝑆 =  
𝑉
𝑎𝑙
 
 
Where V = volume of the hydrocarbon tailgroup; a = headgroup area and l = length of the hydrocarbon 
chain. The packing parameter describes the ratio of the areas occupied, in the plane of the water-lipid 
interface, by the headgroup and tailgroup components of the lipid. Lipids with small headgroup areas 
and large fatty acid chains possess conical geometry, especially if the chains contain unsaturated bonds, 
increasing the volume occupied by the hydrocarbons. Inverse-conical geometry lipids are characterised 
by having larger headgroup than tailgroups areas, i.e. a large headgroup like Phosphatidylcholine (PC) 
and/or low volume short and fully saturated fatty acids. If the areas occupied by the head and tailgroups 
are roughly equal, the lipid topography can be described as cylindrical. The consideration of membrane 
lipids as geometrical shapes interacting within a liquid-crystalline lattice, has been the major impact of 
Helfrichs seminal 1976 paper,[38] and will see much application within this thesis.  
Lipids in aqueous solution will form supramolecular packing arrangements, to minimise 
unfavourable interactions between their hydrophobic tailgroups, and the surrounding water molecules. 
Each packing conformation represents an energy minimum for that lipid,[39] and the particular 
conformation chosen can be predicted based on the lipids packing parameter. Lipids with large 
headgroups and small hydrocarbon volumes, will possess packing parameters < ½, and prefer to form 
structures like micelles and hexagonal phase (figure 1.3).  
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Figure 1.3: Lipid supramolecular structures self-assembled by inverted conical topography lipids when in aqueous solution, with 
the lipid headgroups depicted in red and the lipid tailgroups shown in yellow. (Right) hexagonal phase consists of compact 
tubular structures, with the polar headgroups facing outward, assembled to protect the non-polar acyl chain tailgroups from 
unfavourable interactions with the surrounding water. Typical packing parameter values for lipids which prefer to arrange in 
this manner are between 1/3 and ½. The tubular structures will often aggregate, resulting in a hexagonal array, from which the 
phase takes its name. (Left) micellular structures are another possibility for inverted conical lipids, with a packing parameters < 
1/3, where the lipids arrange themselves into spherical structures, again to protect their hydrophobic cores from interactions 
with the surrounding water. 
 
Lipids with small headgroups and large hydrocarbon volumes will form inverse-hexagonal phase, 
typically constructed by lipids with packing parameters > 1 (figure 1.4). Lastly, lipids with packing 
parameters between ½ and 1 have roughly cylindrical geometry, caused by similarity in their headgroup 
and tailgroup areas, and will prefer to adopt bilayer structures (figure 1.5).  
 
   
Figure 1.4: Lipids with packing 
parameters > 1 can form inverse 
hexagonal phase, where the lipids 
are arranged in a cylindrical 
structure around a water column, 
with the polar headgroups facing 
the water. The tubes pack 
together into a hexagonal array, 
protecting the non-polar acyl 
chains from interactions with 
water. 
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Lipids can be separated into two broad classes based on topographical character; bilayer lipids 
which prefer to form flat bilayers, and non-bilayer lipids which form more highly curved structures. 
Moreover, in heterogeneous lipid systems, the packing parameter is additive;[40] i.e. the average bulk 
structure will be based on the average packing parameter of the lipid mixture. A collection of lipids with 
an average packing parameter of < ½ forms supramolecular structures with associated positive 
curvature, those with packing parameters around 1 form flat non-curved structures, and those with 
packing parameters > 1 adopt negatively-curved structures. Other phases than those pictured are 
possible, like saddle and cubic phases, with more complex geometrical arrangements of lipids and 
associated curvatures. Note that due to packing parameter additivity, bilayer structures can be formed 
which contain non-bilayer lipids, and indeed completely from non-bilayer lipids.[40] Aggregation of non-
bilayer lipids has been connected to cellular processes, including cell fusion;[41] cell budding and 
fission;[30][42][43] membrane protein function[32][33] and protein translocation across membranes.[44][45] 
 
1.8.3. The lipid bilayer 
Prokaryotic and eukaryotic cellular membranes are bilayer structures, and the target of LCAMPs. 
The physical structure of a lipid bilayer consists of two opposing lipid monolayer (figure 1.6), with the 
hydrophobic acyl chains sequestered together from thermodynamically unfavourable interactions with 
the surrounding water molecules.[30] 
Figure 1.5: Lipids with packing 
parameters between ½ and 1 will 
prefer to form bilayer structures in 
aqueous solution. The similar lipid 
headgroup and tailgroup areas 
ensuring that the flat structure of 
the bilayer represents the lowest 
energy conformation for that 
particular lipid. 
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Figure 1.6: Side-view of a bilayer using Helfrichs geometrical packing model, constructed from cylindrical topography lipids, with 
lipid headgroups depicted in red and tailgroups shown in yellow. The acyl chains of the two opposing monolayer form a non-
polar hydrocarbon core to the bilayer, about 3 nm thick, while the polar headgroups and associated water molecules form a 1 
nm thick interfacial layer, between the hydrophobic bilayer core and the surrounding water molecules. 
 
The two layers of interacting acyl chains form the membranes hydrocarbon core, about 3 nm thick, 
surrounded by the headgroup interfacial region, protecting the core form the water. The interfacial 
region is ~ 1.5 nm thick, when the accompanying hydrating water molecules are included, meaning the 
thickness of a fully hydrated lipid bilayer is comprised of approximately equal parts hydrophobic and 
hydrophilic components. The bilayer is strengthened by hydrogen and electrostatic bonds between the 
lipid headgroups in the interfacial region, and Van der Waals interactions between the lipid fatty acids 
chains in the membranes core.  
 
1.8.4. Lipid domains and phases 
The forces and interactions experienced by lipids within a membrane structure are not equal, 
different lipid components show selective interaction preferences with each other, leading to a non-
uniform structure at the molecular level.[46] Lipid domains never reach equilibrium, they are strictly 
dynamic structures; Almeida and co-workers[46] calculated that a nanodomain of 150 lipid molecules 
would dissipate in less than 10 µs, given the fast lateral diffusion characteristic of fluid-phase lipid 
membranes. Three lamellar lipid phases are worth further consideration here; the liquid-disordered (Ld) 
phase; the liquid-ordered (Lo) phase and the solid gel-phase. The Ld phase is the most biological relevant, 
with many membrane proteins in the fluid phase.[30][47] The fluid phase is characterised by faster lateral 
diffusion, and low order within the acyl chain region,[30][33] and is composed primarily of lipids featuring 
unsaturated fatty acids (figure 1.7).  
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Figure 1.7: Diagram of a lipid membrane in the liquid-disordered phase, with lipid headgroups depicted in red, and fatty acid 
tailgroups in yellow. Large blue arrows indicate the fast lateral diffusion that is characteristic of fluid lipid membranes. 
 
In contrast the gel-phase contains lipids with acyl chain compositions dominated by long, saturated 
fatty acids (figure 1.8). Gel-phase lipids demonstrate a slower rate of lateral diffusion than in the fluid-
phase, and the order parameter of the acyl chains is markedly higher.[30]  
 
Figure 1.8: Diagram of a lipid membrane in the gel phase, with lipid headgroups depicted in red and fatty acid tailgroups in 
yellow. Small blue arrows indicate the slower lateral diffusion characteristic of gel lipid membranes. The closer packing of the 
lipids is a result of the increased interactions between the acyl chains, generating order in the hydrocarbon core. 
 
Lo phase possesses characteristics of both fluid and gel-phases, and is uniquely found within 
eukaryotic cells.[48] Lo phases are composed of bilayer lipids and cholesterol, demonstrating the fast 
lateral diffusion of an Ld membrane, together with the ordered acyl chains of the gel-phase (figure 1.9). 
 
Figure 1.9: Diagram of a lipid membrane in the liquid-ordered phase, with polar lipid headgroups depicted in red, the non-polar 
fatty acid tailgroups in yellow and cholesterol molecules in green. The cholesterol intercalates with the lipid acyl chains, where it 
both condenses and fluidises the hydrocarbon region. Large blue arrows indicate the faster lateral diffusion encountered in 
liquid-ordered membranes. The closer packing of the lipids is a result of the increased interactions between the acyl chains and 
cholesterol, generating order in the hydrocarbon core. 
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It is worth noting that the leaflet phase behaviours of a bilayer are coupled together, with phase 
formation in one leaflet reported to induce phase formation of the opposite leaflet.[30] Artificial lipid 
systems mimicking eukaryotic plasma membranes display well understood phase behaviours, with large 
micron-scale Lo and Ld phase coexistence; however in-vivo behaviour is more complex. The In-vivo 
evidence of phase coexistence suggests much smaller lipidic domains (< 300 nm), which cannot be 
visualised by conventional fluorescent microscopy, as domain diameter smaller than wavelength of 
excitation light.[30] It is speculated that large-scale phase discrimination does not occur in-vivo, due to 
the confinement of lipid lateral diffusion by abundant membrane proteins. Membrane properties can 
change abruptly at phase boundaries (figure 1.10), showing large variations in headgroup charge and 
composition; acyl chain saturation and length; overall membrane thickness and membrane protein 
composition between different membrane phases.[33] 
 
Figure 1.10: Diagram showing a liquid-ordered raft contained within a liquid-disordered membrane, with lipid headgroups 
depicted in red, tailgroups in yellow, cholesterol in green and membrane proteins in blue. The condensing effect of cholesterol 
contained within the liquid-ordered raft increases the hydrophobic core thickness, resulting in an increase in membrane 
thickness compared to the surrounding fluid phase. Many membrane proteins show a distinct phase preference, and are often 
found contained within lipid rafts with similar compositions. 
 
The rate of lipid transfer between membrane leaflets, or lipid “flip-flop” varies significantly 
depending on the lipid charge and topography, resulting in a range of membrane half-lives from hours 
or even days for lipids with large and/or charged headgroups like PG, to seconds for sterols,[30][33] 
however the rate of lateral diffusion is always several orders of magnitude faster. 
 
1.8.5. Prokaryotic versus eukaryotic membranes 
The plasma membranes of prokaryotes and eukaryotes exhibit significant variation in 
physiochemical properties like headgroup composition and charge, as well as differences in fatty acid 
composition. It is these fundamental differences that render bacterial membranes an attractive target 
for novel antimicrobial therapeutics. 
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1.8.5.1. Eukaryotic membranes 
The largest class of eukaryotic lipids is the glycerophospholipid family, comprising of PC/PE/PS/PI 
and PA species, with PC typically representing about 50% of the total lipid content of a eukaryotic 
membrane.[30][33] Phosphatidylcholine lipids feature large zwitterionic headgroups, and typically contain 
one cis-unsaturated fatty acid, these properties result in the majority of PCs being in fluid phase at room 
temperature. The large headgroup results in packing parameters around 1, and as a result most PC lipids 
are bilayer forming in aqueous solution. Spingolipids are the next most represented class of eukaryotic 
membrane lipids,[30] split between the sphingomyelin and glycosphingolipids classes, both typically 
containing saturated or trans-unsaturated acyl chains. The fatty acid composition of sphingomyelin and 
glycosphingolipids result in taller, narrower inverted conical topographies, and many lipids of these 
classes are gel-phase at room temperature, and can be fluidised by sterols to form liquid-ordered 
domains. Phosphatidylserine is the main anionic lipid component of eukaryotic membranes, and is 
sequestered within in the inner membrane leaflet,[49] resulting in a large charge asymmetry across the 
membrane leaflets of eukaryotic cells. Several other lipid classes are asymmetrically distributed across 
the membrane leaflets, including PE and PI, which are also largely sequestered to the inner membrane 
leaflets. As a result of this preferential lipid segregation between leaflets most eukaryotic membranes 
display considerable lipid composition asymmetry, e.g. human erythrocytes contain SM and PC in the 
outer leaflet, and virtually no PS, while the inner leaflet contains PS, PE and PI.[50] The interleaflet lipid 
gradients are maintained by a network of ATP-dependent lipid transporters, called flippases, floppases 
and scramblases. Flippases transport lipids from the outer extracellular leaflet into the cytoplasmic 
leaflet, whereas floppases perform the opposite function, transporting lipids from the inner to the outer 
membrane leaflet. Scramblases are directionally non-specific, capable of redistributing lipids across 
either membrane leaflet.[50] In summary, eukaryotic membrane leaflets are highly asymmetric, with PS, 
PE and PE sequestered to the inner leaflet. This renders the outer membrane composed mainly of lipids 
like PC and SM, i.e. electrically neutral and with packing parameters typically between ½ and 1, i.e. 
bilayer lipids. Extracts of eukaryotic cellular membranes typically display large spontaneous curvatures, 
for example DOPC displays radii of curvature of -11 nm, and DPPC has radii of curvature of +14.7 nm.[51] 
Of all the component lipids of eukaryotic membranes, only cholesterol displays considerable negative 
curvature, with radii of curvature of 2 nm.[51] 
 
1.8.5.2. Prokaryotic membranes 
The membranes of prokaryotic cells display several contrasting features to eukaryotic cell 
membranes. The primary difference is the overall negative charge of the outer membrane leaflet of 
prokaryotes, due to the inclusion of anionic lipids like CL and PG.[52][53] Bacterial membranes also display 
more subtle topographical differences in their outer leaflets, namely the inclusion of large amounts of 
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high packing parameter lipids, i.e. lipids with small headgroups and/or large hydrophobic volumes like 
PE. These differences in membrane lipid topography lead to prokaryotic membranes showing intrinsic 
curvatures much greater than eukaryotic membranes, for example Osterberg and colleagues[54] report 
that total lipid extracts from Acholeplasma laidlawii form inverted hexagonal phases with diameters 
between 5.8 – 7.5 nm, i.e. spontaneous radii of curvature of ~-3.3 nm on average. Moreover, the 
bacteria maintain this curvature profile when grown in conditions containing either palmitic or oleic 
acid, despite the large differences in hydrophobic volume induced by inclusion of these fatty acids into 
the membrane, via modulation of the membrane headgroup composition. Kollmitzer and co-workers[51] 
present the typical radii of curvatures for many of the lipids found prokaryotic membranes, they 
reported that DOPE membranes display a radii of curvature of -2.5 nm, and POPE -3.2 nm. Literature 
values for the radius of curvature of inverted hexagonal phase structures show good agreement with 
these values, for example the -3.5 nm radius of curvature for POPE membranes in Siegel and Epand.[54]  
Although comparison of curvature values between papers is complicated by the dependence of the 
value on the precise experimental conditions, like salt content, temperature, variable inclusion of short 
chain hydrocarbons and pH,[52][54] it is never-the-less clear that bacteria maintain the curvature of their 
membranes within a narrow band, keeping their membrane much close to the lamellar to non-lamellar 
phase boundaries than mammalian cells. The large amount of cellular resources bacteria devote to 
plasma membrane topographical homeostasis has been suggested to indicate that membrane curvature 
is a functionally important membrane parameter carefully regulated by the organism.[55] To summarise 
membrane composition differences between prokaryotic and eukaryotic membranes, it is necessary to 
place emphasis on two factors; first, that the outer leaflet of bacterial cells contains a high net amount 
of anionic lipids, while mammalian cells have zwitterionic outer leaflets; second, that the topography of 
bacterial membranes high negative curvature, while the curvature of mammalian membranes is neutral. 
 
1.9. Linear cationic antimicrobial peptides (LCAMPs) 
The urgent need for novel antimicrobials has driven a resurgence of interest in naturally occurring 
antibiotic molecules, with LCAMPs appearing among the most promising for future development as 
antibacterial chemotherapies. LCAMPs are part of the innate immune system, responsible for first-line 
quick response to bacterial invasion of the host.[56][57] Almost ubiquitously expressed within nature, 
LCAMPs are found in taxonomically diverse groups such as insects;[58][59] amphibians[60] and mammals.[61] 
Such widespread expression suggests that LCAMPs are evolutionarily ancient components of host 
defence against invading pathogens, and have remained remarkably effective as the front line host 
defence against invading pathogens.[18] The LCAMP family is remarkably diverse, with over 1000 
members listed to date.[63] 
Lipid shape and lytic peptides Page 33 
 
1.9.1. LCAMP activity 
LCAMPs generally exhibit broadband antimicrobial activity,[56][63] with many peptides displaying 
secondary viricidal and tumouricidal activities.[63] They are highly potent, with most peptides bactericidal 
at low micromolar concentrations,[64][65] with some operating at even lower levels.[18] LCAMP potency 
compares well to conventional antibiotics; to demonstrate this we can compare the activities of two 
widely studied LCAMPs, magainin and melittin, to two widely prescribed antibiotics, amoxicillin and 
azithromycin, against the bacteria S.pneumoniae. Amoxicillin is an orally taken beta-lactam antibiotic, 
and displays MICs against multiple strains of S.pneumoniae of between 43.8 nM and 15.3 µM.[66] 
Azithromycin is a macrolide antibiotic, possessing MICs against S.pneumoniae of between 80.1 nM and 
341.8 µM.[67] The LCAMP magainin II amide returns MICs against a similar variety of S.pneumoniae 
strains of 1.6 µM to 51.6 µM, while melittin returned a MIC of 2.2 µM.[68] Some LCAMPs are highly 
selective between prokaryotic and eukaryotic cells, e.g. magainin,[60] and the peptides as a class show 
remarkable immunities to the development of acquired bacterial drug-resistance. The combination of 
high potency, selectivity and immunity from bacterial drug-resistance render LCAMPs into promising 
candidates for development as antibiotics.[58][65] 
 
1.9.2. Physiochemical properties 
Unusually for a protein family, it is shared physiochemical and structural properties, rather than 
sequence homology, which characterises the LCAMP protein superfamily.[64] The primary marker for an 
LCAMP is a pronounced amphipathic helix when bound to a lipid membrane, with the polar and charged 
amino acid residues distributed along one face of the helix, and the opposite face composed of non-
polar residues.[58][62] The amphipathic helix facilitates the interaction of the helical peptide with other 
amphipathic structures, like phospholipid membranes, and indeed many LCAMPs only adopt 
amphipathic helical conformation upon binding to lipid membranes or when aggregated together.[62][63] 
Another feature of LCAMP amino acid sequence is the high proportion of the cationic residues lysine, 
arginine and histidine, giving the peptides their characteristic positive charge. 
 
1.9.3. Biological target of LCAMPS 
There are many excellent reviews in the literature of the antimicrobial activity exerted by 
LCAMPs,[57][58] with the consensus that their mode of action involves membrane disruption and pore 
formation within the cellular membranes of bacteria, although some evidence of intracellular targets 
exists. Strong evidence for this comes from the observation that LCAMPs with inverted sequences, or 
composed from all D-isomers of amino acids, possess identical antibiotic and pore-forming properties to 
their parent peptides.[57][62] This indicates that the antimicrobial effect of LCAMPS is not exerted through 
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interactions with specific chiral proteins targets, and instead LCAMPs are widely reported to target the 
cellular membrane itself, disrupting membrane integrity. This results to the dissipation of 
transmembrane ionic gradients, increased water flow across the membrane and leakage of intracellular 
contents.[58][62] Bacterial membranes are underutilised targets for antibiotic therapy, with significant 
differences existing between prokaryotic and eukaryotic membranes.[64] 
 
1.9.4. Mechanisms of action of LCAMPs 
The LCAMP family has been widely studied, but controversy still exists over their exact mechanism 
of action. Several general models have been proposed to explain their membrane disruption and 
antimicrobial activity, with perhaps the most widely accepted being the Shai-Matsuzaki-Huang (SMH) 
model.[64] It has been suggested that no single model is capable of adequately describing the activity of 
this diverse peptide family,[18][63] and that LCAMPs may act through a variety of different 
mechanisms.[69][70] Strong evidence for multiple leakage mechanisms is the contrast in the size-
dependence of LCAMP-induced leakage from model membrane systems, with studies reporting both 
size-dependent leakage[69] and size-independent leakage.[71] 
 
1.9.4.1. Shai-Matsuzaki-Huang model  
The SMH model begins with the spontaneous binding of the peptide, from aqueous solution to the 
outer leaflet of the target membrane. The peptide initially inserts in helical form, parallel to the plane of 
the bilayer, often referred to as the S-state.[58][60][63] Peptide insertion is accompanied by membrane 
thinning,[62][63] reported to be non-uniform across the bilayer, but instead concentrated around the 
inserted peptide.[72] Once a threshold concentration of membrane-bound peptide has been achieved, 
the peptide helix begins to insert parallel to the membrane normal plane, referred to as the I-state. The 
critical concentration required to induce the change from S-state to the I-state, varies with both peptide 
and lipid compositions.[63] The change of orientation is associated with the initiation of membrane 
disruption,[63][73] although the exact mechanism of LCAMPs membrane permeation is unknown, with 
several models proposed in the literature, including pore formation, carpet and detergent-like 
mechanisms, depicted in figure 1.11. 
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1.9.4.2. Barrel-stave pore mechanism 
Barrel-stave transmembrane pores are composed of bundles of individual peptides, with a central 
pore lumen, with alamethicin a well-studied example of a peptide operating via the barrel-stave 
model.[62][63] Barrel-stave pores can contain varying amounts of peptide helices, which line the pore 
lumen with their polar and charged residues pointing inwards, forming a water filled central channel. 
Crucial to this model is the ability of membrane-bound peptide monomers to recognise and aggregate 
with each other, at low surface concentrations, as it is extremely energetically unfavourable for a single 
helix to transverse the membrane, due to unfavourable interactions between the polar/charged 
residues of the peptide, and the hydrophobic core of the bilayer.[57] The barrel-stave model for LCAMP 
action has become disfavoured for several reasons, primarily because the structural parameters of the 
pores do not match those expected for barrel-stave pores. Firstly, peptides forming barrel-stave pores 
form walls around 1.1 nm thick,[73] approximately the same diameter as an alamethicin helix, while 
LCAMP pores display channel walls with a diameter of ~2.0 nm, significantly wider than a peptide helix. 
Secondly, most LCAMP helices are not long enough to fully span the bilayer.[73] Other reasons why the 
barrel-stave mechanism is disfavoured include the repulsive Columbic energy, which would prohibit 
association of the cationic LCAMPs; alamethicin is zwitterionic, allowing the peptide helices to exist in 
close proximity. Fluorescent energy transfer studies also indicate that LCAMP monomers are not closely 
associated when in its membrane-bound S-state.[74] The size of the pores formed by LCAMPs also rule 
out the barrel-stave mechanism, being typically 3 – 4 nm in diameter, which if of barrel-stave 
construction would require > 10 peptide helices to fully line the pore lumen, and likely be unstable to 
shape deformation.[73] 
 
1.9.4.3. Toroidal pore mechanism 
Proposed by Matsuzaki and colleagues[75] the toroidal pore mechanism also proposes that peptide-
induced membrane permeability is caused by transmembrane pore structures. Unlike the barrel-stave 
model however, the pore lumen is lined with both lipid and peptide molecules.[62][63][75] Idealised toroidal 
pore structures require considerable curvature induction of the membrane lipids, both negative 
curvature to form the pore lumen, and positive curvature to bend the two membrane leaflets in the 
bilayer normal plane, until the two leaflets merge[73] – the leaflet fold structure. When forming a toroidal 
pore, the polar/charged face of the amphipathic peptide helix interacts with the polar/charged 
headgroup region of the lipids, and the non-polar hydrophobic face interacts with the non-polar 
hydrophobic lipid acyl tailgroups.[63][73] The pores formed within the membrane have been reported as 
both transient and stable within the literature,[58][76] and cooperative inter-helix behaviour has been 
implicated in the formation of the pores.[76][77] Peptides thought to at least partially operate via toroidal 
pore mechanisms include magainin and melittin.[58][63][65] Several experimental observations support 
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toroidal pores as the mechanism of membrane permeability employed by LCAMPs, including the rapid 
flip-flop of both lipids and peptide induced by LCAMP pore formation;[75][76] visualisation of pores 
induced by structurally similar peptides, e.g. x-ray diffraction images for Bax toroidal pores;[78] the high 
variability of LCAMP electrophysiology results, unlike alamethicin-like barrel-stave pores, which produce 
consistent electrophysiology traces;[73] and pore ion selectivity, which can be modulated via the charge 
of the target membrane, suggesting a role for lipid molecules in the pore structure.[79] Sengupta and co-
workers[80] suggest a less well defined toroidal pore structure, where the majority of the pore is lined 
with lipid molecules, and only one or two LCAMPs insert into the membrane for each pore, with the 
remainder binding to the pore edge. Figure 1.12 depicts a comparison between ordered and disordered 
toroidal pore structures. 
 
Figure 1.12: Comparison of ordered and disordered toroidal pore structures, with lipids represented by cylindrical and inverted-
cone geometrical shapes. Lipid headgroups are depicted in red, and the lipid tailgroups in yellow, with peptide helices in blue. 
(Left) Diagram of an idealised toroidal pore, with regular arrangement of helices within the structure, and tight positive 
curvature within the leaflet fold structure. The pore lumen requires negative curvature generation, where lipid tailgroups occupy 
more volume than headgroups. (Right) Diagram of a disordered toroidal pore, showing only one peptide helix that has fully 
inserted into the membrane, with the remainder of pore-associated peptides binding to the pore edge. 
 
1.9.4.4. Carpet mechanism 
Peptides that disrupt lipid membranes via the carpet mechanism self-associate within a membrane, 
forming an extensive peptide “carpet” on the surface of the membrane leaflet.[57][62][63] The model is 
based upon intercalation of the LCAMP helix into the bilayer, followed by cooperative binding between 
the peptides. After a critical threshold of membrane-bound peptide is reached, membrane solubilisation 
occurs in a detergent-like manner, with the loss of mixed peptide-lipid micelles into the surrounding 
solution.[62][82] The presence of anionic lipids facilitates the self-association of the typically cationic 
peptides, by reducing the electrostatic repulsion present for peptides in close proximity,[62] and appears 
to facilitate leakage via carpet mechanism.[70] Contrary to the barrel-stave and toroidal pore 
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mechanisms, it is not necessary for the peptide helices to fully penetrate into the hydrophobic bilayer 
core, nor assemble with their hydrophilic residues facing each other.[57] Prior to membrane collapse, 
transient holes may appear in the membrane, enabling passage of low-molecular weight compounds 
across the membrane, which maybe toroidal in nature.[57] Factors counting against the carpet 
mechanism as the sole cause of LCAMP-induced membrane disruption include the low concentration of 
peptide required to generate membrane permeability, in both dye leakage and electrophysiology 
experiments.[58][79] The carpet mechanism requires a very dense accumulation of peptide,[65] and several 
papers link the disruption of membranes via the carpet mechanism to the intrinsic curvature of the 
target membrane.[62][63] 
 
1.9.4.5. Intracellular target mechanism 
Membrane disruption has long been implicated as the primary bactericidal mechanism of LCAMPs, 
but there are some indications that some LCAMPS may interact with intracellular targets. Brogden[63] 
reports LCAMPs can induce the activation of phospholipases and autolysins within cells. 
 
1.9.5. Experimental investigation of LCAMP activity 
As membrane disruption is the crucial bactericidal activity of LCAMPs, a popular experimental 
technique is to study the release of enclosed fluorescent molecules from within biological or artificial 
model membrane systems, through the LCAMP-induced pores.[69][76][82] Incorporation of differently sized 
fluorescent markers within the membrane systems can provide information on pore sizes.[69] 
 
1.9.6. LCAMPs and drug-resistance 
Compared to conventional antimicrobial therapies which encounter rapid development of drug-
resistance in bacterial populations, LCAMPs are extraordinary evolutionary success stories. Unlike 
antibiotics like penicillin, which bacteria easily circumvent through the mechanisms of acquired drug-
resistance, bacteria display a surprising lack of resistance to AMPs.[56][64] Repeated attempts to generate 
drug-resistance to pexiganan through exposure of > 3000 clinical isolates to subinhibitory levels of 
peptide were unsuccessful.[56] In contrast to conventional antibiotics, which attack specific high-affinity 
targets, LCAMPs have maintained effectiveness over millions of years by targeting a low-specificity 
target – the bacterial plasma membrane. Nature has ensured that bacteria cannot easily develop 
resistance by slight changes to their genome, which would rapidly occur due to their high mutation rate. 
Because the drug target is the bacterial membrane, to acquire resistance a bacteria must substantially 
redesign its membrane structure, incurring a fitness cost and requiring a more complex resistance 
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acquisition process, i.e. requiring a large raft of simultaneous mutations.[64] Some strains of bacteria 
have nevertheless displayed resistance to AMPs through a variety of mechanisms, demonstrated by the 
following two examples of the acquired resistance to LCAMPS. Strains of S. aureus achieved resistance 
by transporting D-alanine from the cytoplasm to the outer leaflet membrane surface, reducing the net 
negative charge by the esterification of the anionic phosphate groups of the teichoic acid polymers 
found in the outer membrane, with basic amino groups.[18] Bacteria can also acquire resistance through 
expression of proteolytic enzymes which target the LCAMPs,[64] a strain of S.aureus can cleave LL37 using 
a metalloprotease called aureolysin.[83] However resistance acquired via proteolytic degradation is an 
inefficient mechanism, as LCAMPs in general lack unique amino acid sequence motifs to serve as binding 
sites for selective proteolytic destruction. Despite these reported examples of resistance, bacteria as a 
whole remain remarkable susceptible to the action of these potentially therapeutically useful peptides, 
with the wide range of bacterial susceptibilities to LCAMP action remaining unexplained.[64] Peschel and 
Sahl[18] suggest that bacterial resistance to LCAMPs has coevolved over evolutionary timescales, leading 
to a delicate balance between host defence and pathogen susceptibility. 
 
1.9.7. Comparison of two prototypical LCAMPs 
Two of the most well studied LCAMPs are magainin and melittin, with several excellent reviews in 
the literature.[58][59][60] The next section will present brief reviews of the sources, physiochemical 
properties and key points for both these peptides. 
 
1.9.7.1. Melittin 
Melittin is the principle component (~50% of the dry weight) of the venom of the European honey 
bee Apis mellifera. It is comprised of 26 amino acid residues, which can assemble into an amphipathic 
helix. Its amino-terminal is primarily comprised of hydrophobic residues, and its carboxy-terminal 
contains a KRKR motif.[58] Its sequence is GIGAVLKVLTTGLPALISWIKRKRQQ-CONH2, and possesses a +6 
charge at physiological pH, composed of its amino-terminal, K7 and the KRKR motif at the carboxy-
terminal. In aqueous solution it adopts a random-coil conformation, and is typically found as a 
monomer, although it is capable of forming an aqueous helical tetrameric aggregate at high peptide and 
salt concentrations. The terminals of melittin, i.e. GIG and KRKRQQ, are thought to not participate in the 
assembled helix in the membrane-bound peptide.[58] The P14 residue interrupts the assembled helix, as 
well as adding a kink to the assembled helix, with the angle between the two helical segments estimated 
at 140 – 160°. Melittin is non-selective between mammalian and bacterial cells, displaying high levels of 
haemolytic activity; melittin is capable of lysing erythrocytes at sub-micromolar concentrations. 
Melittin-induced leakage reported to be biphasic, with fast and slow components.[58][77] Degrado and 
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colleagues[77] report that 40% of haemoglobin release from erythrocytes occurs quickly, with a rapid 
decrease in cell number, with the remainder of the leakage occurring over longer timescales. 
 
1.9.7.2 Magainin II 
Magainin is a 23 residue LCAMP isolated from the skin of the African clawed frog Xenopus laevis, 
and has the sequence GIGLFKHSAKKFGKAFVGQIMNS. Like melittin, it carries a significant positive charge 
of +4 at physiological pH, forms membrane-bound helices, and is believed to exert its antimicrobial 
effects through membrane disruption. Unlike melittin, it displays a high level of selectivity between 
prokaryotic and eukaryotic cells.[75] 
 
1.9.8. Structure-function relationships of LCAMPs 
It is understood that an LCAMPs amphipathic structure and physiochemical properties exert the 
majority of its membrane disruptive effects,[57][58] This section examines the structure-function 
relationships of LCAMPs, to determine their effect on peptide activity, with a particular focus on factors 
effecting prokaryotic and eukaryotic selectivity. 
 
1.9.8.1. Amphipathic helix charge distribution 
Both the angle subtended by polar residues on the helical face, and positive charge distribution 
along the helix are important. Shai[57] reports that peptides with their positive charge concentrated at 
the terminal ends of the membrane-bound helix (e.g. melittin) are more lytic to eukaryotic cells, than 
peptides with a large positive charge distributed along the backbone (e.g. magainin). 
 
1.9.8.2. Polar angle subtended on helical face 
Membrane binding involves penetration of the hydrophobic face of the peptide into the 
hydrophobic core of the bilayer, while the hydrophilic face remains in contact with the polar 
interfacial/headgroup area, or with the aqueous solution.[65] It is therefore a reasonable assumption, 
that the depth of LCAMP membrane penetration will therefore depend on the arrangement of the 
hydrophobic/hydrophilic amino acid residues around the assembled peptide helix, i.e. the angle 
subtended by the polar and charged residues around the assembled helical face (figure 1.13). 
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Figure 1.13: Diagram of the effect of the angle subtended by the polar/charged residues on the peptide helical face, on the 
membrane penetration of two LCAMPs. Polar areas of the bilayer and peptide are coloured red, and non-polar regions coloured 
in yellow. (A) A peptide with large polar angles can only insert a limited portion of its helical volume into the hydrophobic bilayer 
core. (B) Peptides with small polar angles can insert a greater volume of helix into the membrane core. 
 
Peptides with narrow angles subtended by polar residues on helical face (i.e. melittin) penetrate 
deeper into bilayers,[58][84] and generate negative curvature strain within the membrane, by increasing 
the volume of the hydrocarbon bilayer core to a greater extent than the interfacial headgroup region. 
Conversely, peptides with wide subtended angles (i.e. magainin) lead to shallower penetration, and 
positive curvature induction.[65][84] The membrane disruption of LCAMPs is found to decrease with 
increasing polar angle, although the reasons are as yet unclear, although it can be explained by less 
peptide volume inserted within the lipid bilayer, as well as increased electrostatic repulsion between the 
peptides due to more charged residues.[65] 
 
1.9.8.3. Key residues of magainin and melittin 
Despite the lack of sequence homology between LCAMP family members, and the widely held 
position that it is the physiochemical structure of LCAMPs that are responsible for the bactericidal 
activity of the peptides, key residues have been identified for the membrane disruption induced by 
these LCAMPs. In this section we will dissect the key residues of the prototypical LCAMP melittin. The 
single tryptophan residue of melittin (W19) has been identified as a particularly crucial amino acid 
residue, although its actual position in the helix was found to be relatively unimportant.[58] Melittin 
substitution analogues with a single tryptophan residue displayed haemolytic activity in the order of 
potencies W17 > W19 = W11 > W9,[85] and variation of the W position effected the aggregation 
behaviour of melittin in solution. Tryptophan prefers residing in the complex interfacial environment of 
the membrane leaflet, as the π-electronic structure of its aromatic ring and flat rigid shape prevents 
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entry into hydrophobic bilayer core,[57][86] and phenylalanine may also show a preference for the 
interfacial headgroup area of the membrane leaflet.  
Structure-function studies of melittin indicate that removal of P14 eliminates the helix-breaking 
kink in membrane-bound melittin, increasing the helical content of the LCAMP, and longer amphipathic 
helices are associated with higher haemolytic ability for many LCAMPs,[58] for example P14A substitution 
increases the haemolytic activity of melittin twofold. However P14A melittin displays less stable 
electrophysiology behaviour, indicating that channel formation may not dominate its haemolytic 
behaviour, unlike the native peptide.[87] This implies that selective peptides can be rendered into non-
selective peptides by substituting the proline residue, and thus increasing the helical content.[65]  
Alteration of the KRKR carboxy-terminal motif has been reported to decrease its haemolytic 
activity.[58] Several of the residues in the hydrophobic face of melittin have also been reported to 
modulate peptide activity, in particular the leucine residues. Leucine is an ideal residue for penetration 
into membrane bilayers, due to its low steric activity and high hydrophobicity.[88] Magainin, a shallow 
membrane penetrator, contains only 2 leucine and isoleucine residues, while melittin, a deep 
penetrator, contains seven of these amino acids. Substitution of the leucine residues in melittin 
(especially L9) leads to reduced haemolytic activity compared to native peptide,[85] and in parallel, 
replacement of W19 with leucine lowers haemolytic activity.[89] LCAMP activity appears to be controlled 
by a complex network of interdependent factors, and key to these residues modulation of LCAMP 
activity has not yet been elucidated within the literature. 
 
1.9.8.4. Aggregation of melittin within membranes 
No consensus exists within the literature about the aggregation state of melittin contained within 
membranes, with several conflicting papers published.[58] However, the SMH model proposes that 
melittin exists as a membrane-bound monomer at low peptides concentrations and low ionic strength, 
although kinetic studies strongly suggest that melittin aggregation within the membrane acts as a 
precursor of pore formation in at least some cases.[77] Takei and co-workers[90] demonstrate that 
formation of a melittin dimer is the rate-limiting step in the kinetics of pore formation, indicating that 
peptide aggregation is likely under specific conditions. 
 
1.9.9. Factors underpinning prokaryotic and eukaryotic selectivity 
Melittin and magainin possess similar pore-forming activity,[73][75][76] yet display very different 
selectivity between prokaryotic and eukaryotic cells. Degrado and co-workers[77] report rapid haemolysis 
induced by melittin at sub-micromolar concentrations, while magainin is almost inactive against 
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erythrocytes at considerably higher concentrations.[91] Both peptides possess a high net positive charge 
at physiological pH, and can be expected to interact more strongly with anionic membranes. Both 
magainin and melittin show a preference for bacterial membranes, whose outer membrane leaflet 
contains anionic lipids, in preference to mammalian membranes, which feature zwitterionic outer 
membrane leaflets.[57] In addition, the outer surface of gram-negative bacteria contains anionic 
lipopolysaccharide, which can increase bacterial resistance to LCAMPs, through binding and 
sequestering the cationic peptides, preventing their access to the bacterial membrane.[57] Selective 
LCAMPs, such as magainin II, tend to be accommodated within the interfacial region of the bilayer, while 
non-selective LCAMPs like melittin, tend to penetrate deeper into the hydrophobic core of the 
membrane leaflet.[57] Magainin with its increased polar angle, possesses less hydrophobic residues 
available for insertion into the hydrophobic membrane core. As a result magainin displays decreased 
affinity for zwitterionic membranes, and a greater preference for anionic bacterial membranes than 
melittin.[65] Unfortunately however, there appears to be no simple relationship between peptide charge 
and antimicrobial activity.[65] Cholesterol is found within eukaryotic membranes, yet is totally absent 
from bacterial membranes, and induces tighter lipid packing and increases the bilayer bending energy. It 
has been reported to reduces both binding and membrane penetration depth of LCAMPs, and it renders 
model membrane systems resistant to LCAMP-induced membrane disruption.[58][91] The presence of 
liquid-ordered cholesterol containing rafts seems to exert influence on membrane-disruption by 
LCAMPs, with HcHenry and colleagues[92] reporting that cholesterol exerts a substantial inhibitory effect 
in non-raft containing membranes, but the effect disappears in raft containing membrane systems. 
 
1.9.10.  Magainin and melittin pores 
Magainin and melittin are generally accepted to be toroidal pore forming peptides.[58][73] Both 
peptides form pores of similar sizes; magainin forms pores with diameters of 3 to 5 nm, comprising of 4 
to 7 magainin monomers and around 90 lipid molecules,[59][60] while melittin forms pores 2.5 to 5.0 nm 
in diameter.[69][73] The diameter of the pores induced by melittin, increases with increasing peptide 
concentration,[76] with Katsu and co-workers[93] reporting a pore radius of 1.3 nm at a peptide 
concentration of 0.2 µM, and a radius of 2.4 nm at a peptide concentration of 0.8 µM. Melittin pore 
lifetime was reported as <10 ms,[76] but again the lifetime appears to vary with peptide concentration 
and lipid composition.[58][76][94] There is no consensus within the literature of the leakage kinetics of 
LCAMP-induced pores from artificial model membranes, with two major mechanism noted; “all-or-
none” leakage, where an individual vesicle will either display 100% leakage or remain unaffected; 
graded leakage, where vesicles will display partial leakage of contents.[71] However both magainin and 
melittin have been reported to operate via both mechanisms in the literature; magainin 2 reported to 
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operate via graded mechanism[95] and via all-or-none;[96][97] melittin reported as operating via all-or-
none[98] and by graded release.[99] 
 
1.9.11.  LCAMP homology with other proteins 
Helical amphipathicity is a characteristic of many membrane proteins, and putative transmembrane 
segments of membrane proteins.[58] For example, the two LCAMPs that are the primary focus of this 
thesis, magainin and melittin, possess structural or sequence homology with numerous proteins and 
peptides with significant current research interest. The proapoptotic proteins of the Bcl-2 family that 
control the release of apoptogenic factors from mitochondria share many structural features with 
LCAMPs, and are thought to operate via the formation of toroidal pores in the mitochondrial outer 
membrane.[100] The structural and mechanistic homology seen between LCAMPs and certain amyloid 
proteins are even more striking, and Last and Miranker[101] demonstrate that magainin 2 and the islet 
amyloid polypeptide possess incredible synergy at bacterial membrane disruption. Mixtures of the two 
peptides show activities two orders of magnitude greater than the simple sums of the activities of the 
individual peptides. The LCAMP family also shares sequence and structural homology with viral coat 
peptides linked to membrane disruption and fusion, for example the Nef1 – 25 HIV1 virulence factor,[102] 
and the tobacco mosaic virus coat protein.[58] Research into the membrane disruptive effects of LCAMPs 
has therefore a broader scope than just investigation of antimicrobial activity, and magainin and melittin 
are ideal for investigation of the mechanisms underpinning the action of all these peptides. 
 
1.10. Lipid-peptide interactions 
The heterogeneous lipid composition of cellular membranes leads to a complex set of interactions 
with proteins embedded within the membrane. These interactions create a free energy landscape for 
the lipid-peptide system, with local minima representing the interaction of proteins with lipids that 
lower the free energy of the system, and maxima that occur when interacting with lipids that raise the 
free energy.[103] It is reasonable to assume the formation of dynamic lipid-peptide rafts around 
membrane-bound proteins, based on these free energy considerations, and indeed Almeida and co-
workers[46] suggest that the most probable cause of nanodomain rafts within the membrane is dynamic 
lipid aggregates centred around individual proteins. Jacobsen and colleagues[104] suggests three length 
scales for lipid domains, with the smallest being nanoclusters, consisting of sub 10 nm dynamic 
associations of lipids, or the immediate surroundings of membrane-bound proteins, that can have 
properties different from the larger scale structures, i.e. significant fluctuations of local energies, lipid 
densities and composition. Expanding the length scale, we next encounter nanodomains, 10 to 100 nm 
domains possessing slower dynamics and lower fluctuations than nanoclusters. Microdomains are the 
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largest in scale, representing clusters of lipids and lipid-peptides > 1 µm in scale, possessing the slowest 
dynamics and lowest fluctuations. 
Membrane proteins show distinct phase preferences, with the fluid Ld phase generally 
preferred,[105] although gel-phase partitioning can occur if there is precise hydrophobic matching 
between the peptide and surrounding lipids.[30][33] Cholesterol binding domains confer upon the protein 
a preference for Lo phases,
[48] although it is unclear as to whether the protein binds to existing 
cholesterol-rich lipid phases, or initiates the assembly of a Lo phase around itself. Formation of protein-
induced dynamic lipid rafts is well understood within the literature, with many proteins requiring the 
presence of select lipids in order to function.[106][107] Membrane protein function is modulated by a wide 
variety of lipid bilayer properties,[31] including fluidity; lateral pressure; intrinsic curvature; lipid packing 
and hydrophobic mismatch. Lazaridis[108] provides computational support for the effects of membrane 
properties on protein conformation and orientation, and concludes that membrane physiochemical 
properties can drive protein aggregation within membranes. 
 
1.10.1.  Lipid clustering around membrane-bound LCAMPs 
As noted above, membrane protein function has been reported to be influenced by the properties 
of the surrounding lipids, however when considering the interaction of lipids with LCAMPs, it is 
necessary to consider the reciprocal of this arrangement, that peptides embedded within the 
membrane can affect the membranes properties. Evidence for this assertion can be found both 
experimentally and computationally. Dibble and Feigenson[109] determined that helical peptides can 
induce the formation of non-bilayer phases at a concentration of a few mol%, and lipid domain 
formation can be initiated by interactions with membrane-bound peptides.[110] When inserted into a 
membrane, magainin disrupts the lipid packing for an estimated 5 nm radius around the membrane-
bound LCAMP,[111][112] creating a membrane “hotspot” of increased free energy, i.e. a local maxima in 
the membranes energy landscape. Factors identified as controlling the clustering around membrane-
bound LCAMP helices include electrostatics,[113][114] fatty acid unsaturation[58][115] and curvature.[60]  
 
1.10.2. Lipid interactions and LCAMP activity 
If the mechanism of action of LCAMPs depends on selective aggregation with membrane lipids, 
then the lipid composition of the target membrane should have pronounced effects on the membrane-
disruptive effects of LCAMPs. This is found to be the case, with distinct differences in activity and 
selectivity induced by varying the membrane composition of the target membrane.[65] The electrostatic 
properties of the target membrane have been shown to exert a powerful effect on the activity of 
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LCAMPs.[57][58][65] The influence of lipid charge appears to go beyond the increased affinity of the cationic 
peptide for membranes containing anionic lipids; e.g. although the affinity of the LCAMP melittin for 
anionic lipid membranes is a hundred fold higher than for neutral lipid membranes,[116] > 98 % of M2a 
binds to zwitterionic POPC membranes within a short time frame.[65] This indicates that the increased 
rate of binding due to the electrostatic interaction between cationic peptide and anionic lipid, cannot 
solely account for the increased activity of the peptide within the anionic membranes, as the total 
amount of bound peptide is almost identical between the differently charged membrane systems.  
The intrinsic curvature of the membrane lipids has also been shown to effect LCAMP activity,[58][84] 
for example, M2a is more active in POPG membranes than in POPS membranes.[60] Both lipids have the 
same charge and acyl chains, but the PS headgroup is considerably smaller than the PG headgroup, 
rendering POPG a cylindrical geometry lipid, and POPS a conical geometry lipid. Further evidence for the 
preference of magainin for positive curvature lipids comes from the NMR work of Strandberg and 
colleagues,[117] who found that M2a does not insert within membranes (i.e. does not achieve the I-state) 
containing negative curvature lipids. In contrast, within membranes containing positive curvature lipids, 
magainin quickly transitioned from S-state to I-state.  The data unequivocally shows that the surface-
associated helical form of magainin is stabilised by negative curvature lipids. Lipid unsaturation has been 
demonstrated to affect the penetration depth and secondary structure of LCAMPs. Raghuraman and 
Chattopadhyay[115] use REES and W19 fluorescent lifetime studies to demonstrate that a greater degree 
of lipid unsaturation leads to shallower penetration of LCAMP helices. The reduced helical content 
within membranes containing multiple unsaturated lipids, detected by OCD, indicates melittin has 
trouble penetrating the hydrophobic core as a helix, when the membrane contains multiply unsaturated 
acyl chains.  
The presence of cholesterol has been found to generally reduce LCAMP activity in a concentration 
dependant manner.[118][119] Cholesterol is totally absent from bacterial membranes, but is present in high 
proportions within eukaryotic membranes.[119] The sterol has been reported to both reduce LCAMP 
binding to cholesterol containing membranes,[65][119] as well as reducing the penetration of melittin into 
the bilayer.[119] By using fluorescent quenching experiments, Raghuraman and Chattopadhyay[119] 
detected decreased penetration of W19 of melittin of ~0.8 nm in membranes containing 40 % 
cholesterol, compared to cholesterol-free membranes. The factors influencing lipid clustering around 
membrane-bound LCAP helices, are the same factors that exert an effect on the peptides activity, with 
this consilience forming a key link between lipid clustering and the mechanism of action of these 
peptides. Lateral segregation of lipids into dynamic lipid-peptide nanoclusters may therefore be of 
crucial importance to the mechanism of action of LCAMPs,[62][120] by forming lipid domains with 
significantly different local properties to the bulk membrane phase.  
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1.10.3.  Lipid interactions inducing pore formation 
One of the key points of this thesis is that lipid-LCAMP interactions can induce the formation of 
toroidal pores, through manipulation of local membrane properties, via selective aggregation with 
preferred lipids. Even in peptide-free membranes, it has been demonstrated that selective aggregation 
of lipids can induce the formation of pores,[121] with the inclusion of lipids with extreme inverse-conical 
geometry (DHPC) forming micron-scale pores within DPPC GUVs. Interestingly, above the phase 
transition temperature of DPPC, the GUVs display spherical non-porated forms. Upon decreasing the 
temperature below the phase transition of DPPC, the formation of solid-phase DPPC domains occurs, 
forming fluid domains enriched with the positive curvature DHPC. Large micron-scale pores would then 
form within the vesicle membrane. This can be explained using the Helfrich geometrical model of lipid 
interactions, to consider the changes in the vesicle membrane during the phase transition from 
homogeneous DHPC:DPPC fluid-phase to DPPC solid-phase and DPPC:DHPC fluid-phase coexistence. As 
the solid-phase domains form the surrounding bulk membrane becomes increasing enriched with the 
non-bilayer lipid DHPC, which forms spherical micelles in aqueous solution, with an associated increase 
in membrane packing frustration. The increase in the bilayer free energy eventually overcomes the 
energy required for the lipid remodelling into a pore, with the inverse-conical lipids forming a tightly 
curved cap at the pore rim. The phase transition and supramolecular reorganisation process is depicted 
in figure 1.14.  
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Figure 1.14: Diagram of a DPPC:DHPC membrane in the membrane normal plane, depicting the phase transition and 
supramolecular reorganisation reported within Sakuma and coworkers (2010), upon the cooling of a DPPC:DHPC membrane, 
from above the phase transition temperature (TM) of DPPC (40.1 ᵒC) to below the phase transition temperature. The bilayer lipid 
DPPC is shown as a cylinder, and micelle-preferring DHPC lipids as inverse cones. (A) Above the TM the DPPC:DHPC system exists 
as a bilayer, with the DHPC dispersed throughout the bulk DPPC lipids, creating a homogeneous liquid-disordered (Ld) phase. The 
presence of non-bilayer lipids in the bulk phase induces packing frustration, raising the energy of the bilayer compared to pure 
DPPC, indicated by the amber shading of the Ld label. (B) As temperature approaches TM the DPPC begins to coalesce into a gel-
phase, excluding the DHPC and increasing its concentration within the surrounding Ld-phase. This creates a lower energy DPPC-
rich phase, indicated by the green shading of the gel label, and a higher energy DHPC-rich phase, indicated by the red shading to 
the Ld label. (C) Below TM the DPPC-rich domains grow and the surrounding Ld-phase continues to increase in energy, until 
supramolecular organisation of the Ld phase bilayer is less energetically favourable than reorganisation of the DHPC-rich phase, 
into a leaflet fold structure capping the edges of a pore. This results in the DPPC lipids occupying their preferred bilayer 
organisation, and the DHPC lipids existing as micelle-like structures, reducing internal packing frustration and minimising the 
free energy of the system. 
 
This conformation minimises the free energy of the system, with the pore rim minimising the DHPC 
free energy, and the surrounding DPPC phase achieving a packing parameter ~ 1. Sakuma and co-
workers[121] provides an elegant example of the lipid-lipid interactions of large microdomains inducing 
large (~5 µm) pore formation, while lipid-LCAMP interactions work at the nanocluster levels, able to 
exploit the higher fluctuations in the free energy landscape at the nanoscale. 
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2. Materials and methods 
2.1. Design of microfluidic device 
Several considerations were taken into account during the design process, including generating a 
low back pressure microfluidic device, and the requirement for high throughput capability. The design 
chosen is presented in figure 2.1, and allows for integrated on-chip GUV production; washing; trapping 
and precise control over vesicle exposure to LCAMPs.[122] 
 
 
 
The device features a chamber for the electroformation of GUVs, then utilises the precise control 
over fluid flow offered by microfluidics to manoeuver the vesicles into nanofabricated PDMS traps. The 
traps are manufactured in dense arrays, allowing multiple trapped GUVs to be analysed within one 
experiment, increasing the throughput of the device. The design incorporates two separate channels for 
the introduction of solutions to the entrapped vesicles, allowing washing steps to be easily integrated 
Figure 2.1: Schematic for the microfluidic device, for 
the high-throughput manufacture, trapping and 
analysis of artificial biomimetic GUVs. Labelled as 
follows: (1) Microfluidic channel for moving the GUVs 
into the microfabricated trap arrays; (2) Channel for 
the introduction of the LCAMP solution to the 
entrapped vesicles; (3) Washing channel to remove 
peptide and extraneous dye from the entrapped 
GUVs; (4) Electroformation chamber for the on-chip 
production of biomimetic GUVs; (5) Chamber 
containing the high density microtrap array, for the 
entrapment of GUVs, using microfluidic flow to pin 
vesicles within PDMS pillar traps. 
 
1 
2 3 
4 
 
5  
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into the experimental protocol, and for LCAMPs to be introduced. Microfabricated pillars within the 
microfluidic channels, as well as the trap geometry, act as size filters allowing only GUVs with diameters 
between 10 and 40 µm to be trapped. 
 
2.2. Device microfabrication 
A PDMS device was manufactured by constructing a master mould of SU8 on a silicon wafer, using 
standard photolithography techniques as depicted in figure 2.2. The negative photoresist SU8-3050 
(Microchem Corporation, USA) was applied onto a four inch silicon wafer (University Wafer, USA), using 
a spin-coater (Headway Research Inc., USA) at 3000 rpm, to produce a 50 µm layer. The wafer was then 
given a pre-exposure bake, at 95 °C for 15 minutes on a hot plate, to remove the solvent. After cooling 
back to room temperature, an MA6 mask aligner system (Suss Micro Tec AG, Germany) was used to 
pattern the device design onto the SU8 layer, using an exposure time of 42 seconds. The wafer was then 
post-baked for 1 minute on a hot plate, at a temperature of 65 °C, before being transferred to a 95 °C 
hotplate for a further 4 minutes. The wafer was allowed to cool to room temperature, before being 
developed in Microposit 2-methoxy-1-methylethyl acetate EC solvent (Shipley European Ltd., UK). The 
development was performed in an ultrasonicator, to ensure complete removal of SU8 photoresist from 
the fine details of the design. After the non-exposed photoresist was removed, the mould was carefully 
rinsed with isopropyl alcohol (Sigma-Aldrich, UK), and dried under a stream of nitrogen. The mould was 
then hard baked at 180 °C for two hours, to harden the resist, and increase the number of pulls from the 
finished master mould. To confirm depth of resist, a Dektak 6M depth profiler (Veeco Europe, Germany) 
was used to confirm the height of the channels as 50 µm. The wafer was then coated in silane (XXX), to 
ease the removal of the PDMS chips from the mould, by gas-phase deposition under vacuum for 45 
minutes. The completed wafer was then mounted into a glass petri dish, and secured in position with 1 
cm of Sylgard 184 PDMS (Dow Corning, Massachusetts, USA), mixed as a 5:1 ratio of monomer to curing 
agent. A section of PDMS was excised, leaving a margin of 1 cm around the device, and PDMS chips 
could then be cast from the finished mould, using a 10:1 ratio of monomer to curing agent to cast a chip 
with depth ~3 mm. A chip was visualised using a Hitachi S-4700 scanning electron microscope (Hitachi 
High-Tech Co., Japan), to check the microtrap array geometry (figure 2.3), and then further chips cast.  
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Figure 2.2: Diagram depicting the photolithography process, to create the silicon master mould for the GUV microtrap array 
device. (A) Four inch silicon wafer (grey), with a 50 µm layer of SU8-3050 negative photoresist (red), applied via spin-coating at 
3000 rpm. (B) After a pre-exposure bake at 95 °C for 15 minutes, the photoresist was exposed to UV light (blue arrows) through 
a negative photomask. The wafer is then given a post-exposure bake at 95 °C for 4 minutes, then developed in Microposit EC 
solvent, to remove the non-exposed photoresist. (C) The wafer is then hard baked at 180 °C for 2 hours, to produce the final 
negative master-mould. 
 
(A) 
(B) 
(C) 
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Figure 2.3: Scanning electron microscopy pictures of the device geometry, with the scales as depicted on each image: (A) Low 
magnification image (x45), demonstrating the high density of the microtrap array, enabling high-throughput analysis. (B) Higher 
magnification image taken at an angle of 45°, depicting the trap geometry. (C) Close up image of a single GUV trap, taken at a 
magnification of x900 and an angle of 45°. (D) View of the PDMS pillars within the microfluidic channel, between the 
electroformation chamber and the microtrap array, designed to act as a size filter, allowing only GUVs with a diameter between 
10 and 40 µm to pass. 
 
Once cast, the electroformation chamber was excised using a scalpel, taking care to not block the 
microfluidic channels. Holes were punched into the PDMS to allow the entry and exit of the solutions 
into the channels, and the chip was plasma bonded to a clean glass microscope slide. The slides were 
immediately transferred into a solution of 100 mM glucose containing 0.1 % BSA, and sonicated to fill 
the microfluidic channels, with care taken to completely remove air from the microtrap array chamber. 
The BSA coated the inside of the PDMS device, presenting a more hydrophilic surface to the vesicles, to 
increase their stability within the device when pinned to the PDMS microtrap pillars. The chips were 
kept within the glucose and BSA solution until needed, then flushed with 100 mM glucose solution. 
 
2.3. GUV electroformation 
The production of GUVs via electroformation relies on passing an alternating electric field across 
hydrating lipid layers, causing the lipids to reorganise into lamellar vesicular structures. The microfluidic 
device was designed to be compatible with both on- and off-chip electroformation of GUVs, and the 
protocols for both are presented below. The selected lipid compositions are presented below in table 1, 
and represent a varied mix of lipid topography, with large variations in headgroup, fatty acid 
composition and unsaturation and charge. All lipids were ordered from Avanti Polar Lipids (Alabaster, 
USA), and used without further purification. 
(A) (B) 
(C) (D) 
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LIPID MIX* Molar percentage 
DOPC 100 
DOPC:DPPC 80:20 
DOPC:DOPE 80:20 
DOPC:DOPE:DOPG 60:20:20 
DOPC:DOPE:DPPG 60:20:20 
DOPC:DPPC:DOPG 60:20:20 
DOPC:DPPC:DPPG 60:20:20 
DOPC:DOPE:LPG 60:20:20 
DOPC:DOPE:DEPG 60:20:20 
DOPC:DOPE:POPG 60:20:20 
DOPC:DOPE:DOPG:DPPG 60:20:10:10 
DOPC:DPPC:cholesterol 35:35:30 
 
Table 1: List of the lipid compositions used in the dye-leakage experiments, showing the lipids within each mic and their molar 
percentage compositions. The selected lipids present binding LCAMPs to a wide variety of lipid topographies, featuring varying 
lipid headgroups, fatty acid composition and charge. DOPC as a cylindrical geometry bilayer lipid was used as a base membrane. 
*for fluorescence visualisation 0.05 mol% of DHPE-Rhodamine was added to each lipid mixture. 
 
2.3.1. Off-chip electroformation protocol 
The desired lipids were made up to a final concentration of 3.75 mg/ml, in a solution of 95:5 % 
chloroform:acetonitrile, and sonicated for 30 minutes to ensure even dispersal of the lipids within the 
solution. An electrical connection was made with an ITO-coated slide, with approximate dimensions 30 x 
30 mm, using either copper conductive tape or a copper wire secured with conductive paint. The 
conductivity for the slide was obtained using a multimeter to measure the resistance, between the ends 
of the wire and the centre of the ITO slide, and only those slides with < 40 Ω were used. The lipid 
solution was then spin-coated onto the conductive surface of the ITO-coated slide, at 300 rpm, to give a 
uniform coating of lipids across the entire slide. The thickness of the lipid film was assessed by AFM 
(XXX), and the results presented in figure 2.4. After spin-coating, the slides were dried under vacuum for 
two hours, to ensure the removal of all solvent traces from the lipid film. The coated slide was then 
separated from the conductive surface of another ITO-coated slide by a 1.5 mm spacer, either a rubber 
o-ring or a PDMS block with an excised centre, and sealed with vacuum grease. The electroformation 
process requires two solutions; an interior electroformation buffer consisting of 100mM sucrose, 5 mM 
HEPES (pH adjusted to 7.4 using 25% KOH) with 10 µM 3kDa dextran-AlexaFluor488 and 15 µM dextran-
AlexaFluor647; and an exterior washing buffer consisting of 100mM glucose, 5 mM HEPES (pH adjusted 
to 7.4 using 25% KOH). 
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Figure 2.4: Scanning AFM picture of the lipid film on an ITO-coated glass slide, after spin-coating with a 3.75 mg/ml solution of 
the lipid DOPC in a 95:5 % chloroform:acetonitrile solution. Although appearing uniform at a macro-scale, the micro-scale 
structure displays a “holes and rims” topography, of dried lipid layers surrounding flat areas, assumed to be the basement glass 
slide. The average depth of the lipid layers is approximately 40 – 50 nm. 
 
The space between the ITO slides was filled with electroformation solution, and an AC field electric 
pulse sequence was applied between the slides, with the parameters listed in table 2.  
 
Time (minutes) Frequency (Hz) Voltage (Vpp) Pulse shape 
0 -20 10 0.5 Sine wave 
20 – 40 10 1.0 Sine wave 
40 – 60 10 1.5 Sine wave 
60 – 120 10 2.0 Sine wave 
120-180 4 2.5 Square wave 
 
Table 2: Electroformation pulse parameters, listing the length of time each sequence is applied for, the frequency in Hertz, the 
field strength in Vpp and the field shape. The field strength is ramped up to 2.0 Vpp over 60 minutes, allowing small vesicular 
structures to form, then maintained at 2.0 Vpp for a further 60 minutes, where the small structures merge into larger vesicles.  
After 120 minutes, the frequency is adjusted to 4 Hz, the strength changed to 2.5 Vpp and the field shape changed to a square 
wave. This aids in detaching the formed GUVs from the ITO slide. 
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After electroformation, the GUVs are carefully transferred into the excised chamber in the PDMS 
chip, and the chamber filled with washing solution. The density gradient between the sucrose buffer 
within the vesicles, and the surrounding glucose solution, causes the GUVs to quickly settle to the 
bottom of the chamber, aiding both visualisation and transfer into the microfluidic device. The chip was 
sealed with a custom glass microscope slide, machined to include entry and exit ports for the PDMS 
device, forming a glass-PDMS-glass sandwich structure. The device was then sealed using a bespoke 
metal clamp, and the entry and exit ports fitted with tubing connected to syringe pumps, as pictured in 
figure 2.5. The tubes were sealed to the ports using silicon sealant to ensure a watertight seal. 
 
.
 
 
2.3.2. On-chip electroformation protocol 
On-chip electroformation uses the same pulse sequence as the off-chip procedure, but instead of 
the electroformation being carried out in a separate device, it is carried out within the excised chamber 
in the PDMS device. On-chip electroformation requires casting a thinner chip (~1.5 mm), in order to 
maintain the same electric field strength, and that the chip is bonded to an ITO-coated microscope slide, 
before being coated with the glucose/BSA solution. The lipid layer is spin-coated onto a ITO-coated 
Figure 2.5: (Top) Exploded schematic of the 
finished device, showing the glass-PDMS-glass 
sandwich construction. The version depicted is 
the on-chip electroformation, with the PDMS 
chips positioned between two ITO-coated 
microscope slides, with the bespoke metal clamp 
acting to seal the device  (Bottom) Picture of the 
assembled device. Showing the entry and exit 
ports of the microfluidic device are plumbed with 
tubing, connected to syringe pumps 
 
Metal clamp 
 ITO-coated microscope slide 
 
ITO-coated microscope slide 
 
PDMS chip 
 
Metal clamp 
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microscope slide, custom machined to allow access to the entry and exit ports of the PDMS chip, and 
electrical contact points made on the two ITO-coated slides. The device is assembled as shown 
previously, with the excised chamber being filled with the electroformation solution, and the pulse 
sequence in table 2 is applied. 
 
2.4. Dye-leakage protocol 
Once the GUVs are contained within the chamber, either through on- or off-chip electroformation 
as shown in figure 2.6, wash solution is used to flow the vesicles into the microtrap array 
 
Figure 2.6: (A) Equatorial cross-section of a biomimetic mGUV, composed of DOPC:DPPC:cholesterol (35:35:30 mol%), obtained 
via confocal microscopy. The membrane contains 0.05 mol% of the fluid-phase marker DHPE-rhodamine lissamine B, visualised 
in red, and 0.1 mol% of the gel-phase marker cholesterol-BODIPY, visualised in green. (B) SEM picture of the PDMS microtrap 
array, taken at an angle of 45°, showing the high trap density. (C) Fluorescence microscopy picture of mGUVs within the PDMS 
microtrap array, visualising the 3 kDa dextran-AlexaFluor fluorescence. (D) mGUVs within the electroformation chamber, 
showing the high yield possible using electroformation. 
 
To establish a negative control set, a total 292 GUVs were trapped within the microtrap array, and 
left under microfluidic flow for three hours in peptide-free conditions.  
 
2.5. Data processing 
The selection of PIEs that produced pore-mediated leakage events were data processed to remove 
artefacts like fluorescence background, photobleaching and the variation in initiation timings. The data 
processing allowed easy comparison of the leakage data from different GUVs. 
(A) 
(B) (C) 
(D) 
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2.5.1. Background and photobleaching correction 
The raw leakage traces were background and photobleaching corrected, using the data from the 
peptide-free vesicles to construct photobleaching curves, as depicted in figure 2.7. The data was then 
normalised, to ease comparison between GUVs of varying diameters. 
 
Figure 2.7: Graph demonstrating the data processing required to generate the final data, using a 10 kDa dextran leakage trace 
from a DOPC:DOPE:DPPG vesicle, exposed to 5 µM of the LCAMP magainin. The raw data (black squares) was adjusted for 
background fluorescence, which was typically <10 %, to create the background corrected trace (red diamonds). The 
photobleaching curves established using data from peptide-free control experiments (blue triangles), was then used to correct 
the leakage data for photobleaching, and create the final leakage trace (turquoise triangles). 
 
2.5.2. Time correction 
To correct for the variation in initiation of the pore-mediated leakage events, the leakage traces 
were truncated to remove the part of the trace before the initiation of the leak. This allows easy 
comparison of the dye-efflux kinetics from the individual GUVs. 
 
2.5.3. Kinetic grouping behaviour 
After data correction the leakage traces were compared to one another, and were found to 
organise into distinct kinetic groups, where individual GUVs show similar leakage kinetics, with an 
example shown in figure 2.8. 
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Figure 2.8: Compiled leakage traces for the 3 kDa dextran marker from a total of 29 DOPC:DPPC:DPPG vesicles, exposed to 1 µM 
of the LCAMP magainin. The kinetics organise into distinct groups, with each GUV within a group demonstrating similar leakage 
kinetics over considerable time periods (>1000 s). The group showing the fastest kinetics operates via the carpet mechanism, not 
pore-mediated leakage, and is included for comparison only.  
 
 The leakage traces can be compiled into average traces for each group, as shown in figure 2.9, 
which displays the averaged data from figure 2.8. 
 
2.5.4. Multiple leakage phase analysis 
Numerous leakage traces displayed distinct changes in kinetics during the time-course of an 
experiment, with abrupt increases or decreases in kinetics, pictured in figure 2.10.  
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Figure 2.9: Averaged leakage traces for the DOPC:DPPC:DPPG membrane system, for a total of 29 vesicles exposed to 1 µM 
magainin, with the groups identified as in the figure legend. A total of six groups can be identified within the leakage data, with 
the error bars representing the standard deviation of the individual leakage traces within each group. 
 
Figure 2.10: Graph presenting a trace displaying distinct and abrupt changes in the dye-efflux kinetics from a single DOPC GUV, 
expose to 5 µM of the LCAMP melittin. The changes in kinetics are indicated by the dashed red lines, with each individual phase 
lasting between 68 and 474 seconds. 
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To investigate this phenomenon, the individual leakage phase were separated out and 
renormalized, treating each change in the leakage kinetics as the initiation of a new leak. Figure 2.11 
presents the same leakage data seen in figure 2.10, after renormalisation, and allows each individual 
phase to be compared. 
 
Figure 2.11: Graph presenting the individual phases of a multiphase leakage trace, after each phase has been renormalised. The 
individual leakage phase kinetics organise into groups, and switch between the different rates of dye-efflux. The red lines 
indicate the average kinetics of each group, and are intended as a guide to the eyes only. 
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3. Peptide-induced effect (PIEs) profiling 
3.1. PIEs 
The high-throughput dye leakage experiments revealed a complex regime of outcomes to the lipid-
LCAMP interactions of the GUVs caught within the microfluidic device. These set of outcomes have been 
collectively termed peptide-induced effects (PIEs), and are presented below in figure 3.1. The definitions 
of each PIE are presented below, listing the criteria used to classify the results of the interactions of the 
LCAMPs magainin and melittin with GUVs. 
 
Figure 3.1: Diagram depicting the PIEs induced by the microfluidic exposure of GUVs, to the LCAMPs magainin and melittin. 
Some vesicles survived to the end of the experimental timecourse (120 min) with no visible escape of content (no effect); some 
vesicles suffered rapid and total membrane failure (burst); some GUVs had lost a portion of their contents, with no membrane 
alteration (graded); some vesicles had lost all their contents, with no membrane alteration (all-or-none) and some vesicles both 
lost their contents and displayed micellisation of their membranes (carpet). 
 
3.1.1. No effect 
GUVs surviving to the end of the experimental timecourse, with no escape of vesicle contents, or 
reduction in membrane volume, result in the LCAMP being declared inactive within GUV. Melittin was 
typically more active than magainin within the systems tested, with a notable exception; the inclusion of 
DPPG within membrane systems resulted in magainin displaying comparable activity to melittin. 
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3.1.2. Bursting 
Some vesicles suffered complete membrane failure upon exposure to the peptide, and received the 
burst PIE classification.  
 
3.1.3. Pore-mediated leakage 
Vesicles exposed to LCAMPs which displayed loss of contents, with no accompanying loss of 
membrane volume, were classed as leaking via pore-mediated leakage. 
 
3.1.4. Carpet mechanism 
Some GUVs lost their contents after exposure to LCAMPs, with accompanying loss of membrane 
volume, and were classified as leaking via carpet mechanism. A typical carpet mechanism leak involved 
very fast loss of vesicle contents, with a continuous steady reduction in GUV diameter, as lipid-peptide 
micelles were lost to the surrounding solution. 
 
3.1.5. Micellisation 
A small fraction of the entrapped vesicles displayed an instantaneous reduction of vesicle diameter, 
unlike the carpet mechanism, where the loss of membrane volume was continuous and steady. This 
vesicle population was classified as displaying micelle behaviour. 
 
3.2. Membrane systems 
A large proportion of the research done on the membrane disrupting activity of LCAMPs has been 
performed in one component homogeneous systems,[98][112][115] with the remainder being carried out 
within two component binary systems.[113][119] There have been few papers published featuring the 
interaction of LCAMPs with complex membranes featuring heterogeneous lipid topography. The studies 
carried out are understandably skewed towards popular and cheaper lipids, that are easy to work with 
at room temperature, and can easily be manipulated into bilayers. To fully understand the interaction of 
LCAMPs, with the extremely heterogeneous and complex in-vivo lipid membranes, a rigorous 
examination of the lipid-peptide interactions within more complex model membrane systems is needed. 
The membrane systems tested (table 1) are built around DOPC as a base membrane, selected as suitable 
due to its neutral  charge, cylindrical geometry (S = 1.08) and ease of electroformation. Binary, tertiary 
and quaternary lipid systems were created, by doping the base membrane with other lipids carefully 
selected to span the desired range of physiochemical properties. The chosen membrane systems 
present a membrane set with variation in several key physiochemical properties known to affect LCAMP 
activity; charge; fatty acid length and unsaturation and intrinsic curvature. The quaternary system 
DOPC:DOPE:DOPG:DPPG (60:20:10:10 mol%) was also selected, and was the most complex membrane 
model tested 
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3.3. PIE-profiles 
The varying PIEs produced can be compiled into PIE-profiles, which are characteristic for each of 
the membrane system tested. The profiles show that significant changes in peptide mechanism can be 
induced via the alteration of membrane composition. 
 
3.4. PIEs of melittin 
The PIE-profile data collected for the LCAMP melittin presented a wide range of activities and 
variation in the PIEs, dependent on the target membrane composition. 
 
3.4.1. Binary lipid systems 
Doping a DOPC base membrane with 20 mol% of lipids with varying physiochemical properties, 
resulting in GUVs with a binary composition, produced the PIE-profiles shown in figure 3.2. The control 
group consisting of 192 DOPC GUVs (average diameter 19.0 +/- 8.3 µm) trapped within the microfluidic 
microarray trap, under identical flow conditions but with no exposure to peptide, produced a 90.5 % 
inactive profile. The control GUVs displayed low amounts of both bursting (3.2 %) and leaking (6.3 %), 
but carpet and micelle effects were completely absent. Exposure of DOPC GUVs to 1 µM melittin 
produced a profile demonstrating 100 % peptide activity (29 vesicles with an average diameter of 23.2 
+/- 6.8 µm), containing mainly bursting (33.3 %) and pore-mediated leaking (50 %) effects. The carpet 
PIE accounted for 6.7 % of activity, and the micelle PIE was completely absent. Inclusion of 20 mol% 
DPPC, a lipid which possesses two 16C saturated fatty acid tails and displays positive intrinsic curvature 
(S = 0.74), deactivated melittin activity compared to pure DOPC membranes (total of 160 GUVs with an 
average diameter of 17.9 +/- 7.8 µm) The DOPC:DPPC membrane displayed an activity of 73.1 %, with 
pore-mediated leakage accounting for 35 % of the total PIEs. The remainder of the PIEs were split 
between bursting (14.4 %), micelle (13.1 %) and carpet (10.6 %). Addition of the conical non-bilayer lipid 
DOPE, with its small headgroup and large volume unsaturated fatty acid tailgroups (S = 1.41), produced 
a more significant shift of PIE-profile from pure DOPC than addition of DPPC (from a total of 227 GUVs 
with an average diameter of 16.2 +/- 6.5 µm). 90.7 % of vesicles displayed a PIE, with the highest pore-
mediated leakage percentage recorded for all of the binary vesicles exposed to 1 µM melittin (53.1 %). 
Unlike pure DOPC and DOPC:DPPC membranes, where the carpet mechanism, was the lowest frequency 
PIE recorded, in DOPC:DOPE membranes GUVs leaking via the carpet mechanism were the second most 
frequent PIE at 19.8 %. Bursting accounted for 12.5 % of PIEs, while micelle made up only 5.3 %. 
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Figure 3.2: PIE profiles produce, by the variation of lipid topography within binary lipid mixtures, from GUVs exposed to 1 µM 
melittin. Membrane topography is indicated by the blue geometrical shapes below the lipid mixes, and a peptide-free DOPC 
membrane control (192 GUVs) is included as the left most PIE profile, with > 90 % of the control vesicles surviving unchanged to 
the end of the experiment. Melittin is highly active within cylindrical DOPC membranes, with 100 % of the 29 GUVs displaying a 
PIE, profile is dominated by bursting and pore-mediated leakage events, with a small proportion (~15 %) of carpet and 
micellisation events. Melittin is significantly less active within DOPC:DPPC membranes, the addition of the inverse-conical 
geometry lipid DPPC lowers the peptide activity by > 30 %, and produces a PIE profile dominated by pore-mediated leakage. 
Addition of the conical geometry lipid DOPE to DOPC membranes increases both activity and carpet mechanism PIEs compared 
to DOPC:DPPC membranes, but the profile remains dominated by pore-mediated leakage. 
 
In summary, the binary membrane systems exposed to 1 µM melittin produced differing PIE-
profiles, and doping the cylindrical DOPC membrane with the conical DOPE lipid produced a larger shift 
than DPPC doping. Pore-mediated leakage remained the PIE with the highest population for the binary 
systems, but doping with conical lipids like DOPE appears to favour the carpet mechanism. It is 
interesting to note that inclusion of different topography lipids within the neutral topography DOPC 
membrane appears to significantly reduce the frequency of the bursting PIE for both cases; doping with 
the inverted conical DPPC lipid reduced bursting to 14.4 % compared to 33.3 % recorded in the base 
DOPC system, and doping with DOPE reduced it to 12.5 %. Melittin is a negative curvature inducing 
LCAMP, and when targeting membranes containing lipids with the opposite curvature lipids, like DPPC, it 
produces low activity levels. When attacking membranes containing lipids possessing negative 
curvature, like DOPE, the carpet mechanism becomes favoured. 
 
Lipid shape and lytic peptides Page 65 
 
3.4.2. Ternary lipid systems 
Increasing the complexity of the membrane, by the addition of a third lipid with differing 
topographical properties to a base DOPC:DOPE membrane to create a ternary system, produced the PIE-
profiles shown in figure 3.3.  
 
Figure 3.3: PIE profiles produced by the variation of anionic lipid topography, within the DOPC:DOPE:X lipid mixtures, from GUVs 
exposed to 1 µM melittin. Base DOPC:DOPE membrane  (227 GUVs) included on the left for reference, with the lipid(s) doped 
into the base DOPC membrane listed below each profile. Membrane topography is indicated by the geometrical shapes below 
the lipid mixes, with blue shapes indicating neutral lipids and red indicating anionic lipids. Inclusion of the highly positively 
curved anionic lipid LPG within the DOPC:DOPE membrane (138 GUVs) produces a large PIE-profile shift, deactivating melittin 
activity by 20 %, and reducing pore-mediated leakage and increasing bursting. Doping of the DOPC:DOPE membrane with the 
positive curvature anionic lipid DPPG (44 GUVs) produces a similar PIE-profile shift, displaying reduced activity with increased 
bursting and less pore-mediated leaking. Addition of the positively curved lipid POPG (47 GUVs) also produces similar profile 
shifts from the DOPC:DOPE membrane as the addition of LPG and DPPG. Doping with the cylindrical geometry anionic lipid 
DOPG (167 GUVs) produces a contrasting PIE-profile shift, displaying increased melittin activity, and a profile that is dominated 
by carpet leakage, with reduced pore activity. 
 
Melittin introduced to the DOPC:DOPE:LPG membrane system was significantly less active (-20.4 %) 
than within the DOPC:DOPE membrane, from 138 GUVs with an average diameter of 17.1 +/-7.0 µm. 
The extreme inverse-conical geometry of LPG produced a significant profile shift compared to the 
DOPC:DOPE membrane; bursting increased 19.1 % and pore-mediated leakage was reduced by 37.6 %. 
Carpet and micelle PIEs remained constant compared to the DOPC:DOPE membrane, at 18.8 and 6.5 % 
respectively, suggesting these PIEs result from lipid-peptide interactions that do not include LPG. 
Inclusion of DPPG, an anionic lipid with two 16:0 unsaturated fatty acids and possessing positive 
curvature, again produced less activity than the base DOPC:DOPE membrane when exposed to 1 µM 
melittin, with 34.9 % of vesicles surviving unchanged to the end of the experiment (44 GUVs with an 
average diameter of 11.9 +/- 4.8 µm). The profile was similar to the DOPC:DOPE:LPG membrane system, 
Lipid shape and lytic peptides Page 66 
 
except for a 16.5 % increase in bursting, compensated by an 11.8 % decrease in the carpet mechanism 
PIE. Addition of POPG rather than DPPG to the DOPC:DOPE membrane (47 GUVs with an average 
diameter of 11.8 +/- 6.5 µm), decreases the positive curvature of the anionic lipid, by increasing the 
hydrocarbon volume through replacement of one 16:0 acyl chain with an 18:1 (9z) chain. This change of 
hydrocarbon volume increases the amount of pore-mediated leakage by 9.4 % compared to the DPPG 
containing membrane system, coupled to a reduction in both the carpet mechanism (-4.9 %) and the 
micelle PIE (-2.3 %).The final ternary system of DOPC:DOPE:DOPG displayed the largest shift in PIE-
profile, and produced the most active DOPC:DOPE:X system, displaying 100 % activity from 167 GUVs 
with an average diameter of 18.9 +/- 7.7 µm. The profile produced similar levels of bursting and pore-
mediated leakage as the DOPC:DOPE:POPG system, but a substantial 39.2 % increase in the carpet 
mechanism PIE. 
The three inverse-conical anionic lipids with positive curvatures, all display lower melittin activity 
than the base DOPC:DOPE membrane system, while the cylindrical anionic  DOPG displays increased 
melittin activity, indicating that curvature additivity plays a role in the PIE produced. The clustering of 
positive curvature-inducing anionic lipids around the cationic negative curvature-inducing LCAMP 
melittin reduces peptide activity, via reduction of the packing strain induced in the membrane by the 
LCAMP. Arranging the anionic adulterant lipids into increasing packing parameters, i.e. decreasing 
positive curvature, gives the order LPG>DPPG>POPG>DOPG, moving from LPG a lipid possessing only 
one 16:0 fatty acid chain and very low hydrocarbon volume to DOPG, which has two 18:1 carbon acyl 
chains. The positive curvature anionic lipids (LPG/DPPG/POPG) within the series all return similar 
profiles, all featuring high levels of bursting as the primary PIE, and across the LPG, DPPG and POPG 
series the frequency of the carpet mechanism decreases. The jump in PIE-profile shift when moving 
from the positively curved anionic lipids (LPG/DPPG/POPG) to the cylindrical neutral curvature anionic 
DOPC is pronounced, with a 39.2 % increase in carpet mechanism, and overall 34 % increase in activity 
compared to the POPG containing membrane system. This large change in melittin activity and PIE-
profile, is produced from the replacement of one 16:0 fatty acid with its 18:1 (9z) equivalent, 
demonstrating a large change in peptide function produced by a small alteration of the target 
membrane.  
The second set of ternary membranes were of the form DOPC:DPPC:X, before including 20 mol% of 
anionic lipids possessing different topographical properties, produced the PIE-profiles shown below in 
figure 3.4. Compared to the DOPC:DPPC base membrane system, the inclusion of the positively curved 
DPPG produced a higher frequency of pore-mediated leakage (+18.5 %) from a total of 71 GUVs with an 
average diameter of 17.4 +/- 5.6 µm. The overall PIE-profile was similar to the base membrane, with the 
increase in pore-mediated leakage compensated by a slightly higher activity (+4.4%) and a reduction in 
the micelle PIE (-10.3 %). Inclusion of DOPG within the base membrane again produced the largest PIE-
profile shift, and the most active membrane system (total of 86 GUVs with an average diameter of 18.7 
+/- 6.0 µm). Pore-mediated leakage is the highest frequency event at 56.9 %, the highest level for any 
membrane system at this melittin concentration. The carpet PIE also displays a significant increase from 
the DOPC:DPPC base membrane of 20.8 %, with bursting (-10.9 %) and micelle (-9.6 %) both reduced. 
Lipid shape and lytic peptides Page 67 
 
 
Figure 3.4: Graph of the PIE profiles produced, by the variation of lipid topography within tertiary DOPC:DPPC containing lipid 
mixtures, from GUVs exposed to 1 µM melittin. Pure DOPC membrane (29 GUVs), and DOPC:DPPC membranes (160 GUVs) 
included for reference, with the lipid(s) doped into the base DOPC membrane listed below each profile. Membrane topography is 
indicated by the geometrical shapes below the lipid mixes, with blue shapes indicating neutral lipids and red indicating anionic 
lipids. Inclusion of the positively curved anionic lipid DPPG into the DOPC:DPPC membrane (71 GUVs) increases the pore-
mediated leakage, and reduces the micellisation effect, compared to DOPC:DPPC membranes. Doping of the DOPC:DPPC 
membrane with the negative curvature anionic lipid DOPG (132 GUVs) produces a significant PIE-profile shift, compared to 
addition of DPPG to the same membrane. Peptide activity is increased by ~20 %, and the profile is now dominated by pore-
mediated leakage (56.9 %) and carpet leakage (31.4 %). 
 
 The DOPC:DPPC:X membranes generally display higher activity levels than their DOPC:DOPE:X 
counterparts, and produce significantly higher levels of pore-mediated leakage events than either the 
binary lipid systems or the DOPC:DOPE:X ternary lipid systems. To demonstrate this point we can 
compare melittin activity and pore formation within the DOPC:DOPE:DPPG and DOPC:DPPC:DPPG 
membranes systems, which produce activities of 65.1 and 75.5 % respectively, and pore-mediated 
leakage frequencies of 14 and 53.5 % respectively. This indicates that the inclusion of lipids with the 
physiochemical properties of DPPC, i.e. zwitterionic, positive curvature and saturated acyl tailgroups, 
favour both the overall activity and the pore-mediated leakage mechanism of melittin. In both the 
DOPC:DOPE:X and DOPC:DPPC:X membrane systems, inclusion of the anionic DOPG lipid increased the 
carpet effect frequency compared to their respective base membrane systems. Addition of DOPG also 
activates melittin within the DOPC:DPPC:X system, compared to the DPPG containing system it is 20.3 % 
more active. 
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3.4.3. Peptide concentration and PIE-profiles 
To examine the effect of LCAMP concentration on the PIE-profiles produced by melittin, the lipid 
systems DOPC, DOPC:DPPC and DOPC:DOPE were exposed to 5 µM of melittin under identical flow 
conditions, and the profiles compared to the 1 µM results. A total of 72 DOPC GUVs with an average 
diameter of 21.3 +/- 7.7 µm, were exposed to 5 µM melittin, and produced the PIE-profile shown in 
figure 3.5. Both the 1 and 5 µM DOPC vesicles produced similar profiles, dominated by pore-mediated 
leakage events, but the higher melittin concentration of melittin was 30.6 % less active. The DOPC:DPPC 
membrane system also returned comparable profiles across the concentrations, both being dominated 
by pore-mediated leakage from a total of 75 DOPC:DPPC GUVs with an average diameter of 17.5 +/- 6.3 
µm. The higher melittin concentration was 21.6 % more active than the lower concentration, with the 
increased activity evident in the 31.7 % higher frequency of pore-mediated leakage. The DOPC:DOPE 
system again returned similar profiles across both melittin concentrations, but in contrast to the 
DOPC:DPPC system, the addition of negative rather than positive topography zwitterionic lipids 
produced a shift from pore-mediated leakage to carpet mechanism, rather than the increased pore 
formation of the DOPC:DPPC membrane system. 
 
Figure 3.5: Comparison of the PIE-profiles obtained at differing melittin concentrations, 1 (left) and 5 (right) µM, for binary 
mixtures of a base DOPC membrane doped with lipids of varying topography, indicated by the blue block shapes under each lipid 
mix. The base DOPC membrane displays reduced activity, mainly explained by a decrease in bursting, when exposed to the 
higher concentration of melittin, but the profile remains dominated by pore-mediated leakage. Doping the base membrane with 
the positive curvature lipid DPPC, produces higher peptide activity at higher melittin concentrations, with the increased activity 
almost completely represented by the increase in pore-mediated leakage. Conversely, the membrane doped with the conical 
topography lipid DOPE displays similar activities at both melittin concentrations, but a PIE-profile shift from pore-mediated 
leakage to carpet mechanism and increased bursting. 
 
The systems tested in figure 3.5 all produced PIE-profiles broadly comparable across the two 
different melittin concentrations, with all the profiles maintaining their primary PIE across the two 
concentrations; all the zwitterionic binary membrane systems are dominated by pore-mediated leaking 
events, despite varying lipid topography. It is interesting to note however, that the DOPC membrane 
doped with the inverse-conical geometry lipid DPPC produced higher pore leakage at the 5 µM 
concentration, while the inclusion of the opposite conical geometry lipid DOPE, produced a significant 
switch from pore-mediated leaking (-14.6 %) to the carpet mechanism (+7.2 %), although pore-mediated 
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leaking remained the primary PIE. Testing the effect of melittin concentration of the more complicated 
ternary anionic lipid systems produced the PIE-profiles shown in figure 3.6.  
 
Figure 3.6: Comparison of the PIE-profiles obtained at differing melittin concentrations, 1 and 5 µM, for base DOPC membranes 
doped with the lipids indicated below each profile, forming ternary lipid systems with contrasting zwitterionic and anionic lipid 
properties. The lipid geometries are indicated by the block shapes underneath each profile, with zwitterionic geometry indicated 
in blue, and anionic topography depicted in blue. The DOPC:DOPE:DOPG membrane system undergoes a marked profile shift on 
exposure to higher levels of melittin, with the profile becoming dominated by bursting events. The replacement of the negative 
curvature inducing lipid DOPE with the positive curvature lipid DPPC, produced comparable PIE-profiles across both 
concentrations of melittin, with both profiles dominated by pore-mediated leakage events. The increase in concentration of 
LCAMP also produced a decrease in the carpet PIE of -21.9 %. 
 
A total of 67 DOPC:DOPE:DOPG GUVs, with an average diameter of 25.5 +/- 6.5 µm, were exposed 
to the higher 5 µM concentration of melittin, and demonstrated a significant PIE-profile change, moving 
from a profile containing approximately equal levels of bursting and carpet mechanism, to one 
composed almost entirely of bursting (> 85 %). Inclusion of the opposite topography DPPC lipid within 
an otherwise identical lipid mix, produced comparable profiles across the two concentrations, for the 
total of 18 GUVs tested (average diameter of 16.5 +/- 6.9 µm), with a similar shift to that seen in the 
zwitterionic binary lipid DOPC:DPPC system; an increase in pore-mediate leakage couple to a decrease in 
carpet mechanism, again suggesting that the positive curvature lipid DPPC favours pore formation and 
disfavours the carpet mechanism. The 5 µM DOPC:DPPC:DOPG membrane produced the highest level of 
pore-mediated leakage for any membrane system tested (71.4 %). The large difference in PIE-profiles 
obtained, between the 1 and the 5 µM melittin DOPC:DOPE:DOPG membrane systems, is likely to be 
produced by the increased rate of peptide binding to the membrane at the higher concentration. Rapid 
binding of the negative curvature LCAMP melittin, to heterogeneous anionic membranes containing 
negative curvature zwitterionic lipids like DOPE, destabilises the membrane and causes complete 
membrane failure. This effect was not observed within the DOPC:DOPE membrane, indicating that the 
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electrostatic interactions between the anionic DOPG and the cationic LCAMP, play an important role in 
the bursting process. The quicker binding in the DOPC:DPPC:DOPG membrane system causes a shift in 
the PIE-profile, decreasing the amount of bursting relative to pore-mediated leakage events. Unlike the 
DOPC:DOPE:DOPG and DOPC:DOPE membrane systems, comparison of the DOPC:DPPC:DOPG 
membrane to its DOPC:DPPC counterpart, displays that increasing the melittin concentration has the 
same effect in this membrane pairing. This suggests the zwitterionic positive curvature lipid DPPC 
reduces the bursting frequency, as when exposed to 5 µM melittin, the DPPC containing membrane 
displays 73.6 % reduced frequency of the bursting PIE, compared to the otherwise identical membrane 
containing DOPE. 
  
3.5. PIEs of magainin 
The LCAMP M2a was considerably less active than melittin in the majority of the membrane 
systems tested, although the peptide displayed high levels of activity within certain membranes. 
 
3.5.1. Ternary lipid systems 
The addition of 1 µM M2a to ternary lipid systems, containing DOPC:DOPE doped with a series of 
anionic PG lipids, with varying degrees of intrinsic curvature, fatty acid unsaturation and hydrocarbon 
volume, produced the PIE-profile shown in figure 3.7. A total of 35 DOPC:DOPE:LPG GUVs with an 
average diameter of 20.0 +/- 7.5 µm were exposed to the LCAMP, displaying magainin activity of 49 %. 
The PIE-profile produced was dominated by bursting, with the bursting frequency more than twofold 
the frequencies of the pore-mediated leakage and carpet PIEs. Inclusion of DPPG within the DOPC:DOPE 
membrane system (total of 55 GUVs with an average diameter of 13.6 +/- 5.7 µm) resulted in higher 
M2a activity compared to the LPG containing system, presenting a peptide activity of 70.9 %, the highest 
magainin activity of any membrane system tested at this peptide concentration. The profile also 
displayed slightly increased carpet activity (+5.0 %) and reduced bursting frequency (-13.0 %), compared 
to that obtained for the DOPC:DOPE:LPG. Both of the membrane systems DOPC:DOPE:POPG and 
DOPC:DOPE:DOPG displayed low magainin activity, with the POPG membrane producing low amounts of 
bursting (4.3 %) and carpet mechanism (6.5%). The DOPG containing system was effectively inactive, 
displaying activity of < 6 %. Only one membrane system for the DOPC:DOPE:X series displayed peptide 
activity greater than 50 % - the DPPG system, which returned > 22 % higher activity than the second 
most active LPG containing system, although both these systems demonstrated significantly greater 
magainin activity than the POPG and DOPG containing membrane systems. This indicated that the 
positive curvature of the anionic lipids mediates magainin activity, suggesting a role for the electrostatic 
interactions between the anionic PG lipid headgroups and the cationic LCAMP amino acid residues in 
magainin, in activating the peptide within the target membrane. 
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Figure 3.7: PIE-profiles for DOPC membranes doped with the adulterant lipids noted beneath the profile, after exposure to 1 µM 
M2a, with the lipid topographies of each membrane displayed as geometric shapes beneath the relevant profile. Inclusion of 
LPG within a DOPC:DOPE membrane produces a profile dominated by bursting, with lesser amounts of pore-mediated leakage 
and carpet mechanism. The DOPC:DOPE membrane doped with DPPG produces the highest M2a activity of all the lipid systems 
tested, with the PIE-profile comprised mainly of pore-mediated leakage. M2a is almost inactive within both the POPG and DOPG 
containing membrane systems, with activity < 15 %. 
 
The positive curvature inducing LCAMP magainin is activated in membranes with similar (i.e. 
positive) topography anionic lipids, like DPPG (S = 0.78), and deactivated in membranes with containing 
lipids possessing packing parameters closer to one, like DOPG. The PIE-profiles obtained for the 
DOPC:DOPE:LPG membrane system are remarkable consistent for both 1 µM melittin and magainin, 
with both peptides displaying moderate activity of 71 and 49 % respectively. The profiles highest 
frequency PIE is bursting, and both show identical amounts of the pore-mediated leakage and carpet 
events. Addition of the extreme topography lipid LPG produces PIE-profiles that are almost identical for 
both of the LCAMPs, suggesting that the activity of the peptide within LPG containing membrane 
systems may primarily be due to its interactions with the lyso-lipid. Interestingly, the DOPC:DOPE:DOPG 
membrane system exposed to M2a was in fact more stable than a peptide-free system under identical 
flow conditions, with 94.1 % of vesicles surviving to the end of the experimental timecourse, compared 
to 90.5 % for the peptide-free system. Replacement of the DOPE to create the DOPC:DPPC:X systems, 
produced the PIE-profiles shown in figure 3.8, after exposure to 1 µM M2a.  The first member of the 
DOPC:DPPC:x system contains the anionic lipid DOPG, with unsaturated fatty acids and deactivates M2a, 
with less than 12 % of the 76 GUVs (average diameter of 19.4 +/- 7.7 µm) producing a PIE. The second 
member of the DOPC:DPPC:X membrane system contains the anionic lipid DPPG, and is almost fourfold 
more active  than the DOPG containing membrane (45.8 % active), producing a PIE-profile containing 
absolutely no bursting events, the only membrane system for either melittin or magainin to 
demonstrate no absolute membrane failure events. 
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The PIE-profiles for the DOPC:DPPC containing membrane systems again demonstrate the ability of 
the anionic lipid DOPG to deactivate M2a, where the charge clustering of anionic lipids with opposite 
membrane curvature to the LCAMP almost completely removes the ability of the peptide to disrupt the 
target membrane. Positive curvature anionic lipids have the opposite effect, with the three most active 
membranes also containing the three anionic lipids with lowest packing parameters; DOPC:DOPE:DPPG 
(70.9 % active); DOPC:DOPE:LPG (48.6 % active) and DOPC:DPPC:DPPG (45.8 % active). This pattern 
suggests that the topographic qualities of the anionic lipids clustering around a membrane-bound 
magainin helix are the key to the peptides activity. 
 
3.6. Quaternary system PIEs  
The quaternary lipid system DOPC:DOPE:DPPG:DOPG features different topography in its anionic 
lipids, and produced a different PIE-profile from the ternary DOPC:DOPE:DPPG and DOPC:DOPE:DOPG 
systems when exposed to 1 µM melittin, shown in figure 3.9. Inclusion of opposing topography anionic 
lipids favours both pore-mediated leakage and micelle events, in a total of 36 GUVs with an average 
diameter of 19.0 +/- 5.7 µm, resulting in the highest frequency of micelle events of all the membrane 
systems tested (38.9 %). The ternary lipid systems display the effects of including a single topography 
anionic lipid, with the positive curvature inducing DPPG producing one of the less active melittin profiles 
(65.1 % active), with the bursting frequency of 41.9 % threefold higher than the next most frequent 
event (pore-mediate leakage at 14 %). Inclusion of the anionic DOPG lipid, which possesses significantly 
higher hydrophobic volume than DPPG favoured different PIEs, still producing a high rate of bursting 
(34.1 %) but the highest frequency PIE is now the carpet mechanism at 41.3 %. 
Figure 3.8: Graphs displaying the PIE-
profiles for DOPC membranes doped 
with the lipids indicated, after exposure 
to 1 µM M2a, with the lipid geometries 
indicated by the block shapes under the 
profiles. Inclusion of DPPC and DOPG 
within the membrane deactivates 
magainin, with < 15 % activity. Replacing 
the DOPG with DPPG significantly 
increases peptide activity to ~ 50 %, with 
the PIE-profile dominated by pore-
mediated leakage. 
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Figure 3.9: PIE-profiles for the lipid mix DOPC:DOPE:DOPG:DPPG, produced after exposure to 1 µM melittin, with the ternary 
lipid mixes DOPC:DOPE:DOPG and DOPC:DOPE:DPPG included for comparison. Membrane topography depicted by the block 
shapes below each profile, with zwitterionic lipid topography shown in blue, and anionic lipid topography shown as red. 
Inclusion of multiple anionic topographies produces a large shift in PIE-profile compared to the monotopographic anionic 
membranes, which themselves produce significantly different profiles. The quaternary mix is dominated by pore-mediated 
leakage and micelle events, with bursting events occurring at much lower frequency than in the ternary lipid systems. Compared 
to the DOPG containing lipid mix, bursting and carpet mechanisms are reduced in the quaternary system, and pore-mediated 
and micelle events occur much more frequently. Compared to the DPPG containing system, the quaternary is much more active, 
with less bursting events, and a much higher frequency of pore-mediated and micelle events. 
 
A membrane containing multiple anionic topographies produces a significantly different PIE-profile 
from either of the membranes containing homogeneous anionic topographies, and indeed, different 
from any other lipid mix tested. Analysis of the PIEs of the quaternary lipid system after exposure to 1 
µM magainin produced the PIE-profile shown in figure 3.10, from a total of 75 GUVs with an average 
diameter of 16.5 +/- 7.3 µm. Unlike the melittin profile, exposure to magainin produced a profile 
displaying event frequencies in between those produced in the companion ternary lipid mixes, featuring 
single topography anionic lipids. Activity was 46.7 % in the DOPC:DOPE:DOPG:DPPG membrane system, 
compared to 70.9 and 5.9 % in the DOPC:DOPE:DPPG and DOPC:DOPE:DOPG systems respectively. This 
midway trend continued for all the PIEs recorded for the quaternary lipid system; bursting was 9.3 % 
compared to 12.7 and 2.9 % in the ternary systems (average 7.8 %); pore-mediated leaking was 18.7 % 
compared to the 20.0 % ternary average; carpet mechanism was 13.3 % compared to 16.4 and 2.9 % 
(average 9.65 %). 
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Figure 3.10: PIE-profiles for the quaternary lipid mix DOPC:DOPE:DOPG:DPPG, produced after exposure to 1 µM M2a, with the 
ternary lipid mixes DOPC:DOPE:DOPG and DOPC:DOPE:DPPG included for comparison. The lipid topography for each membrane 
is depicted by the block shapes below each profile, with zwitterionic lipid topography shown in blue, and anionic lipid 
topography shown as red. Inclusion of multiple anionic topographies produces a PIE-profile between those produced by 
membranes containing single anionic lipid topography, which themselves produce significantly different profiles. The quaternary 
mix is not dominated by any single PIE, with pore-mediated leakage being the favoured PIE event at 18.7 %, compared to 13.3 % 
for carpet and 9.3 % for bursting events. The peptide activity lies between the two ternary lipid systems at 46.7 %, compared to 
70.9 and 5.9 % for the three component lipid vesicles. 
 
3.7. Fatty acid unsaturation geometry and PIEs 
The influence of unsaturated bond geometry was demonstrated by the inclusion DEPG within a 
DOPC:DOPE base membrane. DEPG contains 18:1 (9E) fatty acid chains, where the unsaturated bond 
takes a trans isomeric form, as opposed to the cis form found in the rest of the unsaturated lipids 
tested, i.e. the 9Z fatty acid chains found in DOPE/DOPC/DOPG etc. The trans DEPG produces the PIE-
profile shown in figure 3.11, after exposure of a total of 31 GUVs with an average diameter of 13.8 +/- 
3.7 µm to 1 µM melittin, and displays the highest level of bursting for any lipid mix (87.1 %). The 
dramatic differences produced by changes in the fatty acid isomerism of the anionic component of the 
membrane, demonstrates the strong dependence of melittin action on the lipid topography of the 
target membrane. Trans isomerism reduces the hydrophobic volume of the lipid; the trans bond reduces 
the kink introduced in the acyl chain by the unsaturation, limiting lipid splay compared to cis 
unsaturated acyl chains. 
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Figure 3.11: Comparison of the PIE-profiles obtained for the inclusion of the 18:1 (9E) fatty acid containing lipid, in a DOPC:DOPE 
membrane exposed to 1 µM melittin, together with the DOPC:DOPE and DPPG and DOPG doped membranes for comparison. 
The DEPG containing membrane produces a profile dominated by bursting PIEs, more than twofold higher than either of the 
other anionic membranes, and the highest recorded for any lipid mix. Bursting is the only PIE recorded for the 9E fatty acid lipid, 
while the other lipid mixes produce much more varied PIE-profiles. 
 
The isomerism change to the membrane resulted in only bursting PIEs being produced, after 
exposure to membrane-bound melittin. DEPG membranes exposed to 1 µM magainin display a much 
less extreme shift to their PIE-profile, shown in figure 3.12, which records the PIEs recorded from a total 
of 95 GUVs with an average diameter of 17.2 +/- 6.3 µm. Magainin is only mildly active in DEPG 
membranes, recording an activity of 25.8 %, compared to the activity of 87.1 % recorded for melittin. 
The much higher activity of melittin in DEPG containing membrane suggests that changes in fatty acid 
isomerism at the depth in the membrane represented by the ninth carbon, i.e. 9Z or 9E isomerism, 
produces a much greater effect on the free energy of the lipid-melittin aggregate, than it does on the 
lipid-magainin aggregate. The complete lack of any other PIEs than bursting in the melittin/DEPG PIE-
profile, suggests that the change in fatty acid isomerism totally disfavours all the other PIEs, as no other 
lipid mix produced a profile so dominated by bursting. The magainin/DEPG profile contained bursting as 
its highest frequency event, but also low levels of the other three PIEs, i.e. pore-mediated leakage; 
carpet mechanism and micelle events. This suggests that M2a is much less sensitive to changes in the 
acyl chain at the depth represented by the ninth carbon in the chain. 
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Figure 3.12: Comparison of the PIE-profiles obtained for the inclusion of the 18:1 (9E) fatty acid containing lipid, in a DOPC:DOPE 
membrane exposed to 1 µM magainin, together with the DOPC:DOPE:DPPG and DOPC:DOPE:DOPG membranes for comparison 
purposes. The DEPG containing membrane produces activity midway between the two companion membrane systems, 
displaying 35.8 % activity, compared to 70.9 and 5.9 % activity for the DPPG and DOPG containing membrane systems 
respectively. Bursting was the highest frequency PIE, but unlike the melittin exposed system, DEPG containing membranes 
displayed other PIEs, when exposed to the same concentration of magainin. 
 
3.8. All-or-none versus graded leakage 
Unlike many reports within the literature, we found no fundamental difference in the pore-
mediated leakage from the entrapped vesicles. The all-or-none model proposes that once leakage has 
been initiated by the peptide, it will continue until all the vesicular contents have escaped, while the 
graded model proposes that only partial leakage will occur, and then membrane will reseal. Under our 
more rigorous, robust and repeatable experimental conditions, it is possible to clearly state that both 
this models are operating via the same mechanism, but merely following different leakage kinetics, as 
once leakage initiates under constant peptide binding conditions it continues until the vesicles contents 
are depleted. 
 
3.9. PIE average initiation times 
The timings of the PIEs varied considerably between membranes with differing lipid compositions, 
and the complete timing list for the lipid mixes mentioned in this chapter are presented in the tables 3 
and 4, for the LCAMPS magainin and melittin. The three membrane systems demonstrating the fast 
average occurrence of each PIE were ringed with the following colours, to highlight them for further 
discussion; fastest bursting membranes (red); fastest leaking (blue); fastest carpet mechanism 
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(turquoise) and fastest micelle events (pink). Note, only membrane PIE timings with >3 GUVs were 
included in the fastest rings.  
 
Table 3: Table containing the PIE timings for the membrane systems exposed to the LCAMP melittin. Included within the table 
are the lipid mixes tested, the concentration of melittin the membranes were exposed to in µM, the average timings for the four 
PIEs (Tburst/Tleak/Tcarpet/Tmicelle), and the standard deviations (SD) for each. The ringed timings are the members of the three 
fastest occurrences that occur within the membrane systems exposed to melittin. 
 
 
Table 4: Table containing the PIE timings for the membrane systems exposed to the LCAMP magainin. Included within the table 
are the lipid mixes tested, the concentration of melittin the membranes were exposed to in µM, the average timings for the four 
PIEs (Tburst/Tleak/Tcarpet/Tmicelle), and the standard deviations (SD) for each. The ringed timings are the members of the three 
fastest occurrences that occur within the membrane systems exposed to melittin. 
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In conjunction with the PIE frequency, the average initiation time of an effect within a particular 
membrane provide information on two factors. Firstly, a quick initiation time indicates that the lipid-
LCAMP interactions necessary to start the PIE occur quickly, with a slow initiation time indicating the 
converse situation, where the effect requires considerable binding of the peptide and longer lipid-
LCAMP interaction times to initiate. Secondly, the population of each effect demonstrates whether the 
individual effect is energetically favoured within that membrane. For example, a quick initiation time 
with a low event population, suggests only a few membrane-bound peptide molecules are necessary to 
start that effect, but the process is high energy and unflavoured within that membrane system. The 
converse situation, where a long initiation time is coupled to a high event frequency, suggests the 
opposite; that the process requires more membrane-bound LCAMP and/or longer timescale lipid-
LCAMP interactions to produce the event. The first thing noted about the PIE timings is the high 
variability of the initiation of the events, reflected in the large standard deviations. Secondly, increasing 
the concentration of the LCAMP fivefold does not always result in quicker event timings; e.g. DOPC 
vesicles exposed to 1 µM melittin displays an average bursting time of 762.5 s, compared to 2062.5 s for 
vesicles exposed to 5 µM melittin. It is interesting to note which membrane systems returned the 
quickest initiation of each PIE for each peptide, and to comment on the lipid topography and 
physiochemical properties of each lipid within the vesicle. Generally speaking it is interesting to note 
that although magainin was typically less active than melittin within all the membrane systems tested, 
the peptide still returns several fastest initiations of PIEs, suggesting that although magainin may be 
more selective than melittin, it is nevertheless capable of inducing quick membrane disruption within 
target membranes, if the lipid composition permits.  
 
3.9.1. Burst initiation times (red circles) 
Melittin rapidly induces bursting within DOPC:DPPC and DOPC:DOPE:DOPG membrane systems at a 
concentration of 5µM, the two quickest timings for any lipid mix tested. For DOPC:DPPC the average 
bursting time of 402.5 s is displayed by 14.4 % of the vesicles, suggesting that rapid binding of 5 µM 
melittin pushes a small proportion of the vesicle membranes to complete failure, without triggering any 
other PIEs. Only those membranes which survive for longer periods go on to experience alternative PIEs, 
with pore-mediated leakage being the most common (35 %). In the DOPC:DOPE:DOPG membrane 
system exposed to 5 µM melittin, a contrasting situation occurs with relation to the proportions of GUVs 
that quickly initiate bursting, with ~88 % displaying the effect at an average time of 219.4, the quickest 
average bursting time displayed by any membrane-LCAMP system. Three quarters of the remaining 12 
% of vesicles go on to exhibit the carpet mechanism PIE (9.3 % total). The third fastest system to initiate 
bursting is the DOPC:DOPE:POPG membrane system, after exposure to 1 µM magainin; unlike the 
melittin systems, where the higher peptide concentrations returned the fastest bursting times, a 
magainin system at the lower concentration displayed the fastest bursting time, indicating that lipid 
composition is more important for magainin than peptide concentration for initiating the bursting PIE.  
 
3.9.2. Pore-mediate leakage initiation times (blue circles) 
The quickest membrane to initiate pore-mediate leakage effects was the DOPE:DOPE:DPPG system 
exposed to 1 µM magainin, where 41.8 % of GUVs displayed pore formation with an average initiation 
time of 289.5 s. This time was much quicker than any of the other PIEs observed within this membrane 
system, indicating that at this peptide concentration, the lipid-LCAMP interactions rapidly form toroidal 
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pores. The higher 5 µM magainin concentration decreased the initiation times for the other PIEs, but the 
average initiation time for the formation of pores increased by almost an order of magnitude. This 
indicates that rapid binding of the LCAMP at the higher peptide concentration deactivates the pore 
formation process, perhaps via decreasing the time available for peptide diffusion within the 
membrane. The next two fastest initiations of pore-mediate leakage were both within 1 µM melittin 
systems, and displayed very similar times; the DOPC:DPPC:DOPG system returned a 56.9 % pore-
mediated leaking frequency with an average initiation time of 450.6 s, and the DOPC:DOPE:DPPG:DOPG 
quaternary system produced 41.7 % pore formation with a time of 441.7 s. Note that all these systems 
contain lipid displaying opposite topography, i.e. DPPC (packing parameter of 0.78) and DOPG (packing 
parameter of ~1) in the DOPC:DPPC:DOPG system, and DOPE (packing parameter of 1.41) and DPPG 
(packing parameter of 0.81) in the DOPC:DOPE:DPPG:DOPG system. Together with the negative 
curvature induction of the peptide, variation in lipid topography produces rapid pore formation in 
membrane systems exposed to melittin, although inclusion of two opposing anionic topographies in the 
quaternary system seems to disfavour pore formation slightly. All three membrane systems that 
produced rapid pore formation went on to record pore-mediated leakage as their highest frequency PIE, 
suggesting that when the lipid composition allows pore formation, it is the energetically favoured lipid-
peptide interaction. 
 
3.9.3. Carpet mechanism initiation times (turquoise circles) 
The DOPC:DOPE:LPG membrane system exposed to 1 µM magainin produced the fastest initiation 
of carpet mechanism, for all lipid mixes tested, and again the average time of 187.5 s was much smaller 
than the initiation times for the other PIEs demonstrated by the system. Only 11.4 % of vesicles 
produced the carpet mechanism PIE, with 48.6 % total activity in that membrane system, with the 
highest frequency effect being pore-mediated leaking. Melittin at 1 µM in the DOPC:DOPE:DPPG 
membrane system produced the second fastest average initiation time for carpet mechanism effect, of 
258.3 s, with 7 % of vesicles displaying the effect (65.1 % overall activity). With the quick initiation time 
but low event population, this suggests that although the conditions necessary for initiation of carpet 
mechanism occur quickly, the process is energetically unflavoured, compared to the other PIEs; i.e. in 
contrast to the bursting effect, which displayed an average initiation time of > 3700 s but a high 
population of 41.9 %. These facts suggest that this PIE requires a longer time for initiation, but is much 
more energetically favoured under identical conditions, than the carpet mechanism within this 
membrane system. The third fastest average initiation time for the carpet mechanism was recorded in 
the DOPC:DOPE:DOPG membrane exposed to 1 µM melittin, with 41.3 % of GUVs from a total activity of 
100 % producing this effect, making it the highest frequency PIE. Compared to DOPC:DOPE:DPPG 
system, replacement of the positive curvature DPPG with DOPG, produces both a fast initiation time and 
a high frequency event. The increased hydrophobic volume of DOPG leads to both quick onset of the 
conditions for the carpet mechanism, and in contrast to the DPPG containing system, energetically 
favours the process. 
 
3.9.4. Micelle initiation times (pink circles) 
Although the micelle PIE is only present at low levels in most membrane systems, one of the 
quickest average initiation times of 410.7 s, comes from the quaternary DOPC:DOPE:DPPG:DOPG 
membrane system, which contains the highest frequency of micelle PIE displayed by any membrane 
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system (38.9 %). The next two highest frequency of micelle events occurred in the DOPC:DPPC 
membrane system, with 13.1 and 9.3 % recorded after exposure to 1 and 5 µM melittin respectively. 
The DOPC:DPPC systems returned initiation times of 2544.7 s for 1 µM melittin, indicating that at the 
same peptide concentration, the lipid-LCAMP interactions for the micelle event both require less 
membrane-bound peptide and are much less energetically favoured, than in the 
DOPC:DOPE:DPPG:DOPG membrane system. Addition of DOPG to the DOPC:DPPC:X system produced 
the second fastest average initiation time for the micelle PIE, recording a time of 361.7 s when exposed 
to 1 µM melittin. With just 3.5 % of vesicles producing the effect, the addition of DOPG to the 
DOPC:DPPC membrane decreases the initiation time of the micelle effect by almost fivefold, compared 
to the base DOPC:DPPC membrane system. This indicates that the rapid clustering of DOPG around the 
membrane-bound melittin helix within the bulk DOPC:DPPC membrane rapidly produces the conditions 
needed for the micelle effect, but also energetically disfavours the process. This suggests that 
aggregation of melittin with lipids featuring bulky hydrophobic volumes, like DOPG with its two 18:1 (9Z) 
fatty acid tailgroups, is a vital part of initiating the micelle PIE. This suggestion receives support upon 
consideration of the membrane with the fastest average initiation times for the micelle event, the one 
component DOPC system. Within this system the membrane-bound peptide can only interact with 18:1 
(9Z) containing lipids, and hence produces the rapid initiation of micelle events, the low population of 10 
% of DOPC GUVs showing this effect suggests however that it is still energetically disfavoured. 
 
3.10. PIE summary 
Doping a base membrane of cylindrical (i.e. neutral) geometry DOPC lipids with adulterant lipids of 
varying topography and charge, produces a range of PIE-profiles after exposure to the LCAMPs melittin 
and magainin, with anionic lipids producing a greater shift from the DOPC profile than zwitterionic lipids 
for both peptides. The DOPC:DOPE:X and DOPC:DPPC:X membrane systems exposed to melittin 
separate into two distinct groups of PIE-profiles, based on their anionic lipid topography; one group 
characterised by lower hydrophobic volume anionic lipids, and the other characterised by higher 
hydrophobic volume anionic lipids. The overall activity of the lipid-melittin system appears to be 
controlled by the hydrophobic volume of the fatty acids of the anionic lipids within the system. Those 
containing anionic lipids with lower hydrophobic volume fatty acids (i.e. positive curvature topography 
lipids like LPG, DPPG and POPG) are significantly less active than those containing DOPG, a negative 
curvature topography anionic lipid possessing a large hydrophobic volume, caused by its two 18:1 (9Z) 
oleic acid chains. 
The pore-mediated leakage activity of these membranes exposed to melittin however, shows a 
dependence on the zwitterionic lipid DPPC, with the DOPC:DPPC:X containing systems returning average 
pore activity of ~55 %, compared to the relevant DOPC:DOPE:X systems average of ~17 %. It can 
therefore be stated that pore formation is strongly favoured by the presence of DPPC, a zwitterionic 
lipid, with a large phosphatidylcholine headgroup and low hydrophobic volume. Comparison of the 
peptide activity of the DOPC:DOPE:X and DOPC:DPPC:X systems, when exposed to magainin also 
produces two groupings based on anionic lipid topography, but the topographic characteristics for 
higher activity are reversed compared to melittin. Within lipid-magainin systems, lipids with lower 
hydrophobic volumes and inverse conical geometry (i.e. LPG and DPPG) activate the peptide, and the 
highest anionic hydrophobic volume system (DOPC:DOPE:DOPG) returns the lowest activity for any lipid-
peptide system tested, lower in fact than a peptide free system under the same experimental 
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conditions. Unlike melittin, the pore-mediated leakage activity of magainin appears to be independent 
of the zwitterionic lipid topography, depending only on the anionic content of the membrane. 
Despite the trend of lower activity of magainin, compared to melittin within equivalent 
membranes, the selective magainin displays quick initiation of both leaks and carpet mechanism within 
certain membranes. This rapid initiation of PIEs once again appears to depend on the topographic 
character of the anionic membrane components, requiring the presence of large headgroups and low 
hydrophobic volumes, i.e. inverse-conical geometry negative lipids. It is notable that only certain PIEs 
occur quickly, for example magainin within DOPC:DOPE:DPPG membranes initiates pore-mediated 
leakage after an average of 289.5 s, but the other PIEs displayed by this system, the bursting and carpet 
mechanisms, occur after 4407.1 and 1808.3 s respectively. This indicates that specific electrostatic/steric 
interactions between DPPG and the membrane-bound magainin helix enables quick pore formation, 
suggesting that lipid-AMP interactions of inverse-conical anionic lipids with the magainin helix 
significantly lower the barrier to pore formation. A similar effect is seen in the DOPC:DOPE:LPG system, 
where the bursting PIE occurs rapidly (187.5 s), and the bursting and pore-mediated leakage PIEs initiate 
after considerably longer time periods (1677.8 and 3191.7 s respectively). An opposite trend in anionic 
topography versus PIE initiation time is noticed for the anionic lipid-melittin systems, where quick 
initiation of PIEs is generally linked to the large hydrophobic volume DOPG lipid, with six of the fastest 
seven PIEs induced in the anionic systems containing this specific lipid. This indicates that the large 
hydrophobic volume generated by the two 18:1 (9Z) oleic acid chains can quickly initiate PIEs when 
interacting with the melittin helix. 
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4. Pore-mediated leakage in zwitterionic membranes 
4.1. Melittin dye-efflux kinetics 
The pore-mediated leakage events of the AMP melittin, induced within zwitterionic lipid 
membranes containing a variety of lipid topographies, display a complex and interesting set of leakage 
kinetics. This chapter will present the leakage kinetics for melittin, starting with simple one component 
lipid systems, and gradually increasing the system complexity to include binary zwitterionic membrane 
systems, to examine the effect of physiochemical properties like fatty acid unsaturation and lipid 
geometry on the pore-mediated leakage process. The inclusion of two differentially sized fluorescently 
tagged dextrans within the entrapped GUVs will allow estimation of the LCAMP-induced pore size. 
 
4.1.1. DOPC membrane system 
The base DOPC membrane contains only cylindrical topography lipids, with each fatty acid acyl 
chain containing a single unsaturated carbon-carbon bond, located at the ninth carbon along from the 
glycerol backbone; i.e. an 18:1 (9Z) acyl chain. When DOPC GUVs containing both 3 and 10 kDa 
fluorescently tagged dextrans, are exposed to the AMP melittin at a concentration of 1 µM, the enclosed 
dextrans escape with the kinetics shown in figure 4.1.The leakage kinetics group together into distinct 
modes displaying similar leakage kinetics, with figure 4.1 displaying the average leakage traces compiled 
from the following number of vesicles; group 1 compiled from 3 GUVs; group 2 from 6 GUVs; group 3 
from 4 GUVs; group 5 from 5 GUVs and group 6 from 3 GUVs. The averaged carpet traces, included for 
comparison, is compiled from 3 GUVs. The quantised nature of the leakage kinetics suggests that pore-
mediated leakage can only proceed via the formation of pores with tightly restricted size and/or 
number. The standard deviations for the 10 kDa dextrans are larger than the 3 kDa standard errors, 
indicating the pore-mediated leakage for the larger dextran is subject to increased variability than the 
smaller molecule. A DOPC lipid membrane is composed of almost perfectly cylindrical lipids; any 
curvature induction within the membrane must be generated by the AMP itself. The pore-mediated 
leakage events that generate multi-component traces can be separated into their individual 
components, and overlaid with the leakage groups compiled from the single component leakage traces. 
For the DOPC membrane at a melittin concentration of 1 µM, the multi-component traces overlay with 
the groupings established by the single component traces, and do not result in the creation of any 
groupings not visible from the single component leakage traces. An example leakage trace containing 
three components is presented in figure 4.2. 
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Figure 4.1: Dye leakage kinetics for the dextran-AlexaFluor conjugates contained within DOPC vesicles, after exposure to 1 µM of 
the AMP melittin, displaying the complete leakage kinetics compiled from the single and multimodal traces. The kinetics for both 
the 3 kDa (top) and 10 kDa (bottom) traces show distinct grouping into quantised kinetics modes, with the error bars 
representing the standard deviation for the traces contained within each group. Six pore-mediated leakage groups are visible 
within the smaller 3 kDa dextrans leakage data, with the carpet mechanism leakage kinetics included for comparative purposes. 
In contrast to the 3 kDa results, two of the corresponding modes from the larger 10 kDa dextran kinetics follow almost identical 
kinetics (groups 1 and 2). 
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Figure 4.2: Graph demonstrating the overlaying of the individual component leaks from multi-component traces (red), with the 
kinetic groupings assembled from the single component leakage traces (black). A GUV displaying a three component leaking 
behaviour was chosen, and demonstrates complex group switching behaviour. The first leakage component (red pentagons) 
displays leakage kinetics in parallel with group 1, and maintains this behaviour for > 200 s, before switching to match the 
kinetics of group 5 in its second leakage component (red hexagons). It demonstrates group 5 leakage kinetics for a further 200 s, 
before beginning its third leakage phase (red stars), where it matches group 4 leakage kinetics until the vesicle contents are 
completely depleted. 
 
The multi-component leakage traces, where each individual component leak overlays with the 
leakage kinetic groupings established by averaging the single component leakage traces, provides 
further evidence for the pore-mediated leakage process occurring via a set of quantised pores. The 
continual binding of AMP to the lipid membrane during the pore-formation process can alter membrane 
conditions such that the leakage parameters change from one quantised leakage state to another. 
When exposed to a melittin concentration of 5 µM melittin, a similar averaged leakage graph for the 
escape of the enclosed 3 and 10 kDa dextrans can be constructed from the single component leaks, and 
is depicted in figure 4.3. The number of leakage traces compiled to produce the averaged leakage chart 
were groups 1 – 3 compiled from 2 GUVs; group 4 from 6 GUVs; group 5 from 3 GUVs and group 6 
compiled from 4 GUVs. The carpet group depicted on the chart was produced by averaging the leakage 
kinetics from 5 vesicles demonstrating the carpet mechanism. 
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Figure 4.3: Dye leakage kinetics for the pore-mediated leakage process initiated by the exposure of DOPC vesicles to a melittin 
concentration of 5µM, constructed by averaging the single component leakage traces. The efflux of the 3 kDa (top) and 10 kDa 
(bottom) dextrans again form distinct groups of similar leakage kinetics. 
 
In contrast to the leakage graphs compiled from the multimodal leakage traces at a melittin 
concentration of 1 µM, which do not demonstrate the creation of any novel leaking groups, the graphs 
compiled including the multi-component traces displays a leakage group not found within figure 4.3 
(group 3). The novel leakage group follows an individual leakage kinetic in the 3 kDa data, but initially 
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follows the leakage kinetics of group 4 in the 10 kDa data set, before shifting to slower kinetics after 
~450 s. 
 
Figure 4.4: Dye leakage kinetics for the pore-mediated leakage process initiated by the exposure of DOPC vesicles to a melittin 
concentration of 5µM, constructed by averaging the single and multi-component leakage traces. The efflux of the 3 kDa (left) 
and 10 kDa (right) dextrans again form distinct groups of similar leakage kinetics, with the presence of a new grouping, not 
present in the graph compiled from the single component leakage traces (group 3). 
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The graph in figure 4.4 was compiled from the following number of leakage traces; group one from 2 
traces; group 2 from 2 traces; group 3 from 8 traces; group 4 from 4 traces; group 5 from 3 traces; group 
6 from 8 traces and group 7 from 12 traces. The carpet leakage trace was compiled by averaging 10 
leakage traces. To compare the effect of AMP concentration on the dye efflux kinetics induced by 
melittin from DOPC GUVs, the leakage graphs for both 1 and 5 µM melittin were overlaid, to create the 
graph shown in figure 44. 
 
Figure 4.5: Overlaid grouping data for DOPC membrane system, with 1 µM melittin traces shown in black, and 5 µM melittin 
traces depicted in red. The higher melittin concentration produces traces which almost perfectly overlay with the lower, with the 
exception of an additional leakage group demonstrating fast leakage kinetics (group 6). 
 
The overlaid data for the two different melittin concentrations match almost perfectly, 
demonstrating that within mono-topographic membranes, increasing the AMP concentration does not 
affect the allowed leakage states. Instead the increase of peptide concentration induces faster onset of 
pore-mediated leakage. 
 
4.1.2. DOPC:DPPC membrane system 
Inclusion of DPPC within the DOPC membrane increases topographical variety; DPPC is a lipid 
possessing positive curvature, induced by its two sixteen carbon saturated fatty acid chains (16:0). 
Combined with its large choline headgroup, the reduced hydrophobic volume of DPPC compared to 
DOPC, results in a packing parameter of 0.74 and positive curvature generation within membranes. The 
leakage data for the DOPC:DPPC (80:20 mol%) membrane system again displayed grouping of the 
leakage traces into distinct modes, shown in figure 4.6. 
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Figure 4.6: Modal dye leakage kinetics for the 3 (top) and 10 (bottom) kDa dextran-Alexafluor markers entrapped within 
DOPC:DPPC vesicles, exposed to 1 µM melittin, with the error bars representing the standard deviations from the averaged 
traces within each group. There are seven groupings visible within the leakage kinetics, shown in the diagram key above. Six of 
the groups represent pore-mediated leakage, with the seventh and fastest leakage group, representing leakage through the 
carpet mechanism (blue diamonds). 
 
The groupings in figure 4.6 were compiled by averaging 6 traces for group 1; 5 traces for group 2; 
10 traces for group 3; 6 traces for group 4; 3 traces for group 5 and 9 traces for the carpet mechanism 
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group. Similar to the DOPC membrane results, two of the leakage groupings which are clearly separated 
in the 3 kDa data set, appear to follow almost identical leakage kinetics in the 10 kDa traces (groups 3A 
and 3B). Multi-component leakage traces can switch between these two groups during the pore-
mediated leakage process, as demonstrated in figure 4.7, which splits a 3 kDa leakage trace from a 
single vesicle into two components which almost perfectly overlay with the two groups. The DOPC:DPPC 
membrane system produces a similar complex set of leakage groupings to the base DOPC membrane 
system, featuring six pore-mediated leakage groupings, compared to the six groups seen for the DOPC 
system.  
 
Figure 4.7: Graph displaying the group switching behaviour of the 3 kDa leakage kinetics from a DOPC:DPPC (80:20 mol%) GUV. 
The trace (red) for the GUV can be separated into two components, and overlaid with the averaged 3 kDa leakage traces (black), 
demonstrating that conditions in the lipid-peptide systems can change during the pore-mediated leakage process. These 
changes interrupt the leakage process currently taking place, and force a return to the initial stages of the pore formation 
process, as demonstrated by the second leak (red hexagons) closely following the kinetics of group 3B (red pentagons) for ~1000 
s, before separating to following the faster group 3A kinetics until the vesicle contents are depleted. 
 
The group switching that occurs as depicted in figure 4.7 demonstrates that the pore-mediated 
leakage process can be interrupted, presumably by continually binding AMPs forcing changes to the 
lipid-peptide system, and changing the leakage kinetics to another quantised pathway. A further point 
of interest from the DOPC:DPPC membrane system exposed to 1 µM melittin is that at longer 
timescales, the leakage kinetics seem to run parallel, indicating that whatever the leakage pattern 
followed initially by an individual vesicle, the pore-mediated leakage process establishes steady state 
leakage at longer timescales, shown in figure 4.8.  
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Figure 4.8: Graph demonstrating the parallel nature of the kinetics of the averaged leakage groupings at long timescales, for the 
DOPC:DPPC membrane system exposed to 1 µM melittin. Linear slope fitting returned values of the slope of group 1 as -4.59 x 
10
-5
, group 2 as -5.07 x 10 
-5
, group 3A as -5.97 x 10
-5
 and group 3B as -4.99 x 10
-5
. The dye-leakage kinetics of groups 2, 3A and 
3B appear to decrease at longer timescales, until they run in parallel with the kinetics of group 1. 
 
The DOPC:DPPC membrane system exposed to 5 µM melittin produces the leakage kinetics 
displayed in figure 4.9. Clear grouping of the leakage data is again visible within the 3 kDa data set, with 
the 10 kDa data being less defined. Higher melittin concentration resulted in groups with improved 
standard errors compared to the lower peptide concentration; i.e. better defined, more distinct 
groupings of leakage kinetics occurs at a melittin concentration of 5 µM. The merging of two 3 kDa 
leakage groups into one 10 kDa leakage group is again present, with groups 2 and 3, which follow clearly 
different kinetics within the 3 kDa data set, follow almost identical kinetics within the 10 kDa data set. 
The data displayed in figure 4.9 was assembled by the averaging of the following leakage traces for each 
group; group 1 produced by averaging of 9 traces; group 2 from 3 traces; group 3 from 3 traces; group 4 
from 12 traces; group 5 from 4 traces and the carpet mechanism trace from 4 traces. Another feature 
that reappeared within the 5 µM data set for the DOPC:DPPC membrane system is the matching 
between the individual multi-component leakage phases, and the leakage groups established by the 
single-component leakage traces, as demonstrated in figure 4.10. 
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Figure 4.9: Averaged leakage kinetics for the 3 (top) and 10 (bottom) kDa dextrans entrapped within DOPC:DPPC (80:20 mol%) 
vesicles, exposed to 5 µM melittin. Error bars are the standard deviations from the averaged traces within each group. There are 
six groupings visible within the leakage kinetics, shown in the diagram key above. Five of the groups represent pore-mediated 
leakage, with the sixth and fastest leakage group, representing leakage through the carpet mechanism (green triangles). 
 
Figure 4.10 shows a four component leakage trace, which when the individual leakage phases are 
separated and overlaid with the averaged leakage groups, clearly follow almost identical dye-leakage 
kinetics to the averaged data. This figure demonstrates that not only can pore-mediated leakage switch 
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between quantised leakage kinetics during the leakage process, but also that the form of leakage can 
change, with this vesicle demonstrating a change from pore-mediated to carpet-mediated leakage. 
 
Figure 4.10: Graph demonstrating the group switching capabilities of the pore-mediated leakage process in DOPC:DPPC (80:20 
mol%) membranes. The averaged leakage groups are depicted in black, with the individual phases of the multi-component 
leakage trace shown in red. The initial leak (red diamonds) follows the slowest leakage kinetics of group 1 for ~ 850 s, before the 
second leak (red pentagons) switched to match the kinetics of the faster group 4 for ~200 s. The third leakage phase (red 
hexagons) then matches the group 5 kinetics for ~150 s, before the leakage switches groups to match the carpet mechanism. 
 
The overlaying of the 1 and 5 µM data sets for the DOPC:DPPC membrane system produces the 
graph presented as figure 4.11. Unlike the base DOPC membrane, the overlay of the two melittin 
concentrations does not show almost perfect matching. Several groups still display almost identical 
kinetics between the two data sets; groups 2, 3A and 4 of the 1 µM data set display closely matched 
kinetics with groups 1, 3 and 4 of the 5 µM data set respectively. Interestingly several groups in the 5 
µM data set display slower kinetics than their 1 µM counterparts, namely groups 2, 5 and the carpet 
mechanism. 
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Figure 4.11: Overlaid grouping data for DOPC:DPPC membrane system, with 1 µM melittin traces shown in black, and 5 µM 
melittin traces depicted in red. Several of the groups show high levels of similarity across the two melittin concentrations, i.e. 
Groups 2, 3A and 4 of the 1 µM data set closely resemble groups 1, 3 and 4 from the 5 µM data set respectively. The other 
groups do not follow similar kinetics. 
 
Comparison of the Leakage modes for the DOPC and DOPC:DPPC membrane systems gives the 
graph presented in figure 4.12 where the averaged leakage groups are overlaid. The overlaid traces are 
remarkably similar, with both data sets featuring six pore mediated leakage groups, and with four of the 
six groups displaying closely matched kinetics. From the DOPC data groups 1, 2, 5 and 6 closely match 
with the corresponding groups from the DOPC:DPPC data set, with group 4 showing a good match at 
shorter timescales, and only group 3 displaying a poor kinetic match between the two lipid systems. 
Leakage group 3 from the DOPC membrane system data set demonstrates considerably slower kinetics 
than group 3 of the DOPC:DPPC data set, which could result from changes in the pore size, number or 
opening time. The carpet mechanism leakage displays slower kinetics within DOPC:DPPC membranes 
compared to the base DOPC membrane. The close match between the data sets indicates that doping of 
the DOPC base membrane with another bilayer lipid, even with a substantially reduced packing 
parameter (DOPC S = 1.08 and DPPC S = 0.78), produces very little effect in these cases on the pore-
mediated leakage kinetics induced by the negative curvature inducing AMP melittin. The primary effect 
of the inclusion of the positively curved DPPC lipid is seen within the timing of the initiation of the leak. 
The base DOPC membrane initiates leakage an average of 1961.1 s after exposure to melittin, while the 
DOPC:DPPC membrane takes substantially longer, returning an average initiation time of 3623.4 s. 
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Figure 4.12: Comparison of the dye-leakage groupings from the DOPC and DOPC:DPPC (80:20 mol%) membrane systems, after 
exposure to 1 µM melittin, with the DOPC data depicted in black and the DOPC:DPPC data shown in red. Many of the groups 
display very similar kinetics across the two membrane systems; Groups 1, 2, 5 and 6 from the DOPC data set correspond almost 
exactly with the corresponding groups from the DOPC:DPPC data set. Groups 3 and 4 do not show similar kinetics across the two 
membrane systems. 
 
The close matches between the efflux kinetics from DOPC and DOPC:DPPC vesicles indicates that 
the differing lipid compositions of the two membranes exert little influence on the leakage process once 
leakage has been initiated. Instead the lipids exert their affect prior to pore formation, as evidenced by 
the differing initiation times for pore-mediated leakage, and the variation in PIE-profiles between the 
DOPC and DOPC:DPPC membranes. 
 
4.1.3. DOPC:DOPE membrane system 
When exposed to 1 µM melittin, DOPC:DOPE (80:20 mol%) GUVs display the dye-leakage kinetics 
shown in figure 4.13. Similar to the base DOPC and DOPC:DPPC membranes, the 3 kDa leakage data set 
features clear grouping of the dye-leakage traces into distinct kinetic modes, with the 10 kDa data set 
featuring less distinct groupings. Compared to DOPC:DPPC membranes, the DOPC:DOPE membrane 
contains a strong inducer of negative curvature; the smaller headgroup and larger hydrophobic tailgroup 
volume of DOPE giving the lipid a packing parameter of 1.41. 
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Figure 4.13: Modal dye leakage kinetics for the 3 (top) and 10 (bottom) kDa dextrans entrapped within DOPC:DOPE vesicles, 
exposed to 1 µM melittin. Error bars are the standard deviations from the averaged traces within each group. There are six 
groupings visible within the leakage kinetics, shown in the diagram key above. Five of the groups represent pore-mediated 
leakage, with the sixth and fastest leakage group, representing leakage through the carpet mechanism (green triangles). 
 
 The groups displayed in figure 4.13 were averaged from the following number of individual 
leakage traces; group 1 compiled from 3 traces; group 2 from 7 traces; group 3 from 9 traces; group 4 
from 5 traces; group 5 from 9 traces and the carpet grouping is the average of 12 traces. At longer 
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timescales (>1500 s) the groupings begin to run parallel to the kinetics of group 1, indicating steady 
state leaking is taking place. Another similarity with the previously reported data sets, is two clearly 
separated 3 kDa leakage groups demonstrating very similar leakage kinetics within the 10 kDa data set. 
The DOPC:DPPC and DOPC:DOPE data sets both feature the second and third 3 kDa leakage groups 
merging into indistinguishable groups in the 10 kDa data set, while within the DOPC data set it is the 
third and fourth 3 kDa leakage groups which merge. The multi-component leakage traces again 
demonstrate switching between the leakage groups constructed from the single-component traces, as 
shown in figure 53. The close match up between the single-component leakage traces and the individual 
leakage phases of the multi-component traces further demonstrates the quantised nature of the 
observed dye-leakage data. 
 
Figure 4.14: Graph displaying the group switching in multi-component leakage traces, demonstrated by a five phase multi-
component leakage trace, recorded after exposure of DOPC:DOPE (80:20 mol%) GUVs to 1 µM melittin. The leakage groupings 
displayed by the single-component traces are depicted in black, with the individual phases of the multi-component traces shown 
in red. The initial leak (red diamonds) of the multi-component trace runs parallel to the kinetics of group 2 for ~ 500 s, before 
switching to group 1 kinetics for ~450 s (red pentagons). The third leakage phase (red hexagons) displays almost identical 
kinetics to group 4, with the fifth leak (red stars) matching group 5 kinetics. The final leak (red circles) follows the kinetics for the 
carpet mechanism grouping. 
 
When exposed to the higher melittin concentration of 5 µM melittin, the DOPC:DOPE vesicles 
produced the dye efflux kinetics shown in figure 4.15. Again the common feature of leakage trace 
grouping was present, but the number of pore-mediated leakage groups was reduced from five to four, 
compared to the 1 µM melittin DOPC:DOPE data set.  
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Figure 4.15: Averaged dye leakage kinetics for the 3 (top) and 10 (bottom) kDa dextran-Alexafluor488 entrapped within 
DOPC:DOPE vesicles, exposed to 5 µM melittin, with the error bars are the standard deviations from the averaged traces within 
each group. There are five groupings visible within the leakage kinetics, shown in the diagram key above. Four of the groups 
represent pore-mediated leakage, with the fifth and fastest leakage group, representing leakage through the carpet mechanism 
(pink triangles). 
 
The averaged leakage traces for the DOPC:DOPE membrane system exposed to 5 µM of melittin 
were compiled from a total of 32 vesicles, with the distribution between the individual groups as 
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follows: Group 1 compiled from 6 traces; group 2 from 7 traces; group 3 from 7 traces; group 4 from 5 
traces and the carpet mechanism group from 7 traces. Both peptide concentrations in the DOPC:DOPE 
membrane system  produce less complex dye-efflux kinetics than either then DOPC or DOPC:DPPC 
systems, returning lower numbers of groupings in the leakage data. The DOPC:DOPE data set does not 
present the merging of separate 3 kDa leakage groups into similar 10 kDa leakage groups that was a 
common feature of all the data sets previously reported. The data set retains the group switching of 
multi-component leakage traces demonstrated by the previous data sets, with an example presented in 
figure 4.16.  
 
Figure 4.16: Graph of the multi-component group switch determined for the DOPC:DOPE (80:20 mol%) membrane system 
exposed to 5 µM melittin. The averaged single-component leakage groups are depicted in black, with the individual leakage 
phases recovered from the multi-component traces shown in red. The first leak (red triangles) matches kinetics with group 1 of 
the averaged leakage groups for ~450 s, before the second phase (red diamonds) switches groups, matching dye-efflux kinetics 
with group 3 until the vesicles contents are completely depleted. 
 
Comparison of the 1 and 5 µM DOPC:DOPE data sets produces the graph presented in figure 4.17. 
In contrast with the DOPC and DOPC:DPPC data sets, inclusion of the negative curvature lipid DOPE 
results in larger differences between the two peptide concentrations. Only one of the higher melittin 
concentrations leakage groups present a close match with the lower concentrations groups, with group 
1 for both concentrations displaying very similar kinetics. All other 5 µM leakage groups showed no 
good match with groups from the lower AMP concentration data set, with the groups showing a marked 
tendency for faster leakage kinetics, with group 4 the fastest pore-mediated leakage kinetics from any 
data set. 
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Figure 4.17: Overlaid grouping data for DOPC:DOPE (80:20 mol%) membrane system, with 1 µM melittin traces shown in black, 
and 5 µM melittin traces depicted in red. The first group for both peptide concentrations demonstrate closely matched kinetics, 
but subsequent groups do not display similar kinetic matches. Compared to the 1 µM leakage groupings, the groups from the 5 
µM data set rapidly progress to faster leakage kinetics, with group 4 demonstrating especially fast pore-mediated leakage, 
almost comparable to the carpet mechanism kinetics. 
 
To examine the effect of the inclusion of the negatively curved DOPE lipid within the neutral 
curvature (i.e. cylindrical geometry) DOPC membrane, on the pore formation activity of the AMP 
melittin, the averaged group kinetics for the DOPC:DOPE membrane system were overlaid with the 
DOPC system kinetics and presented in figure 4.18. The close match between groups 3, 4 and 5 of the 
DOPC data and groups 2, 4 and 5 of the DOPC:DOPE data indicate that the negatively curved lipid DOPE 
exerts little influence on the properties of the pores that produces these kinetically similar leakage 
groups; e.g. Size and opening times. The average initiation time for pore-mediated leakage in the 
DOPC:DOPE membrane system is 3273.3 s, compared to the 3623.4 s in the DOPC:DPPC membrane, but 
both are considerably slower in initiation of pore-mediated leaking than DOPC vesicles (1961.1 s). 
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Figure 4.18: Comparison of the cylindrical DOPC base membrane (black) dye-efflux kinetics with the DOPC:DOPE membrane 
(red), which contains a strongly negative curvature inducing lipid. Groups 4 and 5 of the DOPC data demonstrate closely related 
kinetics with groups 4 and 5 of the DOPC:DOPE data respectively, and group 2 of the DOPC:DOPE data shows a close similarity 
to group 3 of the DOPC kinetics at short timescales (< 500 s). The remainder of the pore-mediated leakage groups display no 
close relationships between the kinetics of the two different membrane systems, exposed to 1 µM melittin. 
 
An overlay of the dye-efflux kinetics data for the DOPC:DPPC and DOPC:DOPE membrane systems is 
presented in figure 4.19, to demonstrate the influence of the inclusion of opposite topography lipids, 
within a geometrically neutral DOPC membrane. The inclusion of 20 mol% of the negatively curved 
DOPE within the base DOPC membrane, produces a greater shift of the dye-efflux kinetic groups from 
the DOPC kinetics, than the inclusion of identical levels of the positively curved DPPC lipid. 
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Figure 4.19: Comparison of the 1 µM melittin induced dye-efflux kinetics from the DOPC:DPPC (black) and DOPC:DOPE (red) 
membrane systems, which both contain 80 mol% of the cylindrical lipid DOPC and 20 mol% of either the positive curvature lipid 
DPPC or the negative curvature lipid DOPE. Groups 3B and 4 from the DOPC:DPPC data set show close kinetic matching with 
groups 3 and 5 from the DOPC:DOPE data set, with other groups demonstrating no close matches in the efflux kinetics across 
the two membrane systems. 
 
4.2. Zwitterionic leakage kinetics summary 
The grouping of leakage traces into sets is visible within all the zwitterionic membrane data sets, 
and suggests that pore formation can only occur within vesicle membranes possessing a tightly 
controlled set of boundary conditions. A membrane containing lipid-LCAMP interactions matching the 
required conditions can initiate leaking, and follow a defined leakage kinetic pathway connected to the 
initial boundary conditions. The multiphase leakage traces identified within the data sets, when split 
into their individual phases, fit within the framework of previously determined leakage groups, 
suggesting that the membrane is capable of switching between the established boundary conditions, 
presumably as a result of further peptide binding or intraleaflet association. The multiphase traces 
display two types of behaviour; switching back and forth between two adjacent leakage groups, or 
switching to faster kinetic groups until vesicle contents are depleted or vesicle failure occurs. There are 
several examples of adjacent leakage groups from the 3 kDa dextran leakage data, that combine within 
the 10 kDa data set, appearing as a single grouping. This behaviour is noticed within the DOPC, 
DOPC:DPPC and DOPC:DOPE membrane systems, and the most concise explanation for this is the 
simultaneous opening of two differently sized pores within the vesicle membrane. The larger pore 
allows efflux for both the larger and smaller dextrans, but the smaller pore only allows egress to the 
smaller molecule, resulting in increased leakage kinetics only within the 3 kDa data set. 
Overlay of 1 and 5 µM melittin data shows that the leakages occur via very similar kinetics at both 
concentrations, indicating that within zwitterionic membranes, the rate of peptide binding to the vesicle 
does not exert a strong effect over the leakage kinetics. Overlay of the melittin induced leakage kinetics 
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within different membrane systems shows that the dye-efflux proceeds with strikingly similar dye efflux 
kinetics, but significantly different pore initiation timings. For example the average initiation time of 
pore-mediated leakage in DOPC membranes is approximately half (1961 s) the time in DOPC:DPPC 
membranes (3623.4 s); i.e. the addition of 20 mol% of the inverse-conical lipid DPPC dramatically 
increases the initiation time of pore formation. The PIE-profiles for these membranes also shows 
marked differences (figure 3.2), suggesting that the varying lipid-LCAMP interactions occulting within 
the membranes influence the pore energetics and likelihood of occurrence, but when pore formation is 
initiated it proceeds via almost identical kinetics; i.e. via pores with very similar pore size, number and 
opening times. 
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5. Pore-mediated leakage in anionic membranes 
5.1. DOPC:DOPE:DOPG membrane system 
The constituent lipids of the DOPC:DOPE:DOPG membrane system present cylindrical (DOPC) and 
conical (DOPE and DOPG) topographies. Exposure of the membrane system to 1 µM of the AMP melittin 
produced the dye-efflux kinetic shown in figure 5.1. The dye-efflux data from the anionic 
DOPC:DOPE:DOPG system continues to demonstrate some of the trends discovered within the 
zwitterionic membrane systems DOPC; DOPC:DPPC and DOPC:DOPE, notably the grouping of the 
kinetics data into quantised leakage states and the merging of the resulting kinetics groupings within the 
10 kDa dye-efflux data. The averaged kinetic traces are compiled from the following number of 
individual leakage traces; group 1 is the average of two traces; group 2 is three traces; group 3 is three 
traces; group 4 is four traces; group 5 is five traces and the carpet mechanism group was compiled from 
five traces. Groups 3 and 4 are clearly defined within the 3 kDa data set, yet display almost identical dye-
efflux kinetics within the 10 kDa data set.  
Another point of similarity between the dye-efflux kinetic behaviour between the zwitterionic and 
anionic membrane systems is the presence of multi-component leakage traces, which can be split into 
their individual leakage components and overlaid with the grouped average leakage traces, as 
demonstrated in figure 5.2. The figure contains a four component dye leakage trace from the 10 kDa 
leakage data set, with each individual leakage component matched to one of the averaged leakage 
traces, demonstrating the quantised nature of the dye-efflux process. 
Magainin was almost totally inactive within the DOPC:DOPE:DOPG membrane system, even at the 
higher peptide concentrations of 5 µM, interestingly proving that magainins least activity coincides with 
the presence of high fatty acid unsaturation and neutral to negative curvature. 
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Figure 5.1: Averaged dye-efflux kinetics for the 3 (top) and 10 (bottom) kDa dextran-Alexafluor markers entrapped within 
DOPC:DOPE:DOPG vesicles, exposed to 1 µM melittin, with the error bars representing the standard deviation of the traces 
within each group. There are six groupings visible within the data, shown in the diagram key above. Five of the groups represent 
pore-mediated leakage, with the sixth leakage group, representing the carpet mechanism (green triangles). The 3 kDa data set 
contains five distinct kinetic groupings for pore-mediated leakage from the vesicles, while the 10 kDa data contains only four, 
with the 3 kDa groups 3 and 4 merging into one group within the 10 kDa data. 
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Figure 5.2: Overlay of the individual leakage components from a multi-component 10 kDa dye-leakage trace (red), with the 
averaged kinetic groupings of the entire 10 kDa data set (black). The initial leak from the multi-component trace (red diamonds) 
follows the leakage kinetics of group 2 for ~300 s, before the second leakage phase (red pentagons) switches to closely follow 
group 1 kinetics for ~400 s, with a further switch back to match group 1 kinetics for ~350 s (left in place to avoid obscuring the 
initial leakage trace). The third leakage phase (red hexagons) displays the leakage kinetics common to  group 3/4 for around 
900 s, before matching the kinetics of group 5 with its final leakage phase (red stars) until the vesicle contents are depleted. 
 
5.2. DOPC:DOPE:DPPG membrane system  
Replacing the DOPG from the previous membrane system with the inverse-conical shaped DPPG 
increases the variety of lipid geometry present within the membrane. The DOPC:DOPE:DPPG system 
therefore contains a wide mix of topography; DOPC is a cylindrical and zwitterionic lipid; DOPE is 
zwitterionic and conical and DPPG is anionic and inverse-conical. The inclusion of anionic positive 
topography lipids within the membrane system produces a large effect on the pore-mediated leakage 
displayed by 1 µM melittin, with the data for the efflux of the entrapped 3 kDa dextrans collected shown 
in figure 5.3. The inclusion of the positive curvature-inducing anionic DPPG substantially deactivated 
melittin action, proving to be the least activity membrane system for melittin, but the available data still 
demonstrated kinetic grouping. 
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Figure 5.3: Dye leakage kinetics for the 3 kDa dextran-Alexafluor488 entrapped within DOPC:DOPE:DPPG vesicles, exposed to 1 
µM melittin. 
 
In contrast inclusion of DPPG produced the highest levels of magainin activity, and the dye-leakage 
kinetics for the DOPC:DOPE:DPPG membrane system exposed to 1 µM magainin are presented in figure 
5.4. The average initiation time for the start of pore-mediated leakage in this membrane system was 
289.5 s, the quickest initiation time for pore-formation recorded for any peptide, at any concentration in 
any membrane system. The grouped leakage traces are compiled from the following number of 
individual leakage traces; group 1 was a single trace; group 2A was produced by averaging four traces; 
group 2B from two traces; group 3 from four traces; group 4 from two traces; group 5 from four traces 
and the carpet mechanism was compiled from two traces. Both multi-component traces and merging of 
distinct 3 kDa groupings into identical 10 kDa groupings were present within this data set, with the 
merging of the 3 kDa groupings being particularly prominent within the DOPC:DOPE:DPPG membrane 
system. Four 3 kDa groups (2A, 2B, 3 and 4) merge in the 10 kDa data, with the groups 2A and 2B 
presenting parallel kinetics within the 3 kDa for a significant period of time (~450 s), before splitting to 
form separate kinetic groupings within the 3 kDa data. The parallel kinetics presented in the 3 kDa dye-
efflux data at short timescales, suggests that continued binding of the peptide to the lipid membrane 
produced a change within the lipid-AMP system, that favoured a change in the pore-mediated leakage 
process. The change in the pore-formation process favoured the leakage of the smaller 3 kDa dextran, 
while the efflux of the larger 10 kDa dye remained unaffected. 
Lipid shape and lytic peptides Page 107 
 
 
Figure 5.4: Dye leakage kinetics for the 3 (top) and 10 (bottom) kDa dextran-AlexaFluor markers entrapped within 
DOPC:DOPE:DPPG vesicles, exposed to 1 µM magainin, with the error bars representing the standard deviation for the individual 
leakage traces within each leakage group. The merging of two distinct 3 kDa leakage groupings into a single 10 kDa grouping 
occurs twice within this data set, with both the 3 kDa groups 2A and 2B merging within the 10 kDa data, as well as the 3 kDa 
groups 3 and 4. The 3 kDa groups 2A and 2B demonstrate merged kinetics within the 3 kDa data for ~450s, before they split into 
distinct groups, demonstrating a change in the lipid-AMP interactions producing the pore formation, but remain merged within 
the 10 kDa data. 
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Group switching in the DOPC:DOPE:DPPG membrane system exposed to 1 µM magainin is 
displayed in figure 63. 
 
Figure 5.5: Graph presenting an example of group switching membranes, from the 3 kDa dye-efflux kinetics recorded after 
exposure of DOPC:DOPE:DPPG GUVs to 1 µM magainin. The first leakage phase (red pentagons) of a three component leak 
match the kinetics of the group 2A from the single component leakage data for ~1200 s, before the second phase (red triangles) 
reinitiates leakage at kinetics matching the groups 2A and 2B for ~300 s. The final leakage phase (red stars) switches groups to 
match the kinetics of group 4, until the vesicles dextran contents are completely depleted after ~750 s. 
 
Exposure of the DOPC:DOPE:DPPG membrane system to the higher magainin concentration of 5 
µM produces the grouped dye-leakage kinetics shown in figure 5.6. This combination of membrane 
system and peptide concentration produced the highest magainin activity, with 92.6 % of vesicles 
displaying a PIE under these conditions. The averaged leakage kinetic traces were compiled from the 
following number of individual traces; group 1 compiled from two traces; group 2 from four traces; 
group 3 from two traces and group 4 from three traces. The groups 2 and 3 within both the 3 and 10 
kDa data sets display interesting kinetic behaviour, with both groups following similar kinetics at short 
timescales, before separating into distinct groups. However, the 10 kDa traces remain at similar kinetics 
for longer, taking ~450 s to separate, compared to ~300 s in the 3 kDa data. The separation between 
groups 2 and 3 is also less distinct within the 10 kDa data compared to the 3 kDa data set. 
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Figure 5.6: Grouped dye-efflux kinetics for the 3 (top) and 10 (bottom) kDa dextran-AlexaFluor markers entrapped within 
DOPC:DOPE:DPPG vesicles, exposed to 5 µM magainin, with the error bars representing the standard deviations of the individual 
leakage traces contained within each group. 
 
The leakage pattern within the grouped traces at longer timescale within the DOPC:DOPE:DPPG 
membrane system is presented in figure 5.7. Groups 2 and 3 reduce their kinetics, until both groups run 
parallel to the slower leakage kinetics of group 1, after ~1500 s. 
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Figure 5.7: Dye leakage kinetics for the pore-mediated events of the 3 kDa dextran-Alexafluor488 entrapped within 
DOPC:DOPE:DPPG vesicles, exposed to 5 µM magainin, over a longer timescale of 4000 s. All the leakage groupings run parallel 
to group 1 kinetics, after ~1500 s, after an initial phase of following different kinetics. 
 
DOPC:DOPE:DPPG membranes exposed to 5 µM magainin demonstrate group switching in the 
individual leakage phases of the multi-component leakage traces, that has proved a common thread 
running through the dye-efflux kinetics of all the membrane systems and AMPs tested. An overlay of the 
average dye-efflux kinetics for the 3 kDa dextran marker contained within DOPC:DOPE:DPPG vesicles, 
exposed to magainin at 1 and 5 µM concentrations, is presented in figure 5.8. The exposure of 
DOPC:DOPE:DPPG GUVs to the higher concentration of magainin, produces a change in the efflux 
kinetics of the system, when compared to the 1 µM data set. The averaged leakage traces are shifted 
towards slower leakage kinetics, and the average initiation time for pore-mediated leakage in these 
vesicles is 2577.5 s, considerably longer than the 1 µM systems time of 289.5 s, the fastest initiation 
time for pore mediated leakage displayed by any membrane system or peptide. The other PIE initiation 
times for the higher concentration of magainin are significantly reduced compared to the lower 
concentration; the discrepancy in the initiation time for pore-mediated leakage must be explained. One 
of the groupings within the 5 µM data set follows almost identical kinetics to a group within the 1 µM 
data set, but the remaining three groups follow their own unique kinetics. 
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Figure 5.8: Overlaid averaged dye-leakage data for the DOPC:DOPE:DPPG membrane system, with 1 µM magainin traces shown 
in black, and 5 µM magainin traces depicted in red. Groups 2/3 for both concentrations show similar behaviour, initially identical 
leakage kinetics, before branching into two separate groups. The fastest group within the 5 µM data is group 4, and is 
significantly slower than the fastest leakage kinetics of displayed by the 1 µM magainin data. Group 4 of the 5 µM data set 
follows almost identical kinetics to group 3 of the 1 µM data set, but the other averaged traces do not match across the peptide 
concentration data sets. 
 
5.3. DOPC:DOPE:LPG membrane system  
LPG is an anionic lipid possessing extremely pronounced inverse-conical geometry, and the 
DOPC:DOPE:LPG (60:20:20 mol%) membrane system contains a large variation in lipid charge   
topography; DOPC is a zwitterionic cylindrical lipid and DOPE is a zwitterionic conical lipid. Exposure of 
GUVs with this lipid composition produces the grouped dye-efflux kinetics displayed in figure 5.8. The 
grouped leakage kinetics were averaged from the following number of individual leakage traces; group 1 
averaged from two traces; group 2 from three traces; group 3 from three traces; group 4 from two 
traces; group 5A from two traces; group 5B from two traces and the carpet mechanism was compiled 
from the averaging of five traces. 
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Figure 5.9: Dye leakage kinetics for the 3 and 10 kDa dextran-Alexafluor488 entrapped within DOPC:DOPE:LPG vesicles exposed 
to 1 µM melittin, with the error bars representing the standard deviation of the individual leakage traces contained within each 
group. The 10 kDa data set displays much larger error bars than the 3 kDa data, suggesting an increased amount of variability 
within the efflux of the larger dextran marker. Group 5 for both dextrans splits into two distinct kinetic groups, after following a 
phase of initially identical leakage kinetics, with the 3 kDa identical phase lasting ~250 s, and the 10 kDa identical phase lasting 
slightly longer at ~400 s.  
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Multi-component leakage trace group switching was again evident within this membranes dye-
efflux kinetics, with the individual leakage phases recovered from one such multi-component trace 
presented in figure 5.10. 
 
Figure 5.10: Graph demonstrating group switching for 3 kDa data, within a multi-component leakage trace recorded after 
exposure of a DOPC:DOPE:LPG vesicle to the AMP melittin, at a concentration of 1 µM. The first leakage phase (red hexagons) 
follows the kinetics of group 2 for ~250 s, before the second phase (red stars) switches to match the kinetics of group 4 for ~750 
s. The third leak (red circles) then reinitiates leakage at the kinetics of group 4, until the dextrans within the GUV are completely 
depleted. 
 
Exposure of the DOPC:DOPE:LPG membrane system to 1 µM of the bacteria selective and positive 
curvature-inducing AMP magainin, produces the averaged dye-leakage kinetics presented within figure 
5.11. The leakage groups were averaged from the following numbers of individual leakage traces; group 
1 compiled from a single trace; group 2 from two traces; group 3 from two traces; group 4 from two 
traces and the carpet mechanism group contains a single trace. The magainin-induced dye-efflux from 
DOPC:DOPE:LPG GUVs produces uneven leakage of vesicle contents, although this may be a result of the 
low number of individual traces the averaged groups are compiled from. 
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Figure 5.11: Dye leakage kinetics for the 3 and 10 kDa dextran-Alexafluor dextran markers entrapped within DOPC:DOPE:LPG 
vesicle, exposed to 1 µM magainin, with the error bars representing the standard deviation of the individual leakage traces 
within each group. Group 1 displays a low (~10%) level of leakage in the 3 kDa data over the 2000 s of data presented, but 
shows no decrease in the levels of the 10 kDa dextrans entrapped within the vesicle. 
  
5.4. DOPC:DOPE:POPG membrane system 
Inclusion of 20 mol% POPG within the DOPC:DOPE membrane system, results in a mixture of lipid 
charge, topography and fatty acid unsaturation. POPG is anionic with a slightly inverse-conical 
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geometry, which contains one saturated 16:0 palmitoyl fatty acid and one mono-unsaturated 18:1 (9Z) 
oleic fatty acid, while DOPC and DOPE display zwitterionic cylindrical and conical geometries 
respectively. However, not enough good quality traces were recovered to construct leakage kinetics for 
the pore-mediated leakage process for either peptide for this membrane system. 
 
5.5. DOPC:DPPC:DOPG membrane system 
The DOPC:DPPC:DOPG presents a large variation in lipid topography, with the presence of DOPG 
ensuring the immediate environment of the cationic membrane-bound AMP helix is enriched with the 
cylindrical anionic lipid. Clear and distinct groups were unable to be detected within this membrane 
system exposed to 1 µM melittin, as can be seen within the dye-efflux kinetic data presented in figure 
5.12, although the leakage traces were concentrated at faster kinetics. 
 
Figure5.12: Dye leakage kinetics for the 3 kDa dextran-Alexafluor488 entrapped within DOPC:DPPC:DOPG vesicles, exposed to 1 
µM melittin. Only one pore-mediated leakage grouping could be detected within the data, indicated as group 1 (black squares), 
with the error bars representing the standard error for the individual leakage traces making up the grouped trace. The leakage 
trace of GUV 1 (blue triangles) appears to match the kinetics of group 1, for ~200 s, before demonstrating a group switching to 
slower kinetics. The carpet mechanism grouped trace is depicted as red circles, and the majority of the leakage traces are 
concentrated at faster kinetics. 
 
DOPC:DPPC:DOPG GUVs exposed to 1 µM melittin produced high levels of pore-mediated leakage 
events, with > 55 % of vesicles responding to exposure to the AMP by the formation of pores, but the 
leakage data does not present the clear distinct grouping of the leakage traces displayed by the other 
membrane systems. The lack of clear dye-efflux grouping within the DOPC:DPPC:DOPG membrane data 
set, indicates that the leakage events are either unquantised within this membrane system, or the group 
switching demonstrated within this membrane obscures the quantised leakage kinetics. There were too 
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few high quality leakage traces to assemble the dye-efflux kinetics for DOPC:DPPC:DOPG membranes 
exposed to 1 µM magainin, with activity < 10 %. 
 
5.6. DOPC:DPPC:DPPG membrane system 
Replacing the cylindrical anionic lipid DOPG, which features two 18:1 (9Z) mono-unsaturated fatty 
acids, with the anionic inverse-conical DPPG featuring two 16:0 saturated fatty acids, produces a 
significant change in the dye-efflux kinetics of the system upon exposure to 1 µM melittin. The change 
of anionic lipid topography and fatty acid composition produced the dye-efflux kinetics displayed in 
figure 5.13, with clearly distinct groupings of the leakage data again visible. The grouped leakage kinetic 
traces depicted in figure 5.13 are compiled from the following number of individual leakage traces; 
group 1 averaged from five traces; group 2 from four traces; group 3 from five traces; group 4 from five 
traces; group 5 form eight traces and group 6 from four traces. The carpet mechanism was compiled by 
averaging two traces, and is included for comparison only. In addition to the leakage kinetic grouping, 
the DOPC:DPPC:DPPG membrane system also demonstrates the group switching phenomenon (do-doo-
do-do-do), where multi-component leakage traces can be split into individual leakage phases, which can 
then be overlaid with the leakage groupings compiled from single-component leakage traces. An 
example of a two component leakage trace overlaid with the averaged grouped leakage kinetics is 
presented in figure 5.14. The close match between the separated leakage phases of the multi-
component traces, and the averaged leakage traces compiled from the single component traces, again 
demonstrates the quantised nature of the leakage kinetics induced by AMPs. The dye-efflux from 
vesicles not only follow predictable and quantised kinetics, but conditions within the lipid-AMP system 
can change during the process of pore-formation, causing the leakage kinetics to switch from one 
quantised leakage state to another. 
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Figure 5.13: Averaged dye-leakage kinetics for the 3 (top) and 10 (bottom) kDa dextran-AlexaFluor markers entrapped within 
DOPC:DPPC:DPPG vesicles exposed to 1 µM melittin, with the error bars representing the standard error for the individual 
leakage traces making up the group. The 3 kDa data set contains six clearly separated groups of leakage kinetics, labelled 1 to 6, 
with a seventh group identified as operating under the carpet mechanism.  
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Figure 5.14: Graph depicting the group switching, of a multi-component leakage trace of the 3 kDa dextran marker enclosed 
within a DOPC:DPPC:DPPG GUV, after exposure to 1µM melittin. The first leakage phase of the multi-component leakage trace 
(red pentagons) follows the kinetics of group 4 for ~2200 s, before the second leakage phase (red hexagons) switches to follow 
the kinetics of group 5, until the vesicles contents are completely deleted.  
 
Exposure of the same membrane system to 1 µM of the AMP magainin, produced the dye-efflux 
kinetics shown in figure 5.15, which presents the single-component leakage traces and the first leakage 
phases of multi-component traces. The grouped leakage kinetics are compiled from the following 
number of individual leakage traces; group 1 is the average of three traces; group 2 is the average of five 
traces; group 3 is the average of two traces and the carpet mechanism grouping is the average of three 
traces. When the full complement of leakage traces from the 3 and 10 kDa data sets are included within 
the analysis, i.e. both the single component traces and all the leakage phases from the multi-component 
traces, the grouped dye-efflux kinetics shown in figure 5.16 are produced. The traces in figure 74 were 
compiled by averaging the following amount of individual leakage traces; group 1 is the average of three 
traces; group 2 is the average of five traces; group 3 is the average of five; group 4 is the average of four 
traces; group 5 is the average of six traces and group 6 is comprised of a single trace. The carpet 
mechanism group is compiled from the average of five traces. 
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Figure 5.15: Initial dye leakage kinetics for the 3 (top) and 10 (bottom) kDa dextran-Alexafluor markers entrapped within 
DOPC:DPPC:DPPG vesicles exposed to 1 µM magainin, with the error bars representing the standard deviation of the individual 
leakage traces contained within each group. There are three pore-mediated leakage kinetic groups visible, and a fourth group at 
faster kinetics, representing leakage occurring via the carpet mechanism. Groups 1 and 2 are clearly distinct within the 3 kDa 
data, but the groups display much closer kinetics within the 10 kDa data set. 
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Figure 5.16: Complete set of grouped dye-leakage kinetics for the 3 (top) and 10 (bottom) kDa dextran-Alexafluor markers 
entrapped within DOPC:DPPC:DPPG vesicles exposed to 1 µM magainin, with the error bars representing the standard deviation 
of the individual leakage traces contained within each group. The number of kinetic groupings for pore-mediated leakage 
increases, from three to six, compared to the initial leakage graph shown in figure 5.15, with groups 1, 4 and 6 being unique to 
the complete data set. 
 
Note that the complexity of the dye-efflux kinetics significantly increases within the complete data 
set, as compared to the grouped kinetics assembled from only the single component and initial phases 
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of multi-component traces. The number of groups increases from three to six, suggesting that the pore-
formation process can be complicated, by the translocation of magainin across the membrane as part of 
initial pore formation. The translocated peptide then goes on to participate in pore formation from the 
inner membrane leaflet, resulting in the creation of novel leakage kinetics. The group 1 of the complete 
data set shows ~ 20 % loss of vesicle contents for the 3 kDa dextran, but displays 100 % retention for the 
10 kDa dextran. This provides additional evidence for the formation of a population of small pores, able 
to expel the smaller dextran, but too small to expel the larger molecule. This defines the size of the 
group 1 pore as between the diameter of the 3 kDa dextran as a minimum, and the diameter of the 10 
kDa as a maximum; i.e. the pore diameter lies somewhere between 2.26 and 4.13 nm. Groups 1, 4 and 6 
are unique to the complete data set, and together comprise one third (8/24) of the total leakage traces, 
and the fact that it only appears within the later leaks of multi-component traces, suggests a role for 
translocated peptide within the pore-formation process for these leakage groups. Group switching 
behaviour is again present in the multi-component dye-leakage traces of DOPC:DPPC:DPPG membranes 
exposed to 1 µM magainin, with the overlay of a five component traces overlaid with the complete data 
set, using the 3 kDa leakage data presented in figure 5.17. 
 
Figure 5.17: Graph showing the group switching behaviour of a five-component leakage trace, from a DOPC:DPPC:DPPG GUV 
exposed to 1 µM magainin, with the individual leakage phases of the multi-component trace shown in red, and the averaged 
leakage kinetics shown in black. The first leakage phase (red pentagons) follows the leakage kinetics of group 3 for ~800 s, 
before the second leakage phase (red hexagons) switches to group 2 kinetics, for ~ 550 s. The third leakage phase (red stars) 
matches the kinetics of group 5 for ~150 s, before the four leakage phase (red circles) switches to match the kinetics of group 4 
for ~450 s. The final leakage phase of the multi-component trace, then changes from following group 4 to following group 5 
kinetics, until vesicle contents are completely depleted. 
 
The group switching behaviour noted for the multi-component traces displays a general trend 
towards faster kinetics, but may switch back and forth between faster and slower leakage groups. The 
traces displayed in figure 5.17 for example, show that the leakage kinetics of the multi-component trace 
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follow a complex path through the quantised leakage kinetic landscape, moving first from a faster 
leakage group (group 3) to a slower group (group 2). The leakage kinetics of the multi-component trace 
then switches to a faster leakage kinetic group (group 5), then back to the slower kinetic group (group 
4), before returning to the faster kinetics of group 5. To compare the leakage kinetics produced by 
exposure of the DOPC:DPPC:DPPG membrane system, to 1 µM of the AMPs magainin and melittin, the 
averaged leakage traces obtained for both peptides was overlaid, and the 3 kDa data set is presented as 
figure 5.18. 
 
Figure 5.18: Graph of the overlaid averaged kinetic data for the 3 kDa dextran marker, for the DOPC:DPPC:DPPG membrane 
system exposed to 1 µM of the AMPs melittin (black) and magainin (red). Some averaged dye-efflux kinetic groups display 
closely matched leakage kinetics between the data sets for both AMPs, with groups 1, 3, 4, 5, and 6 for the melittin data set 
closely matching to the groups 2, 3, 4, 5 and 6 respectively, from the magainin data set. The kinetic groupings within the 
magainin data set display smaller standard errors, than the groupings contained within the melittin data, indicative of the 
tighter grouping of the individual leakage traces, within each leakage group produced by the AMP magainin. 
 
The overlaid averaged kinetics both AMPs show similarities, with five of the six groups following 
similar kinetics, for both peptides. This close matching between the grouped leakage kinetics has 
profound implications for the mechanism of action of LCAMPs (see discussion), although it must be 
noted that significant differences exist in the initiation times of the pore-mediated leakage process. In 
the DOPC:DPPC:DPPG membrane system, melittin initiates the leakage process an average of 2541.0 s 
after first exposure of the vesicles to the peptide, while magainin returns a longer average initiation 
time of 3255.4 s. This suggests magainin takes a longer time to establish the lipid-AMP interactions in 
the DOPC:DPPC:DPPG membrane system, which result in the formation of pores than melittin. Magainin 
also displays lower levels of activity compared to melittin, within the DOPC:DPPC:DPPG membrane 
system, as demonstrated by the PIE profiles for the two AMPs presented in figure 5.19. 
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Figure 5.19: Comparison of the PIE profiles for the LCAMPs melittin and magainin, obtained by their interactions with the 
DOPC:DPPC:DPPG membrane system, at a peptide concentration of 1 µM. Although melittin is significantly more active within 
the membrane system than magainin, with 77.5 % of vesicles exhibiting a PIE during the time course of the experiment (8000 s) 
compared to 45.8 % of vesicles exposed to magainin, the profiles for the two peptides are remarkably similar. Both profiles are 
dominated by pore-mediated leakage events, with 53.5 % of the GUVs exposed to melittin displaying the behaviour, compared 
to 35.6 % of the GUVs exposed to magainin. The other PIEs display < 10 % activity within this membrane system for both 
LCAMPs. 
 
Marked similarities exist between PIE profiles of magainin and melittin within the DOPC:DPPC:DPPG 
membrane system, with both profiles displaying high levels of pore-mediated leakage, with 53.5 and 
35.6 % of the GUVs exposed to melittin and magainin respectively producing pore-mediated leakage as 
their dominant PIE. With melittin being more active within the membrane, displaying >75 % activity 
compared to 46.3 % for magainin, the selective AMP magainin is actually proportionally more effective 
at producing pore-mediated leakage events within active vesicles than melittin. Magainin produced 76.9 
% of active vesicles displaying pore formation, compared to melittin, which results in 70.2 % of active 
vesicles displaying pore-formation. 
 
5.7. mGUV membrane system 
The mGUV membrane system contains DOPC, a cylindrical zwitterionic lipid; DPPC, a zwitterionic 
lipid with inverse-conical geometry and cholesterol, a zwitterionic negative curvature inducing lipid. 
When mGUV vesicles containing fluorescently tagged dextran markers were exposed to melittin, at a 
concentration of 1 µM, the dye-efflux kinetics shown in figure 5.20 were produced. 
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Figure 5.20: Dye-leakage kinetics for the 3 and 10 kDa dextran markers entrapped within mGUV vesicle, exposed to 1 µM 
melittin, with the error bars representing the standard deviation of the individual leakage traces contained within that group. 
There are three distinct pore-mediated leakage groupings within the dye-efflux data, with the carpet mechanism (turquoise 
triangles) included for comparison only. 
 
The averaged traces depicted in figure 5.20 were compiled from the following number of individual 
traces; group 1 from nine traces; group 2 from seven traces; group 3 from eighteen traces and the 
carpet mechanism trace is compiled from six traces. In addition to the grouping of the leakage data into 
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quantised kinetic groupings, the membrane system also displayed group switching behaviour within 
multi-component traces, when the mGUV membrane system was exposed to 1 µM melittin. The 
individual 3 kDa leakage phases of a three component trace are displayed in figure 5.21, overlaid with 
the averaged kinetic grouping data from the relevant preceding figure. 
 
Figure 5.21: Group switching exhibited by the 3 kDa dextran dye-efflux kinetics, produced by exposure of mGUVs to 1 µM 
melittin, with the averaged leakage grouping depicted in black and the individual leakage phases of the multi-component traces 
shown in red. The first leakage phase of the multi-component trace (red left-facing triangles) follows the leakage kinetics of the 
averaged group 2 for ~150 s, before the second leakage phase (red right-facing triangles) shifts to follow group 1 kinetics for 
~250 s. The third and final leakage phase of the multi-component leak (red diamonds) leaks via the carpet mechanism until the 
vesicles contents are completely depleted. 
 
In common with most other membrane systems, the overlaid data from the multi-component 
leakage traces shows a very close match to the existing averaged leakage groups. Exposure of the mGUV 
membrane system to the higher 5 µM melittin concentration produced the dye-efflux kinetics shown in 
figure 5.22. Unlike the 1 µM data, only part of the data could be resolved into distinct kinetic groups, 
with the majority of the data occurring at fast kinetics. The 5 µM melittin data for the 3 kDa dextran 
efflux-kinetics displayed only one clearly delineated grouping of leakage traces, with a loosely grouped 
number of leakage traces at slower kinetics, but the majority of leakage occurring at faster kinetics, with 
no clear leakage groups. The 10 kDa data show a more distinct leakage pattern, with the slower kinetic 
traces more tightly grouped, and two leakage groups at faster kinetics, as well as a distinct carpet 
mechanism group. The data is still lacks enough clarity for the individual leakage groups to be reliably 
established however, and the ungrouped data is presented. 
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Figure 5.22: Graph showing the 3 and 10 kDa dye-efflux kinetics for the mGUV membrane system, after exposure to 5 µM of the 
AMP melittin. One closely matched group of leakage kinetics was identified within the 3 kDa data, and averaged to create a 
leakage group, represented by the black squares. The error bars represent the standard deviation of the individual leakage 
traces comprising the group. The remainder of the leakage kinetics feature no resolvable groups within the 3 kDa data. The 10 
kDa data presents improved separation and grouping of the kinetics data compared to the 3 kDa data set, with three possible 
kinetic groupings visible; a slower kinetic group (A); two faster kinetic groups (B and C) and the carpet mechanism (D). However 
these groups are not clearly delineated from one another to establish the presence of leakage groups. 
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The closer grouping of the 10 kDa dextran data suggests that less variability exists within the pore-
mediated leakage for the larger 10 kDa marker, while the smaller 3 kDa data encounters higher diversity 
in efflux through the pore structures. The unresolved traces contain 44 individual leakage events, while 
the leakage group is the result of averaging five traces. In common with most data sets, the 5 µM 
melittin mGUV data contained multi-component leakage traces that overlay with the leakage groups 
from the single-component data, with an example of a three component leakage trace presented in 
figure 5.23.  
 
Figure 5.23: Graph demonstrating the group switching of a three component leakage trace, recorded from an mGUV after 
exposure to 5 µM melittin, with the averaged data presented in black and the individual leakage phases of the multi-component 
trace shown in red. The first leakage phase (red left-facing triangle) presents closely matched kinetics to that of group 1 for ~400 
s, before switching to run parallel to the kinetics of group 3 for ~650 s for the second leakage phase (red right-facing triangles). 
The third leakage phase of the multi-component trace displays faster kinetics, possibly via the carpet mechanism, until the 
vesicle contents are completely depleted. 
 
In addition to the multiphase leak group switching, the mGUV membrane system also displayed 
closely matching kinetics between the 1 and 5 µM data sets, but with differing event initiation timings. 
Both melittin concentrations display 100 % activity within the mGUV membrane system, with very 
similar PIE profiles. Melittin at a concentration of 1 µM produces 25.6 % pore-mediated leakage events, 
with an average initiation time of 1572.2 s after exposure to the peptide. At the higher concentration of 
5 µM melittin produces 29.1 % pore-mediated leakage events, occurring on average of 624.1 s after 
exposure. The overlaid data for the mGUV membrane system exposed to 1 and 5 µM melittin is 
presented in figure 5.24. 
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Figure 5.24: Graph presenting the overlaid data for the dye-efflux kinetics, induced by the exposure of the mGUV membrane 
system, to different concentrations of the AMP melittin. The 1 µM peptide concentration data is presented in black, and the 5 
µM concentration in red, with the error bars displaying the standard deviation of the individual leakage traces within each 
group. The 5 µM leakage group presents a close match to the kinetics of the 1 µM group 2. 
 
The close match between the 1 and 5 µM melittin data, suggest that identical pore forming 
processes are occurring within the mGUV membranes, at both concentrations of AMP. It can be 
speculated that the loose grouping of leakage traces displaying slower kinetics than group 1 within the 5 
µM data correspond to group 1 of the 1 µM data, and the two ill-defined groups visible within the 5 µM 
data are the group 3 and carpet mechanism groups seen in the 1 µM data set. The increase in peptide 
concentration increases the variability of the leakage data, especially within the 3 kDa data, which 
suggests the presence of additional smaller pores at the higher concentration. Exposure of mGUVs to 
the AMP magainin at a concentration of 1 µM produced much lower levels of PIEs than melittin, with 
31.1 % of vesicles producing activity, with only 2.3 % displaying pore-mediated leakage and the PIE 
profile dominated by bursting (17.2 %) and the carpet mechanism (9.9 %). The large data set size (354 
mGUVs) allowed grouped leakage kinetics to be established, and produced the grouped dye-leakage 
kinetics shown in figure 5.25. The averaged groups were compiled by averaging the following amount of 
individual leakage  traces; group 1 is the average of two traces; group 2 is the average of three traces 
and the carpet mechanism group is the average of seventeen traces. 
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Figure 5.25: Averaged leakage groups displayed by the mGUV membrane system, after exposure to 1 µM of the AMP magainin, 
with the error bars representing the standard deviation of the individual leakage traces contained within each group. Two pore-
mediated leakage kinetic groupings were produced by the efflux of the 3 kDa (top) and 10 kDa (bottom) dextran markers, with 
the groupings noticeably tighter within the smaller 3 kDa data set, as demonstrated by the reduced error bars. 
 
The data collected for the mGUV system exposed to 1 µM magainin showed an interesting set of 
multicomponent leakage traces, with an example presented in figure 5.26. 
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Figure 5.26: Graph depicting the changes within group 1 kinetics during the pore-mediated leakage event, for 3 (left) and 10 
(right) kDa dextran-Alexafluor entrapped within mGUV vesicles, exposed to 1 µM magainin. The 3 kDa data shows that while 
the efflux rate for the smaller dextran remains constant for GUV 1, there is a pronounced increase in rate of release for GUV 2 
after ~200 s. The 10 kDa data for GUV 2 indicates that the 10 kDa dextran efflux rate increases at the same timepoint as the 3 
kDa data, but that the 10 kDa dextran leakage ceases at ~ 250 s.  
 
The contrasting picture presented in figure 5.26, where leakage kinetics from the same group 
present opposing leakage behaviour, paints a complex picture of the dynamic interactions producing the 
pores within the mGUV membrane. The rate of dextran release from GUV 1 undergoes an increase after 
~200 s for both the 3 and 10 kDa markers, indicating that an increase in the number, size or opening 
time for the pores has occurred. The dye-efflux data for GUV 2 also shows a change occurring at 
approximately the same time point as GUV 1, but with remarkably different results. The 3 kDa leakage 
rate appears to be unaffected, but the leakage rate for the larger 10 kDa dextran completely ceases. 
This indicates that a change within the lipid-AMP system has taken place, which stops the larger dextran 
from passing the lipid membrane barrier, while having little effect on the escape of the smaller 3 kDa 
dextran. Exposure of the mGUV membrane system to the higher magainin concentration of 5 µM 
produces the grouped leakage kinetics displayed in figure 5.27. The Data shown in figure 5.27 was 
compiled by averaging the following number of individual leakage traces; group 1 is the average of two 
traces; group 2 is a single trace; group 3 is the average of three traces and the carpet mechanism group 
is the average of seven traces. 
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Figure 5.27: Graph depicting the averaged leakage groups for the mGUV membrane system, after exposure of the vesicles to 5 
µM of the AMP magainin, allowing the efflux of entrapped 3 (top) and 10 (bottom) kDa dextrans through the peptide induced 
pores. Both dextran markers produce quantised leakage kinetics, with four clearly distinct leakage kinetic groups present, with 
the error bars representing the standard deviation of the individual leakage traces that comprise each group. Three of the 
groups are produced by pore-mediated leakage events, and one group is the result of leakage via the carpet mechanism. 
 
The 5 µM magainin system also displayed the multi-component leakage group switching seen in the 
1 µM system, as well as previous membrane systems. A two component leakage traces is presented in 
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figure 5.28, with both leakage phases from the multi-component trace separately overlaid onto the 
complete leakage data set. 
 
Figure 5.28: Graph showing the group switching of a two component leakage trace, displaying the 3 kDa averaged grouped 
leakage data for the mGUV system (black) exposed to 5  µM magainin, overlaid with the individual leakage phases from the two 
component trace (red). The first leakage phase (red left-facing triangles) presents a close match to the efflux rate of group 1 
from the averaged leakage data, matching kinetics for ~2200 s, where upon the leakage trace switches between leakage modes. 
The GUV then follows the kinetics of the carpet mechanism (red right-facing triangle), until the 3 kDa dextran entrapped within 
the vesicle is completely depleted. 
 
To compare the pore inducing effects of the two magainin concentrations within mGUV 
membranes, the grouped dye-leakage traces for both the 1 and 5 µM data sets were overlaid, and 
presented in figure 5.29. The 1 and 5 µM data sets for the dye-efflux kinetics induced by the exposure of 
mGUVs to the relevant concentrations of the peptide, again display close kinetic matching of the 
averaged leakage groups, indicating that the pore-formation process occurring within the mGUV 
membranes is independent of the peptide concentration. The presence of a unique group of faster 
leakage kinetics at the higher peptide concentration (group 3) suggests that the increase in the rate of 
peptide binding can induce faster kinetics, seemingly at odds with the previous statement, unless the 
pore-formation process is the same, but only the number of pores changes. All three groups from the 5 
µM data set follow the kinetics of group 2 for the first 150 s of the leakage process, before diverging to 
create three separate groups; a slower kinetic group which matches with the kinetics of group 1 from 
the 1 µM data, and faster group 3 which is unique to the higher concentration data set. 
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Figure 5.29: Graph showing the overlaid 3 kDa dextran data for the averaged grouped dye-efflux kinetics produced by the 
exposure of mGUVs to the AMP magainin, at concentrations of 1 µM (black) and 5 µM (red), with the error bars representing 
the standard deviation for the individual leakage traces contained within each group. The traces show a good match for the 
averaged grouped leakage kinetics across the two peptide concentrations, with both groups 1 and 2 of the 1 µM magainin data 
set mapping onto their corresponding groups from the 5 µM data. The carpet mechanism groups also show a close match for 
the kinetics of the two peptide concentrations, but the higher 5 µM concentration contains a unique leakage trace (group 3), 
that is not present within the lower magainin concentration data. The 5 µM data contains an interesting phenomenon, with all 
three groups appearing to follow group 2 kinetics for ~150 s, before branching out, to create both slower (group 1) and faster 
(group 2) kinetic groups. 
 
The primary difference between the 1 and 5 µM magainin data sets is the initiation time of the 
leaks, with the lower concentration producing leaks after an average of 3036.4 s, and the higher 
concentration leaking after an average of 3538.0 s. The other PIEs at the higher concentration of 
magainin are all produced faster than at the lower concentration, in line with expectations. This 
phenomenon is not unique to the interaction of magainin with mGUV membrane systems, and was also 
noted within the interactions of magainin with DOPC:DOPG:DPPG vesicles, and for the interactions of 
melittin with DOPC:DPPC:DOPG membranes. The actions of the selective magainin peptide, with the 
non-selective melittin peptide, within mGUV membranes can be compared to provide information on 
the mechanism of selectivity of the two AMPs. The overlaid data of their 3 kDa leakage kinetics is 
presented in figure 5.30, for the m GUV system exposed to 5 µM of each peptide. 
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Figure 5.30: Comparison of the 3 kDa leakage data for the mGUV membrane, for the AMPs melittin (black) and Magainin (red), 
at a peptide concentration of 5 µM. The first groups for both peptides show a close match between their leakage kinetics, but 
the remainder of the leakage groups do not display kinetic matching. 
 
In contrast to the magainin and melittin overlays within the anionic DOPC:DPPC:DPPG membrane 
system, the two AMPs do not display similar leakage kinetics, with both fewer groups within the mGUV 
data and dissimilar kinetics between the averaged leakage groups. The anionic membrane produced 
both the same number of averaged leakage groups for the two peptides (6), it also displayed matching 
kinetics for five of the six groups, suggesting that the pore-formation process of both magainin and 
melittin was similar within these bacterial facsimile membranes. The zwitterionic mGUV membrane 
system not only presented dissimilar average groupings for each peptide, with the magainin data 
containing three pore-mediated leakage groupings, and melittin five, it also displayed low levels of 
matching between the kinetic groups, with only the first of melittins five groups presenting a close 
match to the first group of magainin. It is interesting to note, that while in the DOPC:DPPC:DPPG 
membrane system it was the slowest kinetic groups that did not match, within the mGUV membrane 
system only the slowest group matched kinetics between the two peptides. Other points of contrast 
between the action of magainin and melittin within the mGUV system include the difference in the 
average timings of the pore-mediated leakage events, with the higher 5 µM concentration of melittin 
producing faster initiation of the pore formation process than the lower 1 µM concentration, returning 
times of 1614.8 and 695.1 s respectively. Together with the differences in leakage kinetics, this indicates 
that the pore formation processes of the selective magainin and non-selective melittin peptides, differ 
within the mammalian facsimile membrane system. In addition, both the peptides showed the expected 
difference in activity between the membrane systems, with melittin proving to be 100 % active within 
the mGUV system at both peptide concentrations test. In contrast magainin proved to be significantly 
less active, returning activity levels of 31.1 % at 1 µM and 52.2 % at 5 µM, within the mGUV system. The 
pore-mediated events within mGUVs exposed to melittin also occurred considerably faster than within 
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mGUVs exposed to magainin, taking place almost twofold faster for the 1 µM melittin vesicles, and 
showing over fivefold quicker initiation of leakage at the higher 5 µM concentration. 
 
5.8. DOPC:DOPE:DOPG:DPPG membrane system 
The DOPC:DOPE:DOPG:DPPG membrane system contains a mix of anionic and zwitterionic 
topographic lipids, with DOPC and DOPE presenting zwitterionic cylindrical and conical geometry 
respectively, and DOPG and DPPG presenting anionic cylindrical and inverse-conical geometry 
respectively. Exposure of DOPC:DOPE:DOPG:DPPG vesicles to 1 µM melittin produces the averaged 
leakage kinetic groups presented in figure 89. The membrane system demonstrates the quantised 
leakage behaviour established within the other lipid-AMP systems. The averaged leakage groups were 
compiled from the following number of individual traces; group 1 is the average of 3 traces; group 2 is 
the average of six traces; group 3A is the average of four traces; group 3B is the average of seven traces; 
group 4 is the average of twelve traces and the carpet mechanism group is compiled from six traces. 
Two of the leakage groups identified within the DOPC:DOPE:DOPG:DPPG data set (groups 3A and 3B) 
present identical leakage kinetics for a short time after the initiation of pore-mediated leakage, then 
diverging to form unique leakage groups after ~400 s. The change in leakage kinetics indicates that the 
continued binding of melittin to the vesicles during the pore-formation process, and/or the 
translocation of lipid and peptide to the inner membrane leaflet, induce changes within the lipid-AMP 
dynamics that favour changes in the pore-formation process within the vesicles of group 3A that reduce 
the rate  of dye-efflux. Large number of traces followed the pattern, suggesting that the changes to the 
lipid-AMP system producing the change in leakage kinetics, are robust and reproducible. The kinetics of 
group 3A appear to run parallel to the group 1 kinetics at longer timescales; i.e. >1500 s. 
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Figure 5.31: Averaged leakage groups for the 3 (top) and 10 (bottom) kDa dextran-AlexaFluor markers, entrapped within 
DOPC:DOPE:DOPG:DPPG vesicles exposed to 1 µM melittin, with the error bars representing the standard deviation of the 
individual leakage traces comprising each group. Five distinct pore-mediated leakage groups were detected, along with a sixth 
group leaking via the carpet mechanism, identified as in the diagram key. Two of the leakage groups (3A and 3B) present similar 
kinetics within both data sets for ~400 s, before separating to form unique groups. The 3 kDa leakage traces display less 
variation between intragroup traces, as demonstrated by their smaller error bars. 
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The membrane system also demonstrates the multi-component trace group switch displayed by 
almost every lipid-AMP system examined, with the 3 kDa dextran dye-efflux data for a three-component 
leakage trace presented in figure 5.32, overlaid with the averaged leakage groups. 
 
Figure 5.32: Group switching graph of a three component leakage trace, with the individual leakage phases of the multi-
component leak shown in red, and the averaged leakage groups for the DOPC:DOPE:DOPG:DPPG membrane system shown in 
black. The first leakage phase of the multi-component traces (red diamonds) presents similar kinetics to group 3A/B for ~ 200 s, 
before switching groups to match kinetics with groups 2 for ~450 s (red pentagons). The final leakage phase of the multi-
component trace (red hexagons) switches back to group 3B kinetics until the vesicle contents are depleted. 
 
Exposure of the DOPC:DOPE:DOPG:DPPG membrane system to 1 µM of the AMP magainin, 
produces the averaged leakage groups presented in figure 5.33. The averaged leakage groups were 
compiled by averaging the following number of individual leakage traces; group 1 is the average of three 
traces; group 2 is the average of two traces; group 3 is the average of three traces and the carpet 
mechanism group is the average of four traces. Groups 1 and 2 of the 3 kDa data set are merged within 
the 10 kDa data, which suggests a difference within the pore-formation process within the group 2 
membranes, which favours the release of the smaller entrapped dextran, while producing no effect on 
the leakage of the larger dextran. 
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Figure 5.33: Grouped dye-efflux kinetics for the 3 (top) and 10 (bottom) kDa dextran markers, enclosed within 
DOPC:DOPE:DOPG:DPPG vesicles after exposure to 1 µM magainin, with the error bars representing the standard deviation of 
the individual leakage traces within each group. Three pore-medaited leakage groups are present within the 3 kDa data set, 
with a fourth group demonstrating leakage via the carpet mechanism, identified as in the diagram key. Two of these groups are 
merged within the 10 kDa data, with groups 1 and 2 displaying similar leakage kinetics within the data for the larger dextran. 
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The data set for the DOPC:DOPE:DOPG:DPPG membrane system after exposure to 1 µM magainin, 
also contains multi-component leakage traces, and figure 92 presents a two component traces, overlaid 
with the averaged leakage groups. 
 
Figure 5.34: Graph presenting the overlay of a two component 3kDa leakage trace, produced by the exposure of a 
DOPC:DOPE:DOPG:DPPG vesicle to 1 µM magainin, with the averaged leakage kinetic groups for the same membrane. The first 
leakage phase of the two component trace (red left-facing triangles) initially follows the efflux kinetics of group 2, for ~900 s, 
before the second leakage phase (red right-facing triangles) switches groups, to match leakage kinetics with group 3 until the 
vesicles contents are depleted. 
 
To compare the pore-formation process and its effect on dye leakage kinetics, for the AMPs 
magainin and melittin within the DOPC:DOPE:DOPG:DPPG membrane system, the grouped 3 kDa 
dextran leakage kinetics for the peptides were overlaid, with the result presented in figure 5.35. In 
contrast to the data from the anionic membrane system DOPC:DPPC:DPPG, the data for the anionic 
DOPC:DOPE:DOPG:DPPG membrane system displays a poor match between both number of quantised 
leakage groups and leakage kinetics between the two peptides. This suggests that the pore-formation 
process is significantly different within this membrane system for the two peptides, more in line with 
the results for the mGUV membrane system, where the selective AMP magainin demonstrated a poor 
kinetics match with the non-selective AMP melittin. 
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Figure 5.35: Comparison of the 3 kDa leakage data for the DOPC:DOPE:DPPG:DOPG membrane system, for the AMPs melittin 
(black) and Magainin (red), at a peptide concentration of 1 µM. The kinetics for the dye-efflux induced by the AMP magainin 
generally occurring at slower kinetics than those generated by the AMP melittin. The averaged kinetic groupings show a poor 
level of matching between the peptides, with only group 4 in the magainin data set showing a slight match to group 3B within 
the melittin data. 
 
5.9. Summary 
 
The leakage traces from the anionic bGUV and zwitterionic mGUV membrane systems follow the 
pattern established by the zwitterionic membranes, by arranging into distinct kinetic groups, again 
suggesting that leakage from vesicles can only occur via a limited set of allowed leakage conditions, 
likely to be related to the specific lipid-peptide interactions occurring within that particular membrane. 
The multiphase leakage traces from the bGUV data set again fit into the previously established 
groupings, indicating that further binding of peptide to the membrane can move the lipid-LCAMP 
system from one allowed leakage condition to another. The simultaneous opening of differently sized 
pores within a membrane, is again demonstrated by the merging of separate but adjacent traces from 
the 3 kDa data set, in the 10 kDa data set.  
Overlays of the data for the two LCAMPs magainin and melittin display good matching between the 
grouped leakage kinetics, suggesting that the leakage process induced by both peptides is occurring 
through pores with similar sizes, numbers and opening times. The PIE-profiles and initiation times for 
the two peptides show significant variation however; e.g. in the DOPC:DPPC:DPPG system, magainin 
displays an average initiation time for pore-mediated leakage of 3255.4 s, while melittin displays an 
average initiation time of 2541.0 s. The quicker initiation of pore formation indicates that melittin can 
form pores via fewer membrane-bound monomers than magainin; i.e. is more effective at generating 
pores within the DOPC:DPPC:DPPG membrane system. Once pore formation has been initiated 
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however, the pores formed allow dye efflux according to almost identical kinetics. When compared to 
the anionic DOPC:DPPC:DPPG membrane, an overlay for magainin and melittin leakage data for the 
mGUV system shows lower levels of matching, between the averaged leakage groups. This suggests that 
the lipid-LCAMP interactions that establish the conditions that allow leakage in the bGUV membrane, 
and the conditions that allow leakage in the mGUV membrane, are different. 
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6. Discussion 
Interactions between lipids and AMP helical faces appear to be a versatile director of membrane 
conformation, able to induce a heterogeneous catalogue of effects, including micellisation, pore-
formation and vesicle bursting. The mosaic of peptide-induced behaviours determined by the high-
throughput exposure of GUVs to AMPs, both selective for bacterial cells (magainin) and non-selective 
between mammalian and bacterial cells (melittin), indicates that a complex set of lipid-peptide 
interactions governs the bactericidal effects of these peptides. The influence of lipid charge and 
topography on the mechanism of action of AMPs is both ill-defined within the literature, and of crucial 
importance to the future development of these peptides as novel antimicrobial agents. This discussion 
contains a new model for LCAMP activity, which considers membrane free energy as the keystone to the 
mechanism of action of the peptides. The model proposes a novel pore structure, and explains the PIEs 
of the LCAMPs magainin and melittin within the different membrane systems. The model was 
constructed using the peptide behaviour presented within this thesis, combined with literature 
knowledge about lipid-peptide interactions, and possesses both explanatory and predictive power.  
 
6.1. The free energy of lipid-LCAMP interactions 
Lipid membrane bilayers can adjust their molecular shape and supramolecular structure in order to 
minimise their free energy.[123] Given the fact that the forces involved in lipid-peptide interactions are 
typically stronger than those involved in lipid-lipid interactions,[46] lipid interactions with membrane 
proteins will take precedence over interactions with other lipids, allowing membrane proteins the 
dominant role in the modulation of the physiochemical properties and free energy of the surrounding 
lipids.[30] The free energy change (ΔG0) associated with the membrane binding of LCAMPs from aqueous 
solutions is comprised of several components, shown in equation 2.[124] 
 
∆𝐺0 =  ∆𝐺𝑛𝑝
0 +  ∆𝐺𝑒𝑙𝑐
0 +  ∆𝐺𝑞𝐸
0 +  ∆𝐺𝑐𝑜𝑛
0 +  ∆𝐺𝑖𝑚𝑚
0 +  ∆𝐺𝑙𝑖𝑝
0  
 
Where ΔGnp = non-polar interactions formed by the expulsion of non-polar amino acid residues from 
water; ΔGqE = electrostatic interactions between basic amino acid residues and anionic lipids; ΔGelc = 
effects related to the hydrogen bonding of the peptide backbone; ΔGcon = energy from protein 
conformational change; ΔGimm = motional degrees of freedom from immobilisation in membrane and 
ΔGlip = energy to perturb the lipid bilayer. In a similar manner to how lipid-lipid interactions produce 
lipids rafts at local minima in the energy landscape, lipid-peptide interactions will search the available 
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landscape to achieve minimal energy conformations.[103][125] Applied to LCAMPs, this concept leads to 
membrane inserted peptides sitting within a free energy minimum in the energy landscape of the 
membrane, determined by its interactions with both the polar lipid headgroups and the membranes 
hydrophobic core.[124][126] To minimise the free energy of the LCAMP-lipid system, both conformational 
and organisation changes can take place; the proteins conformation and orientation can change;[127] the 
lipids can deform can deform via chain splay or headgroup tilt[128][129] and selective lipid clustering can 
take place.[113] The process of LCAMPs binding to membranes is strongly exothermic, but pore formation 
requires the input of energy; i.e. it is endothermic.[118][130] This discussion suggests that the required 
energy for pore formation is contained within the free energy of the lipid-LCAMP interactions. We will 
look at each term from equation 2, and examine the influence of the physiochemical and structural 
properties of LCAMPS, on the free energy of the bilayer during the peptides membrane-bound 
monomer and pore-formation states.  
 
6.1.1. Membrane partitioning (𝜟𝑮𝒏𝒑
𝟎 ) 
Before the partitioning process can be discussed, the energetics of the LCAMP in aqueous solution 
must be considered. LCAMPs are typically highly soluble in water, due to the high positive charge 
density conferred upon the molecule by the presence of lysine and arginine amino acid residues, but the 
peptides also contain a high proportion of non-polar residues. Non-polar amino acids interaction with 
water is thermodynamically unflavoured, and prefer to partition into the hydrocarbon core of the 
membrane bilayer. The energetics of the membrane partitioning process are often studied using the 
thermodynamics of individual amino acid residues, partitioning into hydrocarbons like n-octanol, which 
gives a good approximation of the partitioning energies into a lipid membrane core,[70][124] and it is found 
that the amount of partitioning is dependent on the potential energy of the peptide in the 
membrane.[128] A rough approximation of the partitioning energy of a LCAMP into a membrane leaflet, 
can be obtained by consideration of their amino acid sequence. From the partitioning studies 
mentioned above, we know that certain hydrophobic amino acids commonly encountered in the 
sequence of LCAMPs favour partitioning into the hydrophobic core of the bilayer, in the order of 
preference W > F > L > I > M > Y.[88] Consider the LCAMP melittin with the amino acid sequence 
GIGAVLKVLTTGLPALISWIKRKRQQ; it contains 1 x W, 4 x L, 3 x I, all residues which display a large 
preference for non-polar environment like the hydrocarbon bilayer core, and thus contribute a large 
negative energy to the binding process. The energy of partitioning for melittin, from aqueous solution 
into a membrane leaflet has been calculated as –2 kcal/mol.[70] 
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6.1.2. Secondary structure formation (𝜟𝑮𝒆𝒍𝒄
𝟎 ) 
Protein secondary structures, e.g. α-helices, involve the formation of hydrogen-bonds, a large 
negative energy contributor to the binding energetics of LCAMPs to lipid membranes. For LCAMPs we 
must only consider the energetics of α-helix formation, with each amino acid residue reported to 
contribute -0.4 to -0.6 kcal/mol of residue involved in secondary structure hydrogen bonding.[70][131] 
Again using melittin as an example, there are approximately 18 residues involved in helix formation, and 
the formation of the α-helix contributes -9 kcal/mol.[70] Hydrogen bonding of the peptide backbone 
during secondary structure formation, also reduces the energy cost of inserting the polar groups within 
the membrane core.[70] The random coil to helix transition provides the majority (~65 %) of the negative 
enthalpy that drives the spontaneous binding of LCAMPs to lipid membranes.[118] The AMP helix is 
believed to remain in largely helical form in both its monomer and pore states, and thus this term is 
unlikely to exert a significant influence of the transition between the two states. 
 
6.1.3. Electrostatic interactions (𝜟𝑮𝒒𝑬
𝟎 ) 
Electrostatic interactions will make a significant negative contribution to the free energy of the 
lipid-peptide system in anionic membranes,[132][133] with the contribution for one lysine binding to an 
anionic lipid estimated at 1 kcal/mol. Magainin contains four positively charged amino acids at 
physiological pH, and the contribution to the free energy can be approximated at -4 kcal/mol, while 
melittin contains six cationic residues at identical pH, and electrostatics will contribute -6 kcal/mol 
towards the total free energy of the lipid-LCAMP system. It should be noted here, that the electrostatic 
force is much greater than the other forces encountered in lipid-LCAMP interactions, on a per lipid 
basis.[134] The interaction of the LCAMPs cationic amino acid residues can therefore be expected to 
dominate the accumulation of lipids around the LCAMP in anionic membranes,[113] but to change little 
on transition from membrane-bound monomer to pore peptide states.  
 
6.1.4. Protein conformation (𝜟𝑮𝒄𝒐𝒏
𝟎 ) 
Protein conformation is coupled to the mechanical and physiochemical properties of the bilayer, 
through interactions between the membrane-bound LCAMP and the lipids hydrocarbon core and polar 
headgroups. In relation to LCAMPs, the protein is primarily helical in both monomer and pore-
associated states, so this term will have little influence on the pore-formation energetics.  
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6.1.5. Peptide immobilisation (𝜟𝑮𝒊𝒎𝒎
𝟎 ) 
While the partitioning energy is negative, and thus the process is spontaneous for LCAMPs, the 
binding of the peptide to membranes involves an increase in entropy. Enthalpy drives the spontaneous 
binding process, whereas entropy counteracts binding.[118]This is due to the loss of translational and 
rotational freedoms of the peptide, from moving from random coil conformation to membrane-bound 
helical form.  Moving from aqueous solution to membrane-bound monomer involves a change from 3D 
to 2D diffusion, incurring an entropic penalty. The pore-associated AMP helix may be a permanent 
fixture in the pore structure, again suffering an unfavourable entropic contribution to the free energy of 
the pore state. 
 
6.1.6. Lipid perturbation (𝜟𝑮𝒍𝒊𝒑
𝟎 ) 
One of the largest contributors to the free energy of the lipid system is elastic deformation induced 
by lipid-lipid and lipid-peptide interactions. Non-bilayer lipids like PE within membranes induce 
curvature in the surrounding lipids, producing packing frustration and increasing the free energy of the 
bilayer.[30] The concept can also be applied to the interaction of lipids with membrane proteins, where it 
is possible to induce both membrane bending and stretching through hydrophobic mismatch, between 
helix length and hydrophobic core thickness.[31] The equations governing the energy cost of the bilayer 
deformations are given below in equations 3 and 4.[31] 
𝐸𝑛𝑒𝑟𝑔𝑦 𝑐𝑜𝑠𝑡 𝑜𝑓 𝑠𝑡𝑟𝑒𝑡𝑐ℎ𝑖𝑛𝑔 =  
1
2
 𝑥 𝐾𝑎 𝑥 (
2𝑢
𝑑0
)
2
 
 
𝐸𝑛𝑒𝑟𝑔𝑦 𝑐𝑜𝑠𝑡 𝑜𝑓 𝑏𝑒𝑛𝑑𝑖𝑛𝑔 =  
1
2
 𝑥 𝐾𝑐  𝑥 (∇
2𝑢 − 𝑐0)
2 
 
Where Ka = bilayer compression moduli; u = change in bilayer thickness; d0 = original bilayer thickness; Kc 
= bilayer bending moduli; ∇2𝑢 = Laplacian operator of the change in membrane thickness and c0 = 
intrinsic monolayer curvature. The energy costs for membrane deformation are dependent on the 
bilayer compression and bending moduli, which in turn rely on the constituent lipids. It is clear that it is 
energetically preferable to surround the protein with lipids which minimise the energies of compression 
and bending. To minimise the energy cost of stretching the bilayer in response to the deformation 
around an inserted protein, it is necessary to reduce the influence of the terms Ka and d0, by enriching 
the annulus around the protein with lipids with low compression moduli and longer chain lengths. The 
change of acyl chain length will produce the most significant effect, as d0 has a squared relationship with 
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the energy cost of stretching. The bending cost is also dependent on the intrinsic curvature of the 
surrounding lipid, with the best way to minimise this energy is to minimise the (∇2𝑢 − 𝑐0)
2 term, by 
surrounding the protein with lipids that possess intrinsic curvature that efficient packs the lipids into the 
required curve. Applied to the membrane interactions of the AMPs magainin and melittin, we can see 
that this concept results in a preference for opposite curvature lipids to accumulate around each 
peptide, in order to minimise the energy of the lipid-LCAMP system. One significant difference between 
magainin and melittin, is the opposite curvature induction produced by the membrane-bound AMP 
helix, with magainin producing positive curvature and melittin inducing negative curvature. To maintain 
the free energy landscape of the lipid-AMP system at a local minima, melittin will preferentially interact 
with positive curvature (i.e. inverse-conical geometry) lipids like DPPC, and magainin with negative 
curvature (i.e. conical geometry) lipids like DOPE. We can therefore expect the curvature of the 
surrounding lipids to play a major role in the lipid-AMP dynamics surrounding the membrane-bound 
peptide, influencing both the pore-formation and selectivity mechanism of the two peptides. The 
degree of lipid perturbation is considerable different moving from the membrane-bound monomer to 
the pore state peptide, and this will likely exert a considerable influence on the energetics of the pore-
formation process. 
 
6.2. Membrane free volume and packing frustration 
One pitfall associated with considering lipids as purely geometrical rigid shapes according to the 
Helfrich packing model, is that strict application leads to poorly packed lipid membranes containing 
membrane free volume, or interstices, between the constituent lipids.[39][135] In reality these volumes are 
minimised; the membrane will deform in order to minimise the intrusion of water into the free space, 
and hence into contact with the hydrophobic membrane core. To fill the free volume, the constituent 
lipids of the bilayer can perform several conformational adjustments, including tilting of the whole 
lipid[136] or the headgroup[137] and splaying of the lipid acyl chains.[128][129] Conformational changes of the 
lipids in response to bilayer stress is termed “packing frustration”, representing a deviation from the 
idealised packing situation, and increasing the free energy of the bilayer.[128][135] 
 
6.3. LCAMP behaviour during pore-formation 
At this point, it is worth revisiting the behaviour of LCAMPs within lipid membranes, which are 
widely reported in the literature.[87][58] LCAMPs display random coil conformation in aqueous solution, 
and spontaneously bind to lipid membranes, adopting a pronounced helical character. The helix initially 
orientates parallel to the membrane plane, and increases the area of the outer membrane leaflet, 
thinning and weakening the membrane. Once a critical peptide/lipid ration is achieved, peptide 
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monomers change orientation, from parallel to the membrane plane to parallel to the membrane 
normal plane. The reorientation of peptide helices is associated with the process of pore formation, as 
prior to reorientation, no pores can be detected within the system. Positive curvature lipids greatly 
increase the pore formation activity of LCAMPs. The leakage kinetics are often described as biphasic, 
with both slow and fast components.[58][77] Any new model must explain these facts, and make 
successful predictions about future experimental results.  
 
6.4. Energy of the membrane-inserted monomer 
Interactions of membrane-inserted AMP monomers with their surrounding lipids are not 
homogeneous, factors including lipid curvature, charge and fatty acid configurations will affect the 
energy of the lipid-AMP system. Interactions of peptide helices with lipids generating matching 
curvature to the peptide-induced curvature will create larger defects within the membrane, increasing 
the bilayer free energy and speeding the initiation of PIEs, and vice versa. For example, interactions 
between magainin, a positive curvature inducing peptide and DOPE, a negative curvature inducing 
conical lipid, would result in a reduced packing defect than the interaction of magainin with DPPC, a 
positive curvature inverse-conical geometry lipid. Close proximity of the shallowly-inserted magainin 
helix and the large hydrophobic volume of the lipid DOPE (S = 1.41), reduces the membrane disruption 
surrounding the peptide helix, decreasing the bilayer free energy. Strandberg and colleagues (2013) 
unequivocally show that the surface-associated helical form of magainin is stabilised by negative 
curvature lipids. In contrast, interactions between magainin and DPPC lead to an increase in the free 
energy of the lipid annulus surrounding the peptide helix. The reduced hydrophobic volume of DPPC (S = 
0.78) and its large PC headgroup, coupled to the positive curvature inducing magainin helix, creates a 
mismatch between the volume occupied in the polar headgroup region, and the hydrophobic volume 
occupied by the lipid-AMP raft. The concept of lipid topography controlling the free energy of lipid-AMP 
interactions is presented in figure 6.1,  
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Figure 6.1: Diagram depicting the interaction of deep (melittin) and shallow (magainin) penetrating AMP helices, with 
membranes of varying topography, with the peptide helices shown as blue cylinders. The polar lipid headgroups are depicted in 
red, and the non-polar tailgroups in yellow. (A) The interaction of a magainin helix with cylindrical geometry lipids (i.e. DOPC) 
leads to disruption in the membrane packing of the surrounding lipids, as the peptide occupies a large volume of the polar 
headgroup area, and induces positive membrane curvature. (B) A magainin helix surrounded by positive curvature lipids (i.e. 
DPPC) induces a larger packing defect than (A), caused by the mismatch between hydrophobic and hydrophilic volumes occupied 
by the lipids and peptide, leading to crowding of the interfacial region. (C) Magainin surrounded by negative curvature lipids (i.e. 
DOPE) produces a smaller packing defect than (A), the smaller headgroup of the negatively curved lipid easing the crowding at 
the interfacial region. (D) A membrane-bound melittin helix surrounded by cylindrical lipids produces a packing defect and 
negative curvature, caused by the deep penetration of the helix into the bilayer, which expands the hydrophobic volume of the 
membrane. (E) Lipids with positive topography will pack closely around the deeply penetrated melittin helix, reducing the leaflet 
area increase, and minimising the energy of the packing defect. (F) Melittin surrounded by negative curvature lipids will result in 
larger packing defects, caused by overcrowding in the hydrophobic region of the membrane leaflet. It is clear that the two 
peptides will display their maximal packing defect energies in membranes with opposite topographies; magainin in membranes 
featuring positive topography (B), and melittin in membranes containing negative topography lipids (F). 
 
Figure 6.1 depicts the influence of lipid topography on the scale of the lipid-AMP packing defect, by 
contrasting a shallow penetrating peptide (magainin) surrounded by lipids featuring cylindrical, conical 
and inverse-conical geometries, with a deep penetrating peptide (melittin) interacting with the same 
membrane. The tendency of lipid-AMP systems to minimise their free energy, can be illustrated using 
the membrane systems DOPC; DOPC:DPPC and DOPC:DOPE, interacting with the AMP melittin. Each 
peptide helix will form a dynamic lipid-AMP raft, with raft composition governed by the interactions 
between each lipid and the peptide helix, as depicted in figure 6.2.  
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Figure 6.2: Top-down view of a membrane-bound AMP helical monomer, represented by the blue cylinder, embedded within a 
lipid membrane. The lipid headgroups are depicted as spheres, with the bulk components of the membrane shown in grey. 
Green spheres represent lipids which form favourable interaction with the peptide helix, reducing the free energy of the lipid-
AMP system, while red spheres are lipids which form high energy interactions with the helix, increasing the membrane strain in 
the area surrounding the AMP helix. The yellow arrows represent the lipid exchange taking place in the dynamic lipid-AMP raft, 
with the replacement of a high energy lipid with a low energy lipid being favoured, with a corresponding large arrow. 
Replacement of a low energy lipid with a high energy lipid is disfavoured, resulting in a small arrow. The yellow circles represent 
positively charged residues of the AMP, and their counterpart high energy anionic lipids, forming strong electrostatics but 
unfavourable interactions with the peptide helix, resulting in a high membrane free energy. 
 
Lipids which lower the raft free energy will be retained for longer within the raft than those lipids 
which produce higher energies, which has interesting implications for the mechanism of action of AMPs 
within heterogeneous membrane systems. Consider again the dynamic lipid-melittin raft interacting 
within a DOPC membrane, with all lipids presenting identical topographies and fatty acid saturation, the 
rafts will all possess almost identical free energies. Next consider the raft behaviour within DOPC:DPPC 
and DOPC:DOPE membranes; the inverse conical DPPC will suppress the negative curvature induction of 
the deeply-inserted melittin helix, while the conical DOPE will exaggerate the curvature induction of the 
AMP. Interaction with DPPC will reduce the free energy of the defect, and therefore it is 
thermodynamically favoured for DPPC to remain within the lipid-AMP raft for longer than DOPE. Within 
the DOPC:DPPC system the rafts are enriched with DPPC, while in the DOPC:DOPE system the raft will 
exclude DOPE and contain mainly DOPC. Electrostatics will play a disproportionately large role in 
determining the composition of the lipid rafts around each peptide, due to the strong nature of 
electrostatic interactions compared to the other forces involved in lipid-AMP interactions.[113][134] The 
large electrostatic interactions will dominate other considerations; e.g. curvature, topography and fatty 
acid saturation effects. This results in the forced retention of lipids with unfavourable interactions with 
the peptide helix within the dynamic lipid-AMP raft, increasing the available free energy of the bilayer. 
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In conclusion, the increases of both membrane free energy and leaflet area that occur upon LCAMP 
binding to lipid membranes, can by mediated via interactions with varying topography lipids. 
 
6.5. Energy of the lipid-LCAMP raft  
The low number of lipids directly interacting with the helix within a lipid-AMP raft, results in large 
local fluctuations in the system free energy, caused by the exchange of lipids between the bulk system 
and the raft. Consider a membrane bound melittin helix with a charge of +6 at physiological pH, with a 
helical content of around 70 – 80%.[58] Due to the small size of the peptide helix, only an estimated 7- 9 
lipids can directly interact with the peptide, with each lipid contributing a specific free energy to the 
lipid-AMP raft free energy. Replacement of one lipid with a different lipid from the surrounding bulk 
system will result in a specific change in the energy of the lipid-melittin raft, dependant on the type of 
lipid introduced and its location along the peptide helix. Within the tightly controlled binary, tertiary and 
quaternary lipid systems featured in this work, the lipid-raft energies will be quantised, across the 
energy range covering the complete set of possible lipid-peptide interactions. The energy content of the 
set will range from the minima, where the peptide is completely surrounded with lipids featuring the 
lowest free energy interactions, to the maxima, where the peptide interacts only with lipids producing 
the highest possible increase in the membrane free energy. Due to the tendency of lipid-AMP rafts to 
minimise their free energy, the higher energy rafts will be present at low numbers within the total 
population, while the lower energy rafts will occur more frequently. Within anionic membranes 
electrostatic interactions, between the cationic melittin and the anionic lipids, result in practically 
permanent residents of the lipid-AMP raft.[113] In these membranes the set of possible lipid-AMP 
interactions is greatly reduced, and the energy states for the lipid-AMP raft will be considerably more 
quantised in nature. The concept is presented in figure 6.3, which features the energy minima and 
maxima, as well as intermediate lipid-AMP raft free energy levels. 
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Figure 6.3: Graph depicting the variation in the membrane free energy of a lipid-AMP raft within a heterogeneous membrane 
system. Neutral lipids which neither raise nor decrease the energy of the raft, are represented in grey. Interactions with lipids 
which minimise the free energy of the lipid-AMP system (green) will be favoured, resulting in a lower aggregate free energy for 
the membrane-bound AMP helix and its associated lipids. Replacing neutral and low energy lipids with lipids featuring 
energetically unfavourable interactions with the helix (red), results in stepwise increases in the free energy of the lipid-AMP 
system. 
 
6.6. Membrane penetration of LCAMP monomers 
As an interacting coupled system, the lipids-AMP rafts will locate to a local energy minima within 
the free energy landscape of the system, where the peptides penetration depth may be affected by the 
topography of the surrounding lipids. DOPC:DPPC (80:20 mol%) membranes possess less hydrophobic 
volume than pure DOPC membranes, due to the reduced number of carbons and decrease unsaturation 
of the palymitoyl 16:0 fatty acids of DPPC (average packing parameter of 1.012). Melittin can initially be 
expected to penetrate deeper into the DOPC:DPPC membrane, as the energy penalty for deeper 
penetration will be reduced compared to the DOPC:DOPE membrane system, which possesses an 
averaged packing parameter of 1.144. The greater hydrophobic volume of the DOPC:DOPE hydrophobic 
membrane core will exert an energetic penalty on deeply-inserting peptides, pushing the lipid-AMP 
system away from the energy minima as the increased hydrophobic volume forces the surrounding 
lipids apart, and allows increased water penetration into the hydrophobic core. The local minima for the 
system will involve decreasing the peptide-insertion depth, suffering a penalty to the peptides partition 
energy (∆𝐺𝑛𝑝
0 ), but compensating through changes the energy of lipid perturbation (∆𝐺𝑙𝑖𝑝
0 ).  
The topography of the constituent lipids and the AMP therefore can be seen as components within 
a single system, that cooperatively find a local energy minima for the entire system, by altering 
properties such as peptide-insertion depth, lipid acyl chain splay and headgroup tilt. The penetration 
depth of melittin varies within membranes of different lipid composition, and by taking geometrical 
consideration into account it is possible to reconcile these differences within the same model, based on 
varying hydrophobic volumes and its effect on the location of the free energy minima of the lipid-AMP 
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system. Raghuraman and Chattopadhyay use DOPC membranes containing varying amounts of 
cholesterol,[119] creating a membrane with significantly more crowding within the hydrophobic region 
than the membranes utilised by Glukhov and colleagues, which feature DPPC and DPPG lipid 
membranes[139]. Within DOPC membranes the negative curvature inducing cholesterol results in 
increased lateral pressure within the hydrophobic core of the bilayer, and melittin trying to penetrate 
the outer leaflet faces a higher energetic penalty than within the DPPC/DPPG membranes, where the 
positively curved lipids leave considerable space within the bilayer core for AMPs to insert. The local 
free energy minima of the DOPC membrane will therefore see the peptide occupying a shallower 
position within the bilayer, compared to the deeper position allowed within the DPPC/DPPG system. 
Further supporting evidence is found within Raghuraman and Chattopadhyay,[115] which uses red edge 
excitation shift to probe the penetration depth of LCAMPs in response to lipid fatty acid unsaturation, 
where increased unsaturation disfavours peptide penetration due to the increased hydrophobic volume 
of the component lipids. 
Lysine is a common residue within AMPs, featuring a positive primary amine (at physiological pH) 
located at the end of a four carbon chain, which prefers to locate at a depth within phospholipid 
membranes where it can interact with the anionic phosphate groups. The phenomenon of lysine 
snorkelling is the capability of the cationic amino acid lysine to utilise the four carbon chain to “reach 
up” to its preferred region of the bilayer, granting considerable flexibility to the membrane penetration 
of the inserted AMP helix, in order to achieve a local energy minima within the energy landscape of the 
lipid-AMP system. Planque and Killian present convincing evidence, in an elegant study of the 
interaction of transmembrane helices flanked with cationic and aromatic residues with heterogeneous 
lipid systems, for the snorkelling ability of lysine containing peptides to minimise the perturbation of 
surrounding lipids.[139] Again topographical influences exert a powerful influence on the snorkelling 
capability of membrane-bound peptides; PC systems were  more likely to feature snorkelling helices 
compared to PE systems, with the smaller headgroup and larger hydrophobic volumes of PE  exerting a 
penalty on deeper insertion into the membrane. 
 
6.7. Helical steric asymmetry and membrane tension 
Both magainin and melittin demonstrate steric asymmetry within their helices, i.e. one face is 
composed of amino acids with bulky sterically active side chains, while the opposite face contains 
smaller less sterically active residues. Magainin in particular displays pronounced differences in the 
steric activity of its faces; one face containing three phenylalanine amino acids, and the opposite face 
consisting of less bulky amino acids (L/I/V/A residues). The presence of steric imbalance will exert 
different influences on lipid interactions of the opposing faces of the membrane-bound peptide helix, 
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and that the aggregation of different lipids to the opposing faces may play a role in pore-formation. The 
sterically rough face will induce considerable packing frustration along one face of the helix, and also 
reduce the packing density and hence lateral pressure along one face. The helical steric imbalance 
present in magainin will force association with varying topography lipids on opposing helical faces, 
which may play a part in the selectivity mechanism of AMPs (see later). To link steric asymmetry to lipid-
AMP raft energetics, it is necessary to consider the 3D structure of the membrane-inserted AMP helix, 
and in particular the location of the peptides cationic and sterically bulky amino acid residues. Consider 
a magainin 2 amide helix inserted into the plasma membrane of an E.coli bacteria, whose membrane 
composition is dominated by PE and PG lipids,[53] the steric asymmetry of the magainin helix is clearly 
visible in figure 6.4.  
To examine the effect of the steric imbalance of the membrane-bound magainin helix within the 
E.coli membrane, the sterically bulky face of the helix is presented in figure 6.4, to display the spatial 
relationship between the cationic residues and the sterically bulky residues. The cationic lysine residues 
of magainin will interact preferentially with the anionic PG lipids, and form a strong association via their 
strong electrostatic interaction. Interaction of PG with the lysine residues available on the sterically 
bulky face of the magainin helix will force unfavourable steric interactions with the phenylalanine 
resides; PG lipids interacting with K11 will be forced into close proximity to the sterically bulky F12 
residue. The large headgroup of the PG lipid will be sterically hindered by the position of F12 at the 
interface, increasing the energy of the lipid peptide raft. The other lysine available (K4) will also force 
interacting PG lipids into unfavourable steric interactions with the nearby F5 residues. If we replace the 
PG lipid with a PE lipid, its much smaller headgroup will suffer from much less steric hindrance from the 
phenylalanine residue than the bulky PG headgroup. 
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Figure 6.4: Space filling model of a membrane-bound magainin 2 helix, with hydrophilic residues shown in blue and hydrophobic 
residues in red. The dashed lines approximate the membrane plane (horizontal) and membrane normal plane (vertical), and are 
intended as a guide for the eye only. (A) Viewed down the helical axis, the helical asymmetry of the membrane-bound magainin 
helix is clearly visible, caused by the presence of bulky sterically active amino acids like phenylalanine (F5 and F12) and 
isoleucine (I2), and the residues to the left of the line comprising of less bulky and sterically active residues like leucine (L6). (B) 
Side view of the inserted helix, with both the cationic residues, K4 and K11, and the nearby sterically bulky amino acid residues, 
F5 and F12, are indicated. The anionic PG lipid will preferentially associate with the cationic lysine amino acid residues, due to 
electrostatic interactions, and the high volume PG headgroups will be sterically hindered by the bulky F12 residue, generating 
unfavourable interactions. (C) Opposing side view of the inserted helix, with cationic residues, K10 and K14, and the nearby low 
hydrophobic volume amino acid residues, G9 and A13, are indicated. The anionic PG lipids will preferentially associate with the 
cationic lysine amino acid residues due to electrostatic interactions, and the lack of steric crowding in the interfacial region will 
allow close energetically stable interactions between the lysine residues and PG lipids. 
 
However the electrostatic interactions between the cationic lysines and the anionic PG lipids will 
dominate the polar/hydrophobic interactions offered by the PE lipids,[134] and the sterically bulky face 
will become enriched with PG lipids. The collection of large headgroup lipids along this face increases 
the free energy of the lipid-AMP raft, through greatly increasing the volume of the hydrophilic interfacial 
region between the bilayer hydrophobic core, and the surrounding aqueous solution. If the PG lipid 
possesses unsaturated fatty acids, then in addition to the greater negative curvature of the lipid 
opposing the positive curvature of the peptide, the kink in the acyl chain caused by the double bond 
allows the lipid to deform and fill the available space within the hydrophobic region, reducing the lipid-
AMP raft energy. PG lipids with unsaturated acyl chains cannot adapt as readily to the increased 
interfacial volume, caused by the bulky PG headgroups and phenylalanine residues, and will possesses 
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more positive curvatures which synergise with the curvature induced by magainin, resulting in a higher 
energy defect. The opposing face of the peptide is comprised of much less bulky amino acid residues 
than the opposing face, namely G9 and A13, residues with small volume side chains with low steric 
activity. PG lipids interacting with the lysine residues available from this side of the membrane-bound 
magainin helix, K10 and K14, face greatly reduced competition for the interfacial region of the 
membrane leaflet compared to PG lipids interacting with K4 and K11 on the opposing face. The two 
closest amino acids to the lysine residues on this face are G13 and A9, which possess low volume side 
chains, which interfere with the lysine-PG electrostatic interactions to a lesser extent than the F residues 
on the opposing face. The large PG headgroups will “fit” much more closely to the peptide helical face, 
resulting in a lower energy interaction with less strain induced within the lipid-AMP system. The steric 
asymmetry exhibited by the membrane-bound magainin helix interacting with the E.coli membrane 
results in one face of the helix featuring higher energy interactions through forced electrostatic 
association with PG lipids, due to steric crowding at the leaflet interface between the F residues and the 
large PG headgroups.  
 
6.8. Key residues – Tryptophan and Phenylalanine 
The large sterically bulky W and F residues have been identified as key mediators of the activity of 
LCAMPs.[58][85][86] Both residues preferentially locate at the interfacial region, near to the glycerol 
backbones of the membrane lipids,[46][57][86][108] with a negative contribution to the free energy of the 
system of -4 kcal/mol.[140] This is a significant contribution to the thermodynamics of lipid-AMP systems, 
resulting in a substantial increase in the volume occupied by the peptide within the interfacial region. 
The 3D arrangement of residues around the magainin helix is also worthy of note, and is presented in 
figure 6.5. The arrangement fits well to the proposed leaflet fold structure of a toroidal pore, with the F5 
and F16 residues located deeper into the membrane, and the F12 residue located at a shallower spot, 
leading to an improved fit to the fold structure. 
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Figure 6.5: Diagram depicting the ability of magainin to stabilise the positive curvature of the leaflet fold structure of a toroidal 
pore. (Left) Space filling model of the helix bound to lipid membranes, with hydrophobic amino acid residues depicted in red, and 
hydrophilic residues in blue. The key residues F5/F12 and F16 labelled, and the green arrow depicts the curve created by the 3D 
location of the phenylalanine residues around the peptide helix. (Right) Identical magainin helix contained within the leaflet fold 
structure of the toroidal pore, with the transparent blue section representing the polar interfacial region of the bilayer, and the 
red showing the hydrophobic membrane core. The phenylalanine residues are labelled, and the black arrows indicate the 
residues occupation of the interfacial region, increasing the area and effectively acting as space fillers, stabilising the positive 
curvature required to form the leaflet fold structure. 
 
An approximation of the effect of the interfacial region occupation by the peptides bulky 
phenylalanine residues, can be obtained by consideration of the effect on the packing parameter of the 
surrounding lipids. Consider the non-bilayer lipid DOPE, with a packing parameter of 1.41, calculated by 
dividing the lipid volume (1235.0 Å3) by the product of the lipids molecular area at the lipid-water 
interface (50.0 Å2) and the lipid length (17.5 Å). When DOPE is present within the lipid annulus 
surrounding a membrane-bound magainin helix, it will come into contact with the three phenylalanine 
residues along the length of the peptide helix, with approximately three DOPE lipids able to fit along one 
helical face. The side chain of the F residue occupies an area of 32 Å2 at the interface, when orientated 
perpendicular to the bilayer normal plane; i.e. its minimal area within the bilayer interface, with 62 Å2 
being its maximal area when orientated parallel to the membrane plane. Due to the additive nature of 
packing parameters, it is reasonable to assume that the area occupied by the F residues can act in 
synergy with the lipid interfacial area, during consideration of the packing preference of the lipids 
surrounding the magainin helix.  
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Increasing the headgroup area parameter of DOPE in the packing parameter calculation by the 
minimal area of the F side chain gives a packing parameter of 0.86, while orientating the side chain to 
occupy its maximal interfacial area gives a packing parameter of 0.63. It is clear that small changes to 
the peptide conformation, i.e. changing the orientation of the phenylalanine residues with relation to 
the membrane plane, could exert a powerful influence on the packing preferences of the neighbouring 
lipids. For the case of the bilayer lipid DOPC (S = 1.08) the effect is even more pronounced, giving 
modified packing parameters of 0.72 and 0.56, for F orientated at its minimal and maximal interfacial 
areas respectively. As a packing parameter of S > 0.74 has been reported to be required for stable 
bilayer formation,[40] it is likely that occupation of the interface by the F residues of the peptide 
magainin is enough to destabilise the bilayer structure, and influence the formation of non-lamellar 
micellular phases. Geometrical parameter values of the lipids taken from [141]; [142] and [40]. The 
formation of non-lamellar phases normally results from the presence of large mismatch between the 
polar and non-polar regions of lipids, i.e. packing parameters with values 1<< S >> 1, and induction of 
non-lamellar phases has been reported for alpha-helices flanked with aromatic and cationic residues at 
high concentrations (>1:10 P/L ratios).[139] LCAMPs appear able to induce membrane reorganisation at 
significantly lower concentrations. The new model proposes that both F and W residues act as interfacial 
“space fillers”, occupying headgroup area adjacent to the peptide, and altering the curvature properties 
of the surrounding membrane. The ability of W/F residues to stabilise leaflet fold will only extend a 
short distance from the edge of the membrane-bound peptide helix, and may play an important role in 
determining the size of the pore, as each peptide can only stabilise a short section of the pores central 
channel. 
A further effect of the presence of W and F residues within the structure of LCAMPs, is their ability 
to preferentially associate with cholesterol, but disagreement exists on the effects of cholesterol on the 
membrane interactions of LCAMPs. Cholesterol has been reported to both decrease membrane 
penetration into membranes for AMPs,[119] and also to exert no effect on the penetration depth.[138] This 
can be explained using geometrical considerations, as the association of cholesterol with an LCAMP 
peptide will increase the lateral pressure within the hydrophobic volume of the membrane, disfavouring 
deeper insertion. W and F flanked transmembrane proteins show less sensitivity to hydrophobic 
mismatch between the thickness of the hydrocarbon bilayer core, and the non-polar residues of the 
membrane-spanning helix.[46][139] The large interfacial anchoring energy of the W and F residues changes 
the local energy minima for the lipid-peptide aggregate, forcing the membrane to distort to 
accommodate the transmembrane helix. The ability of W and F to act as buffers against hydrophobic 
mismatch can similarly stabilise the lipid-peptide pore induced by LCAMPs, through mediating between 
the bulk membrane thickness and the pore structure. 
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6.9. Reshaping the toroidal pore 
By consideration of the properties of membrane-bound LCAMPs, namely their flexible membrane 
penetration, steric asymmetry and positive curvature stabilisation, it is possible to propose a novel 
structure for the pores formed by the peptides. Figure 6.6 presents a diagram of proposed pore 
structure, where the peptides and lipids are represented as simple geometrical shapes, as per Helfrichs 
theory. In a small but mechanistically important shift, the leaflet fold is prioritised as the key structure 
within the pore, as it enables the mass transfer between the outer and inner membrane leaflets, and 
the generation of the leaflet fold positive curvature is regarded as the primary mediator for pore 
formation within the model proposed in this thesis. The LCAMPs F and W residues enable efficiently 
packed leaflet fold structures by occupation of leaflet interfacial volume, reducing the pores energy. The 
lysine snorkelling capability of the peptide allows it to adjust its depth penetration in order to conform 
to the new minima in the membranes energy landscape, induced via the change in the membranes 
supramolecular organisation from bilayer to pore state, and allows it to fill in the pore geometry by 
generating the negative curvature for the pore lumen. An alternative structure for the pore includes 
peptide dimers, with the LCAMP helices interacting via the opposing face to the one containing the W 
and F residues, and allowing each leaflet fold structure to be stabilised via the W and F residues from 
two peptides. Interestingly, some support for this proposed structure exists within the literature, with 
several papers indicating that melittin dimers may be involved in the pore formation process.[77][143][98] 
Many LCAMPs possess a leucine zipper motif, where every seventh residue is a leucine or isoleucine 
residue, and substitution of these leucine residues for other amino acids has the effect of reducing the 
peptides haemolytic activity, while retaining comparable antimicrobial activity to the parent 
peptide.[144][145] Leucine zipper motifs provide favourable energy interactions for helical association, and 
may overcome the electrostatic repulsion and allow dimerization within zwitterionic eukaryotic 
membranes. Within anionic prokaryotic membranes, the lipids shield the cationic residues from 
electrostatic repulsion, allowing peptide helical dimerization without the presence of a leucine zipper. 
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` It is possible that both the monomer and dimer pore types are possible, and can occur in 
membranes of different lipid compositions; anionic lipid membranes would reduce the electrostatic 
repulsion between the two cationic peptide helices for example. It is also conceivable that both pore 
types can exist within a membrane simultaneously. Another change to the classical pore occurs with the 
realisation that the pore is an active structure, mediating the transfer of lipids and peptides between 
membrane leaflets, with the constituent lipids (and possibly peptides) constantly changing. This results 
in a necessarily dynamic pore structure, with constant adjustments to pore size and shape in order to 
accommodate the inclusion of different lipids, and possible varying peptide monomer numbers) within 
its structure. This would lead to a significantly disordered pore, bringing the model into line with the 
latest literature on LCAMP toroidal pores. Interestingly, evidence exists for the retention of at least 
some lipids within the pore structure, as the rate of mass transfer between leaflets was found to 
increase if the charges on the headgroup of anionic lipids were neutralised by a low pH.[146] This suggests 
that anionic lipids are at least partially retained within the pore structure, perhaps serving to stabilise 
the pore. 
 
6.10. Pore formation in peptide-free membrane 
The structural parameters of the pore within the membrane will depend on properties of both the 
membranes constituent lipids, and the LCAMP monomers involved within the pore structure. Formation 
of the ideal pore requires remodelling of the lipid-AMP system into a new supramolecular organisation, 
with the formation of a tightly curved leaflet fold structure. Sakuma and colleagues demonstrate the 
formation of similar pores within peptide-free membranes, by the inclusion of non-lamellar lipids 
(DHPC) within DPPC lipid bilayers.[121] The lipid system demonstrated the formation of pores featuring a 
rolled rim resembling the leaflet fold structure, requiring only the cooling of a DPPC/DHPC membrane 
below the transition temperature of DPPC. The process is depicted in figure 6.7, and compared to the 
proposed mechanism for formation of LCAMP pores. DHPC possesses extreme inverse-conical geometry 
(S < 1/3), due to its short (6C) acyl chain and large PC headgroup, and forms micelles in aqueous 
solutions. Above the transition temperature of DPPC, the bilayer exists in a fluid liquid-disordered state, 
with DPPC and DHPC distributed at random throughout the membrane. Below its transition 
temperature, DPPC forms a gel-phase, excluding the DHPC from its liquid-crystalline lattice, and begins 
concentrating the inverse-conical geometry lipid within separate domains, increasing the membrane 
tension within those domains. . Pores then form with the inverse-conical geometry lipids acting as a cap 
for the pore rim, forming a leaflet fold structure, where one leaflet is bent into the other. 
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Figure 6.7: (A – C) Diagram depicting the supramolecular reorganisation reported by Sakuma and colleagues (2010), within 
DPPC:DHPC membranes, inducing the formation of macro-scale pores. The process is driven reduced free energy of lipids 
occupying their preferred geometrical arrangements; a bilayer in the case of DPPC, and micelle-like for DHPC. This section of the 
diagram is repeated from the introduction, while parts D –E show the application to the process of LCAMP pore formation, 
within a homogeneous membrane system comprised of cylindrical bilayer lipids. (D) At low peptide concentrations a small 
number of peptide-induced packing defects exist, with a higher energy than the surrounding liquid-disordered (Ld) phase, shown 
by the amber shading to the Ld label. (E) As peptide concentration increases, associations of lipid-peptide rafts occur, possessing 
significantly higher energies than the bulk membrane, indicated by the red shading to the aggregate label. (F) Above the critical 
P/L* ratio the membranes supramolecular organisation as an Ld phase bilayer, is less energetically favourable than 
reorganisation of the lipid-peptide raft associations, into a pore structure. Bilayer reorganisation into a pore results in a lower 
total energy content than the initial lipid-peptide raft association, indicated by the green shading to the pore label. 
 
The work of Sakuma and coworkers presents direct evidence of strain energy within a bilayer 
structure resulting in membrane supramolecular reorganisation into a pore structure, moreover, it 
closely resembles the key leaflet fold from the proposed new pore structure. In this case the 
reorganisation of the membrane lipids operates at both the micron-scale, producing the diameter of the 
pore lumen, and at the nano-scale, producing the leaflet fold structure. Pore-formation in lipid-AMP 
systems results in much smaller pore diameters, suggesting that the presence of AMP stabilises the 
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formation of tighter pore lumen curves and/or allows the formation of pores at lower concentrations of 
strain energy; i.e. much lower numbers of involved lipids.  
 
6.11. Energy of the pore structure 
Lee and coworkers show that the energy difference (ER) between a pore free bilayer and one with a 
pore, is determined as shown in equation 5.[107] 
 
𝐸𝑅 =  𝛾2𝜋𝑅 −  𝜎𝜋𝑅
2  
 
Where ϒ is the line tension, or energy cost per unit length of the pore rim; R is the radius of the circular 
pore; σ is the membrane tension of the vesicle. The first term represents the free energy cost of creating 
the toroidal pore structure, whereas the second term presents the work done against the membrane 
tension to create a pore of area 𝜋𝑅2. For energetically favourable pores to exist within the membrane, it 
is necessary to minimise the first term, and maximise the second term. Once ER ≤ 0 the pore structure 
becomes energetically favourable, and the membrane can reorganise into the pore state. Equation 5 can 
be applied to the formation of pores by AMP,[107][147] which together with the general behaviour of AMPs 
within lipid membranes, permits two conclusions to be drawn. Firstly the helical orientation change 
occurring on pore-formation indicates the peptide is integral to the pore structure, acting to stabilise the 
structure via reducing pore line tension (ϒ), and secondly that peptide binding to the membrane 
increases the energy of the bilayer in a similar way to membrane tension (σ).[147] The influence exerted 
on ϒ and σ by the AMP enables energetically stable pores to form within membranes, under much less 
extreme tensions than would otherwise be required in peptide-free membranes. The energy of stable 
pore structure equals an energy minimum for the lipid-AMP system, in a similar manner to the various 
packing configurations of peptide-free lipid systems in aqueous solution.[39] 
The free energy of the toroidal pore within a membrane will be primarily determined by the 
efficiency of the lipid-AMP packing within the leaflet fold structure. Lipids that generate the required 
curvature without large scale deviations from their lowest energy geometries, will form pores that are 
more stable than if the pore structure requires significant deformation of the lipids. In combination with 
the occupation of interfacial volume be an LCAMPs W and F residues, positive curvature lipids will rsult 
in an efficiently packed pore with a low line tension. It has been proposed that a negative feedback loop 
exists within the energetics of the pore-formation process, which can partially explain the behaviour of 
the lipid-AMP pores.[107] Formation of pores reduces membrane tension though the changes in peptide 
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orientation that occurs during the transition from monomer to pore state, and through lipid and peptide 
transfer from the outer to the inner leaflet through the pore structure. Both these actions reduce the 
area of the outer leaflet, decreasing the membrane tension which disfavours pore formation, and 
causes the feedback loop. The feedback phenomenon can be understood by consideration of the terms 
within equation 5, where increased membrane tension results in a smaller difference between a pore-
free and pore-containing membrane. Higher membrane tension induces pore formation, which involves 
more peptide transfer from monomer to pore state, which reduces the membrane tension and 
disfavours pore formation. The feedback loop has implications for the pore-forming activity of LCAMPs, 
which are discussed later. 
 
6.12. Global versus local membrane tension 
The membrane binding of AMP helices increases the membrane tension, and can be broken down 
into separate aspects; the global tension and local tension around each membrane-bound AMP helix. 
Addition of peptide helices to the outer membrane leaflet raises the global membrane tension (σG), by 
increasing the leaflet area through the accommodation of the AMP helix, resulting in the inner leaflet 
stretching to occupy the same area as the outer leaflet. The increase in tension per membrane-bound 
helix can be modulated via association with preferred lipids within the raft, but the total increase in the 
global tension will be in rough proportion to the total amount of peptide added. The global tension 
increase is not subject to large fluctuations, being comprised of the total membrane strain induced by 
the whole population of dynamic lipid-peptide rafts. Local membrane tension (σL) represents the lipid-
AMP interactions occurring around each individual helix, and unlike the global tension, will be subject to 
large local fluctuations as individual lipids join and leave the raft. The local and global membrane 
tensions are interdependent in many membranes, a peptide which selectively associates with those 
lipids which minimise its impact on membrane packing, will display low increases per membrane-bound 
monomer to both the local and global tensions. For example, a magainin helix surrounded by DOPE 
lipids will contribute only minimal increases to the local and global membrane tensions. Magainins 
tendency to occupy interfacial volume in the membrane leaflet is compensated via selective aggregation 
with the conical DOPE lipids, leading to only modest increases in outer membrane leaflet area per 
bound peptide helix. Conversely, those peptides which associated with lipids that increase the scale of 
the membrane deformation induced by the AMP helix, will feature large increases to both local and 
global membrane tensions per bound monomer. Melittin surrounded by DOPE produces the opposite 
situation than magainin, with the deeper penetration of melittin into the bilayer and the large 
hydrophobic volume of DOPE leading to hydrophobic crowding in the bilayer. The total membrane 
tension within a defined membrane region, termed a pre-pore region, will be equal to the sum of the 
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global and local tension contained within the lipid-AMP interactions within that region, as shown in 
figure 6.8.  
 
Figure 6.8: Top down view of a lipid membrane, containing laterally diffusing peptide helices. The peptides are depicted as blue 
cylinders, and the lipids as spheres. Grey spheres are lipids that form energetically neutral interactions with the faces of the 
helices, red spheres are anionic lipids forming unfavourable interactions that are held to the peptide via electrostatics, and 
green spheres are lipids which form favourable interactions with the helix. The yellow dashed line represents a 5 nm circle 
indicating an approximate size for AMP-induced pores, termed a pre-pore region, that can go on to undergo reorganisation into 
a lipid-AMP pore when the threshold energy is reached. It is clear that the random diffusion of AMP helices in the outer 
membrane leaflet can accumulate considerable local membrane tension within a small area – a transient raft assembly. 
 
Applying the concept presented in figure 6.8 to equation 5, allows us to reformulate it as shown in 
equation 6, where several AMP helices have come into close association via lateral diffusion in the outer 
membrane leaflet.  
 
𝐸𝑅 =  𝛾2𝜋𝑅 −  (𝜎𝐺𝜋𝑅
2 +  ∑ 𝜎𝐿
𝜋𝑅2
) 
 
Equation 6: Modified version of equation 5, to account for the global and local membrane tensions induced by the binding of 
AMP helices to a region of lipid membrane with area πR
2
. σG represents the global tension in the membrane region, from the 
membrane thinning induced via the generation of leaflet area asymmetry, and ∑ 𝜎𝐿𝜋𝑅2   is the total local tension contained 
within the lipid-AMP rafts in the defined region. The local membrane tension increases the value of the second term, enabling 
the formation of pores at considerably lower global membrane tensions. 
 
5 nm 
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𝐸𝑅 represents the energy of a defined region of radius R that will end up containing the pore 
structure, ϒ the line tension of a translocating toroidal pore, and the second term is split into two 
components, σG and σL representing the global and local membrane tensions within the small defined 
region of the membrane respectively. A membrane containing several AMP helices in close proximity, 
either via random lateral diffusion within the membrane leaflet or through selective aggregation, is 
capable of generating a “hotspot” of membrane tension. This local tension can be far in excess of the 
average tension within the membrane, depending on the constituent lipids of the lipid-AMP raft. 
Associations of lipid-AMP rafts containing high energy interactions, possibly forced through 
electrostatics, will display considerably larger contributions to the second term of equation 6, than 
accumulations of peptides possessing low energy interactions. When the term (𝜎𝐺𝜋𝑅
2 +  ∑ 𝜎𝐿𝜋𝑅2 ) 
exceeds the term 𝛾2𝜋𝑅 then reorganisation of the bilayer structure into a pore-like structure becomes 
energetically favourable. As more peptide binds to the membrane the global membrane tension will 
increase, and more peptides will be contained within any defined region, leading to increasing numbers 
of lipid-AMP raft assemblies. Associations of high energy rafts will achieve the energetic situation 
(𝜎𝐺𝜋𝑅
2 +  ∑ 𝜎𝐿𝜋𝑅2 ) ≥ 𝛾2𝜋𝑅 needed to form the pore structure earlier than associations of low energy 
peptides, due to larger contributions of the high energy rafts to the local membrane tension.  
Support for the concept of pore formation from raft aggregates at a specific spot within a 
membrane, rather than occurring due to peptide widely dispersed across the membrane can be found 
within the literature. Pore-formation occurs after the binding of as few as four melittin monomers to an 
LUV membrane,[99] indicating that low monomer numbers can achieve pore formation. The exact global 
tension required to allow raft assemblies to remodel into the pore state, will be dependent on the 
specific lipid-AMP interactions occurring in that raft, creating a range of threshold energies occurring 
within each peptide-exposed membrane. When the global tension reaches the threshold energy, the 
lipid-AMP raft assemblies within the membrane will reorganise into the pore structure. The pore will 
translocate material from outer to inner membrane leaflets, initiating the negative feedback loop 
already discussed. Several situations can now occur, as demonstrated by the multiple pathways for the 
membrane tension after this point within figure 6.9. 
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Figure 6.9: Energy level diagram depicting the effect of lipid-peptide raft aggregates on the formation of pores, and the release 
of membrane tension via lipid/peptide translocation to the inner membrane leaflet.  σ represents the  initial membrane tension 
prior to AMP exposure, which is indicated by the red arrow. The blue line represents the point where the global membrane 
tension plus the local contribution from an assembly of four maximal energy lipid-AMP rafts enables the energetically 
favourable formation of a toroidal pore. The yellow line indicates where pore formation can occur through the association of 
four intermediate energy rafts, and the green line where pore formation can occur via association of three maximal energy rafts 
within the same area, becomes favourable. The red line indicates the critical membrane tension whereupon the bilayer structure 
itself becomes energetically unfavourable, leading to complete failure. Several possible scenarios are represented, including 
cycling of pore opening and closing (narrow spaced dashed line), steady state pore opening (widely spaced dashed line) and 
consecutive pore openings followed by membrane failure (dotted line). 
 
If the rate of material translocation is able to lower the total tension below the threshold line 
required for pore formation from this assembly of rafts, the pore will close, indicated by the closely 
spaced dashed line. Closure of the pore allows the global membrane tension to increase back towards 
the threshold level, leading to a pore opening and closing cycle around the same threshold energy, so 
long as the required lipid-AMP assemblies remain present within the membrane. Alternatively, the 
translocation of material may not be sufficient to prevent the accumulation of strain within the 
membrane, which increases to the next lowest threshold level. The corresponding lipid-AMP assemblies 
will then be free to reorganise into a pore structure, leading to increased levels of mass transfer 
between leaflets. If this increase in strain relief from the outer leaflet is sufficient to ensure that the 
tension never achieves the threshold level required to activate the next highest energy accumulation of 
assemblies, the pore situation will remain unchanged. The final situation depicts the phenomenon 
where the consecutive opening of all the featured pores and their associated mass transfer, is not 
sufficient to overcome the increase in membrane tension, and the next threshold energy level is 
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reached. The red line represents the critical failure energy of the membrane bilayer, and the vesicles 
structure will fail at this point, resulting in bursting. It should be noted that not all the potential 
threshold energies will be occupied within any particular membrane, as the highest energy lipid-AMP 
raft assemblies are likely rare within the total population, being composed of lipid-peptide rafts with 
unfavourable lipid-AMP interactions. The global membrane tension can then pass through the threshold 
energy without triggering pore formation, although once past the threshold, a pore will form should the 
required raft assembly occur.  
 
6.13. LCAMP modulation of bulk membrane tension 
Presence of non-bilayer lipids within membranes leads to increased strain, which can be mediated 
via interactions with membrane-bound LCAMP helices. Consider the interactions of magainin within the 
DOPC:DOPE (80:20 mol%) system, where the peptide will selectively associate with the DOPE to 
minimise the lipid-AMP raft free energy. The non-bilayer DOPE lipid induces a strain within the bilayer, 
due to its large packing parameter (S = 1.41), resulting in inefficient packing with the bulk DOPC 
membrane. Aggregation with magainin removes DOPE from the bulk membrane, and replaces its 
previously unfavourable interactions with favourable interactions with the magainin helix, lowering the 
global membrane tension. Conversely, within the same DOPC:DOPE system, melittin would increase the 
energy content of the bulk membrane surrounding the peptide defects. The peptides unfavourable 
interactions with DOPE, due to steric crowding in the hydrophobic bilayer core, would act to exclude 
DOPE from the lipid-peptide rafts, increasing its relative concentration within the bulk membrane, and 
increasing the strain energy. 
 
6.14. Selectivity mechanism 
Consider the impact of the steric asymmetry, and forced electrostatic interactions, on the selectivity 
of magainin between prokaryotic and eukaryotic membranes. Within the bacterial E.coli membrane the 
AMP exploits the strong nature of the electrostatic interaction, between cationic lysine residues and the 
anionic PG lipids, to force high energy sterically hindered interactions along one face of the helix. The 
E.coli membrane contains lipids which would allow the lipid-magainin raft to locate at much lower 
energy minima, for example the negative curvature inducing PE lipids, which would both oppose the 
positive curvature induced by magainin, and reduce the steric crowding at the leaflet interface, due to 
its smaller headgroup. The opportunity to locate to a lower energy minima is lost however, through the 
exclusion of PE lipids in favour of anionic PG lipids. The outer leaflet of mammalian membranes, for 
example erythrocytes, are comprised mainly of the electrically neutral lipids SM, PC and cholesterol. 
With no forced electrostatic interactions, the lipid-AMP raft is free to locate to much lower energy 
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minima within the energy landscape of the membrane, free from the steric crowding seen in the 
bacterial membrane. Cholesterol is a negatively curved membrane component, and is known to 
associate with the aromatic phenylalanine residues of proteins. Not only are lipid-magainin rafts free 
from forced sterically hindered electrostatic interactions, they are instead forced into interactions with 
membrane components which oppose the peptides positive curvature, resulting in reduced energy rafts. 
Lipid-magainin rafts will therefore exist at higher energy levels in bacterial membranes than mammalian 
membranes, with increased contributions to the membrane tension-like energy induced by each lipid-
AMP raft.  
The membrane disruptive effects of LCAMPs increase with membrane penetration (Glukhov et al, 
2005), indicating that the deep penetrating melittin has been evolutionary designed to exert maximal 
strain within target membranes, through insertion of its entire helical length into the outer membrane 
leaflet. The shallow penetrating magainin is less disruptive, only inserting ~50 % of its helix into the 
leaflet. With bacterial membranes containing high levels of non-bilayer lipids, like DOPE and CL, they 
operate much closer to the lamellar to non-lamellar phase transition boundaries than mammalian 
membranes.[54] The LCAMP selectivity mechanism operates within the energy gap of prokaryotic vs 
eukaryotic membranes, with mammalian membranes able to take significantly more internal tension 
before passing through the lamellar to non-lamellar transition boundary. 
 
6.15. Charge distribution 
The differences in the charge distribution between melittin and magainin are displayed in figure 
6.10. Of the six positive charges at physiological pH possessed by melittin, five are clustered at the ends 
of the helix, the N-terminus and the KRKR motif, with only one located along the length of the melittin 
helix. In contrast magainin has four cationic residues located along its helical length. 
 
 
 
 
 
Lipid shape and lytic peptides Page 169 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Melittin possesses a larger helical face available for interaction with zwitterionic lipids than 
magainin within anionic membranes, of the 7 – 9 lipids that magainin can directly interact with, five will 
be anionic lipids with only 2 – 4 being zwitterionic. Only one anionic lipid is electrostatically recruited 
along the helical face of melittin, allowing more neutral lipids access to the helical face of the 
membrane-bound peptide. Melittin should therefore show increased sensitivity to zwitterionic lipids 
than magainin, whose PIEs should be dominated by interactions with anionic lipids. 
 
6.16. Model predictions 
The model can be used to make several predictions about LCAMP pore activity within lipid 
membranes. These predictions are listed below, and briefly discussed. We will then review the data 
presented within this thesis, to match the predictions to the experimental data. 
 
 
Figure 6.10: Diagrams showing the charge distribution along the 
helices of the LCAMPs melittin and magainin, represented as blue 
cylinders. Melittins charges are concentrated at the ends of the helix, 
with only one of six charges located along the helical face. Magainin 
displays a differing charge distribution, with four of five charges 
located along the helical face. 
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6.16.1. Prediction 1 - Lipid-AMP raft energetics 
Lipid-AMP raft energetics will vary depending on the precise lipid composition of each raft, with 
lipid topography exerting a strong influence of raft energetics. Lipids with exert similar topography to 
the membrane-bound LCAMP helix will synergise with the peptide, and produce large high energy 
membrane defects. This will result in high peptide activity, especially within those membranes where 
the high energy interactions can be forced via electrostatic interactions. 
 
6.16.2. Prediction 2 - Pore energetics 
The lower the energy of the leaflet fold structure, the more energetically favoured the pore 
becomes. Since the leaflet fold structure is the primary structural component of the pore, and is tightly 
positively curved, membranes containing positive curvature lipids will minimise the pore energy. AMPs 
which will associate with positively curved lipids when inserted into the lipid membrane should 
therefore produce higher levels of pore activity, than those peptides which associate with negatively 
curved lipids. Magainin offers the greatest stabilisation to the leaflet fold structure, from its three 
phenylalanine residues, and so should display higher relative proportions of pore activity than melittin, 
which can only stabilise the fold structure with a single tryptophan. 
 
6.16.3. Prediction 3 - Stochastic behaviour 
The formation of pores should not be deterministic, but instead stochastic, as the formation of 
pores depends on the probability of lipid-AMP rafts with required energies coming into close association 
with each other. It is possible that pore formation requires the presence of one or more specific high 
energy lipid-AMP interactions; i.e. a specific topography lipid interacting with a particular residue of the 
membrane-bound AMP helix. The energy required for pore formation will depend on the length of time 
the membrane is exposed to peptide, with quick pore formation requiring the presence of many high 
energy lipid rafts within a small raft population, and therefore a low probability event. Slower pore 
formation allows more time for the global tension to accumulate within the system, and facilitates pore 
formation from the association of lower energy rafts.  
 
6.16.4.  Prediction 4 - Pore behaviour 
The negative feedback loop between pore formation and global membrane tension should allow 
repeated opening and closing of similar pores, when the rate of material added to the outer membrane 
is less than the rate of material transfer through opened pores, as the global membrane tension cycles 
across the threshold energy of a particular lipid-AMP raft energy threshold. Consecutive opening of 
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pores followed by a stable pore situation can occur, caused by the membrane tension passing through 
consecutive thresholds, when the rate of translocation of material from outer to inner leaflet is similar 
to the rate of material addition to the outer leaflet.  
 
6.16.5.  Prediction 5 - Pore size and quantisation 
The leaflet fold is the key component of the pore structure, and the peptide acts to both stabilise 
the positively curved fold structure through its W and F residues, and to supply the negative curvature 
required to form the pore lumen. Peptide helices within a pore are capable of supporting only a defined 
section of the structure, exerting tight control over pore size. Pore size will therefore depends only on 
the number of monomers within the pre-pore region, and it is likely that pore sizes will be similar across 
membranes of varying composition, and for the pores induced by different AMPs. Although pore size 
and leakage kinetics may be similar, the overall activity and initiation times for pore formation may vary 
widely for different peptides. The differing lipid-peptide interactions occurring within different 
membranes, produce significantly different effects on the defect energy and local/global membrane 
strains, while contributing towards the opening of very similar pore structures. The model permits the 
formation of differently sized pores within single membranes, as both low monomer number assemblies 
of high energy rafts and high monomer number assemblies of low energy rafts can display similar 
contributions to the local free energy within the pre-pore region, permittin pore formation at similar 
global energy levels.  
 
6.16.6.  Prediction 6 - Pore number 
The model predicts that multiple pores will open consecutively during the pore leakage process, as 
lower and lower energy lipid-AMP raft assemblies achieve the energy required to remodel the bilayer 
into the pore structure. Multiple pores can open at once upon crossing a single energy threshold, as 
several raft assemblies with the required energy could exist within the membrane simultaneously. 
Multiple pore openings would occur more frequently for lower energy raft assemblies, which are more 
common within the raft population. 
 
6.17. Application of model to experimental data 
 
The proposed model can be used to explain the patterns of activity seen within the experimental 
data within this thesis. 
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6.17.1. Pore-mediated leakage data 
The pore-mediated leakage events occur within strongly grouped kinetics modes, where individual 
GUVs will display dye leakage through a limited set of dye-efflux kinetics. The average time of initiation 
of the leakage process following exposure to peptide varies widely, yet the dye still follows tightly 
controlled efflux kinetics groups. An example is shown in figure 6.11, for the exposure of the 
DOPC:DPPC:DPPG membrane system, to 1 µM of the LCAMP magainin. The leakage events for this 
system initiate over a large time frame, from about 250 s to 5600 s, with no discernible pattern between 
initiation time and the leakage kinetics followed by the individual vesicle. The probabilistic nature of the 
pore formation can be explained by consideration of the lipid-peptide interactions required to form a 
pore; in a low percentage of lipid-peptide systems, high energy raft assemblies will occur, as the random 
lateral diffusion of the peptide within the outer membrane leaflet brings a large number of peptide 
monomers together. If these raft assemblies contain high energy lipid-peptide interactions, then the raft 
assembly can quickly achieve the threshold energy needed to initiate pore formation. In some 
membranes, the high energy raft assemblies will not occur rapidly, as the diffusion of the peptide 
monomers in the outer membrane never brings large numbers of peptides together, or high energy 
lipid-peptide interactions are not present within the assembly. 
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Figure 6.11: (Top) Normalised leakage data demonstrating the stochastic nature of the pore-mediated leakage induced by 
exposure of 12 DOPC:DPPC:DPPG GUVs to 1 µM of the LCAMP magainin. The initiation time of the pore-mediated leakage varies 
between <300 s to > 5500 s, with no clear pattern in the data. (Bottom) Data from the same 12 GUVs after correcting for 
initiation time, showing that although the timings are widely separated, the kinetics are closely grouped after accounting for the 
differing initiation times. 
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In these membranes, pore formation will occur later, when the increased number of peptides 
bound to the membrane make achieving the threshold energy easier, without requiring high energy 
unflavoured lipid-peptide interactions. If pore formation relies on the formation of a particular lipid-
peptide raft assembly within the membrane, then pore-mediated leakage can be expected to be 
stochastic, and to follow the type of leakage pattern shown. That the data follows this pattern acts as 
evidence in support of prediction 3 of the new model. The model also predicts that pore opening and 
closing cycles should be present within the data, caused by the negative feedback loop between 
membrane tension and interleaflet material transfer through open pores, inducing the membrane 
tension to pass back and forth over an energy threshold. An example of this phenomenon is shown in 
figure 6.12, which demonstrates a pore opening and closing cycle within a DOPC:DOPE:DOPG GUV, 
exposed to 1 µM of the LCAMP melittin.  
 
Figure 6.12: Leakage data presenting the pore-mediated leakage behaviour of an individual DOPC:DOPE:DOPG GUV, after 
exposure to 1 µM of melittin, depicting the negative feedback loop between pore formation and membrane tension. Pore 
formation requires a specific energy threshold to be achieved in the membrane, and as the formation of pores reduces the 
membrane tension it can lower the membrane energy to below the threshold, rendering the formation of that specific pore 
unfavourable. The black dashed lines indicate the two leakage kinetic groups, and are a guide for the eyes only. The inset 
(bottom left) shows the switching of the leakage phases, between a slow and fast kinetic group, as the membrane energy 
repeatedly crosses an energy threshold, leading to repeated cycling of pore opening and closing and confirming prediction 4. 
The coloured arrows indicate the direction of the groups switching, between the faster and slower leakage groups. 
  
TheDOPC:DOPE:DOPG vesicle demonstrates a total of five sequential switches between two 
leakage kinetic modes, as the lipid-AMP system cycles back and forth across a threshold energy. The 
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GUV initially leaks following the faster of the two leakage groups, then as material transfers between 
the leaflets through the open pore, the membrane tension falls below the threshold energy needed to 
render this size pore energetically favourable. The pore structure adjusts by adapting to a lower energy 
organisation, potentially by reducing the number of peptide monomers within its structure, reducing 
both the leakage rate to follow the slower leakage group and the rate of interleaflet material transfer. 
The reduced flow material flow between the outer and inner leaflet allows the membrane tension to 
build up again, until it recrosses the threshold energy needed for the larger pore. The pore structure 
then resumes its prior form, with increased leakage and material transfer rates, and the cycle repeats.  
The cycling of pore activity as the negative feedback loop moves the membrane tension back and 
forth across a threshold energy serves as conformation of the 4th prediction of the proposed model. The 
5th prediction of the model is that pore size and leakage kinetics will be similar for LCAMPs in identical 
membrane systems, as each peptide monomer within a pore is capable of stabilising only a short stretch 
of leaflet fold structure. This can be seen within the data in figure 6.13, which displays the grouped 
leakage modes for the LCAMPs magainin and melittin, within the DOPC:DPPC:DPPG membrane system, 
exposed to 1 µM of the peptides. Both LCAMPs present similar dye-leakage kinetics within the 
DOPC:DPPC:DPPG membrane system, showing six kinetic groups and a carpet mechanism group. Of the 
six leakage groups, five show a very good match between the peptides, indicating that the pore activity 
within the membrane is very similar, despite the different lipid-peptide interactions occurring in the 
membrane. Although the leakage kinetics are similar, the peptide activity, initiation times and PIE-
profiles are significantly different between the two peptides. The peptide activities within the 
membrane are 75.5 and 45.8 %, for melittin and magainin respectively, and the pore-mediated average 
initiation times are 1961.1 and 3255.4 s. The similarity in leakage kinetics represents the formation of 
similar pore structures by the two peptides, while the other factors vary due to the different nature of 
the lipid-peptide interactions leading to pore formation, and is supporting evidence for prediction 5 of 
the proposed new model. 
  
Lipid shape and lytic peptides Page 176 
 
 
Figure 6.13: Tightly grouped leakage traces occurring within the DOPC:DPPC:DPPG membrane system after exposure to 1 µM of 
melittin and magainin confirm prediction 5, which states that the pores induced through the interaction of different LCAMPs 
should be very similar in size/leakage kinetics. With each peptide only capable of supporting a limited section of leaflet fold, the 
pore size depends only on the number of monomers contained within the pore structure, it is the energetics of the process that 
change across different peptides and membranes. 
 
Further evidence to support this prediction comes from the data shown in figure 6.14, which 
depicts the opening of differently sized pores with the same membranes, within the DOPC:DOPE:DPPG 
GUVs exposed to 1 µM of magainin. The opening of a second pore within the membrane, with a smaller 
diameter than the existing pore, is seen within the leakage data. The second pore allows the efflux of 
the smaller 3 kDa dextran, which has a diameter of 2.13 nm, but retains the larger 10 kDa dextran, 
which has a diameter of 4.23 nm. This places the limit of the second pore diameter of between these 
two values, while the first pore remains open. Further evidence for the differential escape of the smaller 
tagged dextran can be found in several other data sets for both peptides, including the 
DOPC:DOPE:DOPG, DOPC:DOPE:LPG, DOPC:DOPE:DOPG:DPPG and mGUV membrane systems, where 
leakage groups display efflux for the 3 kDa dextran but retention of the larger 10 kDa molecule. 
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Figure 6.14: Leakage kinetics demonstrating the sequential opening of differently sized pores within the DOPC:DOPE:DPPG 
membrane system exposed to 1 µM magainin, showing the grouped leakage kinetics of the  3 (top) and 10 kDa (bottom) 
dextran markers. The 3 kDa data clearly depicts a second pore opening event after ~350 s, indicated by the arrow, while the 
kinetics of the 10 kDa trace remain unaffected. This situation is only possible if a second pore state has become energetically 
viable within the membrane, of a diameter larger than the diameter of the 3 kDa dextran and smaller than the diameter of the 
10 kDa dextran. This allows the egress of the smaller dextran, but retains the larger molecule. 
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6.17.2. PIE data 
This section reviews the data from the biomimetic membranes in the light of the new model, allows 
us to map the relevance of lipid and LCAMP topography to the membrane activity of the peptides 
melittin and magainin. Interpretation of the data in this way allows us to determine the factors 
controlling the behaviour of the lipid-LCAMP system, with relevance to equation 6. 
 
𝐸𝑅 =  𝛾2𝜋𝑅 −  (𝜎𝐺𝜋𝑅
2 +  ∑ 𝜎𝐿
𝜋𝑅2
) 
 
Lipids which lower ϒ will decrease the free energy of the pore structure, and increase the likelihood 
of pore formation within the lipid-AMP system. The second term has two components, the local and 
global membrane tensions σL and σG; lipids which increase these terms will result in increased 
membrane disruption, but the likelihood of pore formation will depend on the ϒ value. Lipid-AMP rafts 
that possess the possibility of very high σL energies, for example a membrane-bound magainin helix 
featuring interactions between a large headgroup/small tailgroup lipid and its sterically bulky side, 
should display high levels of pore formation. The concentration of energy within a raft assembly in a 
small membrane region, will exert a much more powerful effect on the activity of LCAMPs, than the 
small increase in global tension caused by one peptide monomer. 
 
6.18. Bacterial biomimetic membranes and melittin 
The three membranes designed to replicate bacterial membranes containing lipids of opposing 
charge and topography were the systems DOPC:DOPE:DOPG, DOPC:DOPE:DPPG, DOPC:DPPC:DOPG and 
DOPC:DPPC:DPPG. Comparison of the PIE-profiles for these systems produced by exposure to 1 µM of 
the LCAMP melittin, presented in figure 6.15, it is clear that the individual PIEs are controlled primarily 
by the presence of one specific lipid within the membrane system.  
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Figure 6.15: PIE-profiles for the bacterial biomimetic membrane systems, produced by exposure to 1 µM of the AMP melittin. 
The individual PIEs are colour coded according to the diagram key. The specific lipid interactions controlling the occurrence of 
each PIE, are indicated within the colour keyed lines connecting the bars on the graph. Certain lipids within the membrane 
system controls the level of the PIE that occurs, for example; the presence of the anionic DOPG lipid influences the PIE-profile 
towards containing carpet mechanism events, and increases overall activity. 
 
6.18.1. Activity 
The most active systems were the DOPC:DOPE:DOPG and DOPC:DPPC:DOPG membranes, 
displaying 100 and 97.7 % activity respectively. Within both of these membrane systems and in line with 
prediction 1 of the proposed model, the lipid-melittin rafts can be expected to be enriched with the 
anionic DOPG, forced into interactions through the strong electrostatic attraction between the cationic 
peptide and anionic lipid. The secondary lipid interactions differ however, with the DOPC:DOPE:DOPG 
raft expected to contain more DOPC than DOPE, and the DOPC:DPPC:DOPG raft expected to contain 
more DPPC than DOPC. This difference is caused by the deep penetration of the melittin helix into the 
membrane leaflet, where it prefers to interact with low hydrophobic volume lipids, which reduce steric 
crowding in the hydrophobic region. The electrostatically forced interaction of melittin with a lipid 
featuring a high hydrophobic volume, i.e. DOPG, produces a large amount of packing frustration within 
the bilayer; i.e. high values for σL and σG. The high energy level of the lipid-melittin rafts in these 
membranes explains the overall high activity of the peptide in these systems. Association with the lipid 
DPPC reduces the energy of the lipid-melittin raft, and hence the DOPC:DPPC:DOPG membrane displays 
slightly less activity than the DOPC:DOPE:DOPG system. The two lowest activity systems are 
DOPC:DOPE:DPPG and DOPC:DPPC:DPPG, which display 65.1 and 77.5 % activity respectively. In contrast 
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to the two previous membranes, these systems will possess forced electrostatic interactions between 
the negative curvature-inducing melittin, and the positive curvature-inducing DPPG lipid. This lowers the 
energy of the lipid-AMP raft, reducing the peptides activity considerably compared to the DOPG 
containing systems. 
 
6.18.2. Bursting 
High levels of bursting were seen within the DOPC:DOPE:DOPG and DOPC:DOPE:DPPG membranes, 
which displayed 34.1 and 41.9 % of the PIE respectively. The systems feature forced electrostatic 
interactions with opposite curvature lipids (DOPG and DPPG), and will preferentially associate with 
DOPC rather than DOPE. The lipid DOPC was assigned to be controlling the bursting, as melittin will 
preferentially associate with the cylindrical DOPC over the conical DOPE. The large hydrophobic volume 
of DOPC will increase ϒ, but compensate via moderate increases to σL and σG. The influence of the 
zwitterionic DOPC appears to override that of the anionic lipids, which possess opposing curvatures, but 
can be explained by considering the greater effect of zwitterionic lipids on the activity of melittin due to 
the charge distribution. This hypothesis is given weight by the high degree of similarity between these 
systems, and the PIE-profile of pure DOPC membranes exposed to 1 µM melittin, which also displays a 
high level of 33.3 % of the bursting PIE. The two lowest membranes for bursting both contained DPPC as 
the most likely secondary interaction, which will result in a significant decrease in ϒ, but also drops 
within σL and σG. Bursting within membranes exposed to melittin is controlled by associations with 
zwitterionic lipids possessing large hydrophobic volumes, in this case dioleoyl unsaturated 9Z chains, a 
fact supported by the DEPG results. Confirmation of the model validity comes from consideration of the 
average timings of the events, with DOPC:DOPE:DPPG taking over threefold longer to burst than the 
DOPC:DOPE:DOPG system. The presence of DPPG reduces the raft energy, and it therefore takes more 
membrane-bound peptides before the membrane reaches the critical failure point. 
  
6.18.3. Pore-mediated leakage 
The membrane systems with the lowest levels of pore formation were DOPC:DOPE:DOPG and 
DOPC:DOPE:DPPG, displaying 21.6 and 14.9 % respectively. Both systems are DOPE containing 
membranes, and the large negative curvature of the lipid will significantly increase the tension within 
the leaflet fold structure of the pore (ϒ), disfavouring pore formation, and resulting in the membrane 
systems returning low pore activity. The large hydrophobic volumes of both DOPC and DOPE increase σL 
and σG, due to the deep insertion of the melittin helix into the bilayer. Although melittin can be 
expected to preferentially associate with DOPC in both these systems, lipid-melittin rafts associated with 
DOPE will occur within this system, giving rise to raft assemblies with high energies. In contrast, the 
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membranes displaying the highest level of pore-mediated leakage are linked by the lipid DPPC, with the 
DOPC:DPPC:DOPG and DOPC:DPPC:DPPG membranes featuring 54.7 and 52.1 % pore activity 
respectively. DPPC is a positive curvature lipid, which will reduce both σL and σG and the pore leaflet fold 
tension (ϒ), and overall favours pore formation. Again the reliance of melittin of secondary zwitterionic 
interactions to control pore formation can be explained by the charge distribution along its helix (refer 
to figure 6.10), with pore formation requiring the presence of positive topography lipids along the 
helical face, lowering the tension within the leaflet fold structure. The presence of the positively curved 
lipids DPPC and DPPG within the pore active membranes confirms prediction number 2 of the proposed 
model. 
 
6.18.4. Carpet mechanism 
The DOPC:DOPE:DOPG and DOPC:DPPC:DOPG membrane systems returned 41.3 and 31.4 % 
respectively for the carpet mechanism PIE, considerably higher than the DOPC:DOPE:DPPG and 
DOPC:DPPC:DPPG systems, which returned 7.0 and 8.5 % respectively. The carpet mechanism for 
melittin appears to be controlled by the presence of the ionic DOPG lipid within the lipid-melittin raft, 
and suppressed by the anionic DPPG. Membrane disruption via this mechanism requires the presence of 
large hydrophobic volume anionic lipids, in this case double oleoyl fatty acids, possessing a single 9Z 
unsaturation. Several papers link the disruption of membranes via the carpet mechanism to the intrinsic 
curvature of the target membrane (Bechinger and Lohner, 2006; Brogden, 2005). In the case of melittin, 
a membrane possessing high hydrophobic volume lipids, like DOPG and DOPC, is more likely to exhibit 
the carpet mechanism. 
 
6.18.5. Micellisation 
The micelle PIE is present at low levels (< 5 %) for all membrane systems tested, and is not strongly 
influenced by the lipid composition of the membrane. Note however, that the micelle PIE is completely 
absent from control membranes, and is therefore induced by lipid-melittin interactions. 
 
6.19. Bacterial biomimetic membranes and magainin 
The PIE-profiles for the bacterial biomimetic membrane systems, produced after interaction with 1 
µM of the AMP magainin, are presented in figure 6.16.  
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Figure 6.16: PIE-profiles for the bacterial biomimetic membrane systems, produced by exposure to 1 µM of the AMP magainin. 
The individual PIEs are colour coded according to the diagram key. The specific lipid interactions controlling the occurrence of 
each PIE, are indicated within the colour keyed lines connecting the bars on the graph. Within the active membrane systems, 
DPPC appears to control peptide activity. 
 
6.19.1. Activity 
Magainin is significantly less active than melittin in three of the four bacterial membranes, showing 
higher activity in only DOPC:DOPE:DPPG vesicles. The shallow insertion of magainin into the outer 
leaflet, causes a smaller increase in the area of the outer leaflet per monomer compared to melittin, and 
hence a smaller rise in σG. Magainin activity is controlled by DPPG, an anionic lipid, with a large PC 
headgroup and low hydrophobic volume in line with prediction 1 of the proposed model. Within 
DOPC:DOPE:DPPG and DOPC:DPPC:DPPG membrane systems, magainin displays activity of 70.1 and 
45.8 % respectively. The lipid-magainin raft in both of the high activity systems will be enriched with 
DPPG, due to the distribution of cationic residues along the helical face of the peptide. The positive 
curvature of the peptide and lipid, combined with steric crowding in the bilayer interfacial region, 
caused by the three phenylanlanine residues of the peptide interacting with the large lipid headgroup, 
causes large increases to σL and σG but decreases ϒ.  
The DOPC:DOPE:DPPG system is more active, as the presence of DOPE within the bulk membrane 
increases its base energy prior to peptide binding, and the peptide needs to contribute a much lower 
level of σL and σG to cause a PIE. The systems displaying low activities, DOPC:DOPE:DOPG and 
DOPC:DPPC:DOPG, both contain the anionic lipid DOPG, and display activities of 5.9 and 11.8 % 
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respectively. The presence of the DOPG surrounds the magainin helix with lipids possessing large 
hydrophobic volumes, able to distort and reduce the packing frustration around the membrane-bound 
magainin helix. The reduction in raft free energy decreases both σL and σG, with the higher activity of the 
DOPC:DPPC:DOPG system caused by the presence of the positive curvature lipid DPPC. Although DPPC 
within lipid-magainin rafts will be disfavoured, it will exist in low population number rafts, which feature 
considerably higher σL than rafts surrounded by the preferred DOPG and DOPC lipids. This explains the 
increase in activity seen in the DOPC:DPPC:DOPG system compared to the DOPC:DOPE:DOPG system, 
which contains only lipids with large hydrophobic volumes and neutral to conical geometries. 
Interestingly, the DOPC:DOPE:DOPG membrane system shows lower activity than obtained from pure 
DOPC membranes in peptide-free conditions. This suggests that the addition of magainin to the 
membrane increases membrane mechanical properties, resulting in reduced membrane failure during 
the timecourse of the experiment. It is suggested that the association of membrane-bound magainin 
helices with the conical lipid DOPE both reduces the σL and σG induced by the peptide, but also removes 
DOPE from the bulk membrane, resulting in decreased tension. A similar phenomenon has been 
reported to occur for detergents, where low volumes of detergent was found to stabilise the 
membrane.[62] 
 
6.19.2. Bursting 
Of the two active membrane systems, only the DOPE:DOPE:DPPG displays any bursting behaviour, 
with 12.7 % of total activity resulting in bursting events. The lipid-magainin raft will be primarily 
enriched with DPPG, through forced electrostatic interactions, resulting in high σL and σG induction. The 
raft will also become enriched with DOPE through secondary lipid interactions, acting to reduce the σL 
and σG of the system. The DOPE present within the bulk membrane results in a higher starting 
membrane tension, narrowing the “energy gap” that magainin operates in; i.e. the energy difference 
between the starting membrane tension, and the critical failure energy of the membrane. The 
DOPC:DPPC:DPPG system has a lower starting membrane tension of the DOPE containing system, but 
lacks the σL and σG reducing effect of DOPE within the lipid-magainin raft, and demonstrates zero 
bursting activity. With the lower starting membrane tension, the system possesses a larger energy gap, 
giving more time for magainin to bind to the membrane, accumulate lipids and form active raft 
assemblies. It is clear that the presence of the non-bilayer DOPE rather than DPPC in the bulk membrane 
induces bursting, indicating that it is easier for raft assemblies to achieve the critical failure energy in 
DOPC:DOPE:DPPG membranes, without activating other PIEs. 
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6.19.3. Pore-mediate leakage 
The two active lipid-magainin systems DOPC:DOPE:DPPG and DOPC:DPPC:DPPG produced high 
levels of pore-mediated leaking, with 53.9 and 74.1 % of the total PIEs produced being pore-mediated 
leakage events respectively. The controlling factor is the forced electrostatic enrichment with the 
positive curvature lipid DPPG, resulting in a lower ϒ which favours pore formation, with the 
DOPC:DPPC:DPPG system displays the highest level of PIEs as pore-mediated leakage events for any 
lipid-AMP system tested. The lack of DOPE in this system lowers the initial membrane tension reducing 
the overall activity compared to the DOPE containing membrane, but the presence of the positive 
curvature DPPC lipid enables more efficient packing within the leaflet fold structure. Combined with the 
higher energy raft assemblies formed through steric interactions between DPPC and the F residues of 
magainin, this leads to the high level of pore-formation. The DOPE containing system returns the fastest 
average time to leakage initiation of any membrane-peptide system tested, resulting in a fascinating 
situation, where one of the two active systems returns the highest levels of pore-mediates leakage and 
the other returns the fastest initiation of leaks.  
This can be explained by consideration of the effect of the lipid composition on the terms contained 
within equation 6. The DPPC containing membrane has a high proportion (40 mol%) of inverse-conical 
geometry, positively curvature inducing lipids, which together with the curvature stabilisation of the 
three F residues of magainin, results in a very low leaflet fold energy, and greatly reduces the pore 
energy. The DOPE containing membrane has higher ϒ, resulting in lower pore formation, but a higher 
initial membrane tension due to the presence of the non-bilayer lipid DOPE. This results in faster 
initiation of pore-mediated leakage events, indicating that the membrane strain induced by non-bilayer 
lipids can play an important part in pore formation by magainin. Non-bilayer lipids that reside near a 
pre-pore region may contribute their strain energy towards pore formation, playing a role in the peptide 
selectivity mechanism, as eukaryotic membranes lack non-bilayer components. Within the active 
magainin membranes the LCAMP melittin displays 54.7 and 52.1 % pore-mediated leakage activity, with 
magainin producing higher levels of pore activity despite being less active overall, thus confirming 
prediction number two of the new model. 
 
6.19.4. Carpet mechanism 
The two active systems produce similar amounts of carpet mechanism events, demonstrating 23.1 
and 18.5 % of total PIEs respectively. It is likely then that the carpet mechanism is controlled via the 
association of the positive curvature magainin with the positive curvature lipid DPPG, with its large 
headgroup and low volume acyl chains. Magainin demonstrates the opposite curvature preference from 
the negative curvature melittin, indicating that carpet mechanism is induced via the aggregation of 
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excess curvature strain within the membrane. This fits with the generation of micelles, which are high 
curvature structures. 
 
6.19.5. Micellisation 
Magainin demonstrates no significant levels of micellisation within any membrane system, with 
only the DOPC:DPPC:DPPG system displaying any micelle activity. 
 
6.20. Mammalian biomimetic membranes and LCAMPs 
Similar dissection of the likely ϒ, σL and σG values of magainin and melittin within the mGUV 
membranes, allows assessment of the influence of lipid topography on peptide selectivity, for bacterial 
versus mammalian membranes. The PIE-profiles produced by the mGUV membrane system after 
exposure to the peptides, at concentrations of 1 and 5 µM, are presented in figure 6.17. 
 
Figure 6.17: PIE-profiles for the mammalian biomimetic membrane systems, produced by exposure to the LCAMPs magainin 
(mag) and melittin (mel), at concentrations of 1 and 5 µM. The individual PIEs are colour coded according to the diagram key. 
The selective magainin is significantly less active in mGUV systems compared to melittin, and both peptides produce consistent 
profiles across the two different peptide concentrations. 
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6.20.1. Melittin and mGUV membranes 
Melittin inserts its helix deeper into the membrane than magainin, resulting in greater increases in 
σL and σG per membrane-bound monomer, and therefore greater activity. The high levels of both pore-
mediated and carpet mechanism within the PIE-profiles indicate that the lipid-melittin raft can both 
contain positive curvature lipids, capable of supporting the curvature of the leaflet fold, and negative 
curvature lipids to generate the carpet mechanism. The mGUV membrane is comprised of 
DOPC:DPPC:cholesterol (35:35:30 mol%), all zwitterionic lipids, and the membrane-bound melittin 
helices are free to locate to a local energy minima, without forced electrostatic interactions. Melittin 
helices can be expected to preferentially associate with the lipid DPPC, due to its lower hydrophobic 
volume compared to DOPC. This association lowers the σL and σG energies, but decreases ϒ, as the 
positively curved DPPC associated with the peptide helix has been shown to initiate pore formation. 
Melittins PIE-profile displays a high level of pore formation at both the 1 and 5 µM concentrations of 
melittin, producing 38.0 and 41.8 % of PIEs as pore-mediated leakage events respectively.  
The lipid-melittin raft may also be enriched with cholesterol, through π-electron interactions 
between melittins tryptophan residue and cholesterol. This will bring a strongly negatively curved 
membrane component into contact with the negative curvature inducing melittin, increasing σL and σG 
values. Melittin only contains one W residue compared to the three F residues of magainin, and thus the 
increase in ϒ should be much greater for the selective magainin, and PIE activity more strongly 
disfavoured. Although interactions with DOPC will be disfavoured within lipid-melittin rafts, the 
potential for large σL energies exist, as 9Z mono-unsaturated acyl chains have been shown to induce 
PIEs, as previously discussed. As the exact PIE produced likely depends in a stochastic manner on the 
presence of specific raft assemblies within the membrane, it is possible to suggest potential lipid-
melittin interactions which could result in the production of high levels of both pore-mediated leakage 
and carpet mechanism events. Lipid-melittin rafts enriched with DPPC will be lower energy, and thus 
more common, than those enriched with DOPC and cholesterol. The lower σL energy means that, 
although pore formation will be favoured by the lipid content of the raft, it will require more melittin 
monomers within a raft assembly to accumulate enough local energy to generate a pore event. The 
DOPC:cholesterol enriched raft is less common within the raft population, but the significantly higher σL 
will result in fewer monomers being required to initiate a PIE. It is likely that cholesterol present in the 
bulk membrane aggregates with membrane-bound LCAMPs, as it has been shown that cholesterol in 
non-raft containing systems affects peptide activity, but has no effect when the cholesterol is 
sequestered within lO lipid rafts.
[92]  
 
Lipid shape and lytic peptides Page 187 
 
6.20.2. Magainin and mGUV membranes 
The expected lipid interactions for magainin interacting within mGUV membranes are very different 
to those expected for melittin. Magainin helices can be expected to form dynamic lipid-AMP rafts 
enriched with DOPC, whose high volume hydrophobic tails can counter the positive curvature induction 
of the shallowly-inserted peptide. This lowers σL and σG energies but increases ϒ, resulting in low 
peptide activity with strongly disfavoured pore-formation. The presence of three F residues enriches the 
raft with the negative curvature cholesterol lipid, again lowering the σL and σG energies but increasing ϒ. 
In contrast to melittin, whose preferential lipid aggregations favour pore formation, the formation of 
magainin-induced pores within mGUV membranes is strongly disfavoured due to lack of association with 
positive curvature lipids. Within anionic bacterial systems, the presence of positive curvature lipids can 
be forced through electrostatic interactions, causing high magainin activity in systems containing the 
positively curved anionic lipid DPPG. 
 
6.21. Application to in-vivo membranes 
Bacterial strains have membrane lipid compositions that are somewhat characteristic for the 
individual strains, for example E.coli typical displays a membrane composition of 80 and 20 % of the 
lipids PE and PG respectively.[53] However the membrane compositions of different strains can vary 
widely, with the complete set of in-vivo bacterial membranes encompassing a large heterogeneous 
population of lipids, with variations in lipid topography, fatty acid unsaturation and headgroups, unlike 
the tightly controlled composition of artificial biomimetic membrane systems.[13] The possible set of lipid 
interactions surrounding a membrane-bound LCAMP helix is therefore much broader, and the complex 
influence of lipid topography on LCAMP activity would be hard to decipher in-vivo, making the utilisation 
of artificial biomimetic membrane platforms necessary. The in-vivo bacterial plasma membrane is 
extremely fluid in composition, responding to changes in the environment like temperature and 
available fatty acids.[52][53][54] The membrane responds to changes in environment through changes in the 
headgroup composition and fatty acid length and unsaturation of the membrane, although the average 
packing parameter is maintained within a narrow range,[54] close to the lamellar to non-lamellar phase 
transition boundary.  
Such energetically taxing manipulation of membrane composition, in order to maintain the 
membrane close to the phase boundary, indicates that membrane packing plays an important biological 
role in cell function.[55] It can also explain why bacteria struggle to acquire resistance to LCAMPs, which 
exploit the close positioning of bacterial membranes to the lamellar to non-lamellar phase boundary to 
easily induce pore formation, compared to mammalian membranes which generally operate further 
from the boundary. The variation in lipid topography between different bacterial strains, combined with 
Lipid shape and lytic peptides Page 188 
 
the activity of LCAMPs reported in this thesis, suggests that the peptides will possess significantly 
different MICs within differing strains, and this is indeed the case.[62][68][148] This opens up the possibility 
of tailored antimicrobial peptides for individual bacterial strains, where the amino acid sequence of the 
peptide can be tailored to adjust the membrane penetration and lipid-peptide interactions, in order to 
achieve the highest σG and σL and lowest ϒ possible within that strains membrane. It is likely that the 
selective LCAMPs like magainin represent compromise sequences, evolutionarily designed to exert 
broadband antimicrobial activity without being optimised for individual bacterial strains, leaving room 
for guided improvement. 
 
6.22. Application to the literature 
The model proposed in this work can be used to answer several contentious points within the 
literature, including the proposed intracellular targets reported for some LCAMPs and the biphasic 
nature of the leakage induced by the peptides. The differences between the graded and all-or-none 
responses contained within the literature can also be explained by the application of the new model. 
 
6.22.1. Intracellular target mechanism 
Several intracellular targets for LCAMPs have been reported, but can be explained by consideration 
of the effects of LCAMP binding on the target membrane, which induce changes to the membranes 
mechanical properties and lipid packing. Coupled to the bacterial cells membrane homeostatic 
responses, which attempt to maintain its preferred membrane packing state, these changes can initiate 
“false-flag” cellular responses, designed to combat similar changes occurring during normal cellular 
processes. For example, treatment of bacteria with the LCAMP melittin activates both phospholipases 
and autolysins.[63] Phospholipases cleave acyl chains from lipids, resulting in a dramatic change in the 
topography of the target lipid, and reducing its packing parameter and hydrophobic volume. Deep 
penetrating peptide helices like melittin which occupy significant hydrophobic volume and increases the 
lateral pressure in the membrane core, could easily induce phospholipase activation as part of a 
bacterial homeostasis response. Autolysins are enzymes which break down peptidoglycan in bacteria, in 
order for cellular growth or division to occur, processes that are accompanied by changes in the 
membranes mechanical properties.[149] Again the increase in lateral pressure and membrane thinning 
that occur during LCAMP binding could lead to accidental activation of a normal cellular process, in this 
case activation of the autolysin pathway. Disruption of membrane domains by binding LCAMPs and the 
modulation of membrane lateral pressure that follows, could also lead to the appearance of pseudo–
intracellular targets by activating/deactivating membrane proteins, leading to downstream effects. 
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6.22.2. Biphasic leakage 
The biphasic leakage reported for LCAMP-induced leakage, with both slow and fast 
components,[58][77] can be explained via two potential mechanisms. The two leakage rates could be the 
result of different leakage modes of the pore-mediated leakage induced by the peptides, or more likely, 
due to the carpet mechanism producing the fast phase and the pore-mediated leakage events producing 
the slow phase of the leakage. This scenario is considered more likely due to the work of Degrado and 
colleagues, which linked the fast phase of the leakage from human erythrocytes, to a rapid decrease in 
cell numbers.[77] This associates the fast leakage phase with the carpet mechanism, which invariably 
ends with the destruction of the vesicle within the in-vivo experiments contained within this thesis. 
 
6.22.3. Graded versus all-or-none leakage 
A conflicting picture of the pore-mediated leakage mechanism induced by LCMAPs from lipid 
vesicles emerges, with reports of graded[95] all-or-none leakage[96][97] behaviour, even from papers 
produced by the same laboratories under different experimental conditions.[98][99] The difference 
between graded leakage, where the entire population of vesicles display steady dye efflux, and all-or-
none leakage, where the population will be split into those vesicles which have completely lost their 
contents and those which retain membrane integrity, can be explained by taking into consideration the 
new model and the microfluidic based experimental protocols. Within conventional dye-leakage 
experiments, an amount of peptide is introduced into a sample containing SUV or LUV vesicles, to 
achieve the desired bulk LCAMP concentration and leakage measured as the averaged leakage from a 
large vesicle population. Uncertainties in both the exact amount of lamellar lipids within the sample, 
and the amount of peptide bound to each vesicle, introduce sample treatment issues into the 
experimental analysis. Coupled to the large variation in initiation times for pore-mediated leakage, this 
could easily result in the interpretation of experimental data as an all-or-none mechanism, when in fact 
the different leakage kinetics result from the heterogeneous population of lipid-LCAMP systems present. 
With the added complicating factor of differing leakage kinetics induced by the same peptide within 
identical membrane systems, it is easy to imagine how a confusing picture of the leakage behaviour of 
AMPs has emerged. The work of Wheaten and colleagues, which seeks to determine the answer to the 
graded and all-or-none question, seems to confirm this assessment.[150] Using acute exposure of GUVs to 
AMPs, they find both the large variation in initiation times for leaks (> 10 min) and significant differences 
in the kinetics for both the graded and all-or-none leakage mechanisms. The tighter control exerted over 
peptide exposure within the microfluidic device reduces uncertainty in the experimental conditions, and 
coupled to the high-throughput nature of the data collection, allows increased confidence in the results 
compared to traditional dye-leakage experiments. 
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